<!DOCTYPE html><html  lang="en" data-capo=""><head><meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Frontiers | The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation</title>
<link rel="stylesheet" href="/ap-2024/_nuxt/entry.CWBB-NGm.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/vue-core.B-WA3Vg5.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/explainer.CMppEa5M.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleDetails.B93eTAmx.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleLayoutHeader.CKWUz2Al.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/AnnouncementCard.Db7nmstV.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/FloatingButtons.xuP8gC33.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleEvent.D0PaxIW7.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/SimilarArticles.BMee4Fk4.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleTemplateBanner.CXmOJ7NH.css">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/v1IBIWh4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B674Mi_H.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BXedFy5e.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eQMj-Fph.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Y8NTh2i4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUyL5Z_3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/m8mdd2tc.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHv8pTSw.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BHPWSuhB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/x5HZk7Le.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CNJXQ6ZR.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dss5ciUI.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Do5q9QoL.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BhVAcJSK.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/y69VltF1.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Bw-bWKkJ.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/sQBxgu5L.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/D5YKKJGW.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CSLdjdGS.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUN89Jk2.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CCeQzihV.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DVDwh0-U.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dw4ta0fP.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CYv-CzHi.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/U-mJlaMn.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/NhyIC1F3.js">
<link rel="prefetch" as="style" crossorigin href="/ap-2024/_nuxt/ArticleHubLayout.q6CU8_bN.css">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/CKQJuUlk.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/D3plh7Cs.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/GWtHKqLR.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/DS3EY-DL.js">
<meta name="theme-color" content="#0C4DED">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<script type="text/javascript" data-hid="4cd079c">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"586843029","agentToken":null,"applicationTime":3.874358,"transactionName":"MQcDMkECCkNSW0YMWghNLwlBDgVcWkJXAWAUC04MXBYWXlJUQUpYCQ4EBUYPBUIeVlcQRwkRAg9WDQdVHFlAEVwFDgQVHElLVl1VXQkbVFJTVB1SVAUDDAVXGgAXDQo=","queueTime":0,"ttGuid":"dc6f6f8f6497484f"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},feature_flags:["soft_nav"],distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594460232",accountID:"230385",trustKey:"230385",xpid:"VgUHUl5WGwYIUllWBAEFXw==",licenseKey:"598a124f17",applicationID:"586843029",browserID:"594460232"};;/*! For license information please see nr-loader-spa-1.303.0.min.js.LICENSE.txt */
(()=>{var e,t,r={384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>s,US:()=>d,Zm:()=>a,bQ:()=>u,dV:()=>c,pV:()=>l});var n=r(6154),i=r(1863),o=r(1910);const s={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function c(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate||n.gm.setInterval,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket},(0,o.i)(...Object.values(e.o))),e}function u(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:s.beacon,errorBeacon:s.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),c(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>d,K7:()=>c,P3:()=>u,XX:()=>i,Yy:()=>a,df:()=>o,qY:()=>n,v4:()=>s});const n="events",i="jserrors",o="browser/blobs",s="rum",a="browser/logs",c={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},u={[c.pageViewEvent]:1,[c.pageViewTiming]:2,[c.metrics]:3,[c.jserrors]:4,[c.spa]:5,[c.ajax]:6,[c.sessionTrace]:7,[c.softNav]:8,[c.sessionReplay]:9,[c.logging]:10,[c.genericEvents]:11},d={[c.pageViewEvent]:s,[c.pageViewTiming]:n,[c.ajax]:n,[c.spa]:n,[c.softNav]:n,[c.metrics]:i,[c.jserrors]:i,[c.sessionTrace]:o,[c.sessionReplay]:o,[c.logging]:a,[c.genericEvents]:"ins"}},944:(e,t,r)=>{"use strict";r.d(t,{R:()=>i});var n=r(3241);function i(e,t){"function"==typeof console.debug&&(console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t),(0,n.W)({agentIdentifier:null,drained:null,type:"data",name:"warn",feature:"warn",data:{code:e,secondary:t}}))}},993:(e,t,r)=>{"use strict";r.d(t,{A$:()=>o,ET:()=>s,TZ:()=>a,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o={OFF:0,ERROR:1,WARN:2,INFO:3,DEBUG:4,TRACE:5},s="log",a=n.K7.logging},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>u,Ze:()=>f,x3:()=>d});var n=r(3241),i=r(7836),o=r(3606),s=r(860),a=r(2646);const c={};function u(e,t){const r={staged:!1,priority:s.P3[t]||0};l(e),c[e].get(t)||c[e].set(t,r)}function d(e,t){e&&c[e]&&(c[e].get(t)&&c[e].delete(t),p(e,t,!1),c[e].size&&h(e))}function l(e){if(!e)throw new Error("agentIdentifier required");c[e]||(c[e]=new Map)}function f(e="",t="feature",r=!1){if(l(e),!e||!c[e].get(t)||r)return p(e,t);c[e].get(t).staged=!0,h(e)}function h(e){const t=Array.from(c[e]);t.every(([e,t])=>t.staged)&&(t.sort((e,t)=>e[1].priority-t[1].priority),t.forEach(([t])=>{c[e].delete(t),p(e,t)}))}function p(e,t,r=!0){const s=e?i.ee.get(e):i.ee,c=o.i.handlers;if(!s.aborted&&s.backlog&&c){if((0,n.W)({agentIdentifier:e,type:"lifecycle",name:"drain",feature:t}),r){const e=s.backlog[t],r=c[t];if(r){for(let t=0;e&&t<e.length;++t)g(e[t],r);Object.entries(r).forEach(([e,t])=>{Object.values(t||{}).forEach(t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])})})}}s.isolatedBacklog||delete c[t],s.backlog[t]=null,s.emit("drain-"+t,[])}}function g(e,t){var r=e[1];Object.values(t[r]||{}).forEach(t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}})}},1741:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(944),i=r(4261);class o{#e(e,...t){if(this[e]!==o.prototype[e])return this[e](...t);(0,n.R)(35,e)}addPageAction(e,t){return this.#e(i.hG,e,t)}register(e){return this.#e(i.eY,e)}recordCustomEvent(e,t){return this.#e(i.fF,e,t)}setPageViewName(e,t){return this.#e(i.Fw,e,t)}setCustomAttribute(e,t,r){return this.#e(i.cD,e,t,r)}noticeError(e,t){return this.#e(i.o5,e,t)}setUserId(e){return this.#e(i.Dl,e)}setApplicationVersion(e){return this.#e(i.nb,e)}setErrorHandler(e){return this.#e(i.bt,e)}addRelease(e,t){return this.#e(i.k6,e,t)}log(e,t){return this.#e(i.$9,e,t)}start(){return this.#e(i.d3)}finished(e){return this.#e(i.BL,e)}recordReplay(){return this.#e(i.CH)}pauseReplay(){return this.#e(i.Tb)}addToTrace(e){return this.#e(i.U2,e)}setCurrentRouteName(e){return this.#e(i.PA,e)}interaction(e){return this.#e(i.dT,e)}wrapLogger(e,t,r){return this.#e(i.Wb,e,t,r)}measure(e,t){return this.#e(i.V1,e,t)}consent(e){return this.#e(i.Pv,e)}}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},1910:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(944);const i=new Map;function o(...e){return e.every(e=>{if(i.has(e))return i.get(e);const t="function"==typeof e&&e.toString().includes("[native code]");return t||(0,n.R)(64,e?.name||e?.toString()),i.set(e,t),t})}},2555:(e,t,r)=>{"use strict";r.d(t,{D:()=>a,f:()=>s});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0};function s(e){try{return!!e.licenseKey&&!!e.errorBeacon&&!!e.applicationID}catch(e){return!1}}const a=e=>(0,i.a)(e,o)},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>s,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>a,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,s=18e5,a={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)},r,i)}},3241:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(6154);const i="newrelic";function o(e={}){try{n.gm.dispatchEvent(new CustomEvent(i,{detail:e}))}catch(e){}}},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>d,TZ:()=>n,Xh:()=>c,Zp:()=>i,kd:()=>u,mq:()=>a,nf:()=>s,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],s=4,a=1e3,c=2e3,u=["PageAction","UserAction","BrowserPerformance"],d={RESOURCES:"experimental.resources",REGISTER:"register"}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>u});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W),s=50;var a=Object.prototype.hasOwnProperty,c=!1;function u(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const s="-"===n.charAt(0);for(let a=0;a<t.length;a++){const c=t[a],u=e[c];l(u)||(e[c]=r(u,s?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,c,u){return l(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach(function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})}),t}catch(e){d([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,l,f;let h;try{a=this,o=[...arguments],l="function"==typeof n?n(o,a):n||{}}catch(t){d([t,"",[o,a,c],l],e)}i(r+"start",[o,a,c],l,u);const p=performance.now();let g;try{return f=t.apply(a,o),g=performance.now(),f}catch(e){throw g=performance.now(),i(r+"err",[o,a,e],l,u),h=e,h}finally{const e=g-p,t={start:p,end:g,duration:e,isLongTask:e>=s,methodName:c,thrownError:h};t.isLongTask&&i("long-task",[t,a],l,u),i(r+"end",[o,a,f],l,u)}}}function i(r,n,i,o){if(!c||t){var s=c;c=!0;try{e.emit(r,n,i,t,o)}catch(t){d([t,r,n,i],e)}c=s}}}function d(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function l(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=s;var i=o.handlers={};function o(e,t,r,o){s(o||n.d,i,e,t,r)}function s(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var s=t[o]=t[o]||{};(s[r]=s[r]||[]).push([e,i])}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>a,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>s,jx:()=>l,sl:()=>f,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",s="-start",a="-end",c="fn"+s,u="fn"+a,d="pushState",l=1e3,f=3e4},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),s=r(8154),a=r(993);function c(e,t,r={},c=a.p_.INFO,u,d=(0,i.t)()){(0,n.p)(s.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(a.ET,[d,t,r,c,u],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(a.p_).some(t=>t===e.toUpperCase().trim())}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>s,O2:()=>l,OV:()=>o,Qu:()=>f,TZ:()=>c,ih:()=>h,pP:()=>a,t1:()=>d,tC:()=>i,wD:()=>u});var n=r(860);const i=["click","keydown","submit"],o="popstate",s="api",a="initialPageLoad",c=n.K7.softNav,u=5e3,d=500,l={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},f={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},h={IP:"in progress",PF:"pending finish",FIN:"finished",CAN:"cancelled"}},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},4261:(e,t,r)=>{"use strict";r.d(t,{$9:()=>d,BL:()=>c,CH:()=>p,Dl:()=>R,Fw:()=>w,PA:()=>v,Pl:()=>n,Pv:()=>A,Tb:()=>f,U2:()=>s,V1:()=>E,Wb:()=>T,bt:()=>y,cD:()=>b,d3:()=>x,dT:()=>u,eY:()=>g,fF:()=>h,hG:()=>o,hw:()=>i,k6:()=>a,nb:()=>m,o5:()=>l});const n="api-",i=n+"ixn-",o="addPageAction",s="addToTrace",a="addRelease",c="finished",u="interaction",d="log",l="noticeError",f="pauseReplay",h="recordCustomEvent",p="recordReplay",g="register",m="setApplicationVersion",v="setCurrentRouteName",b="setCustomAttribute",y="setErrorHandler",w="setPageViewName",R="setUserId",x="start",T="wrapLogger",E="measure",A="consent"},4387:(e,t,r)=>{"use strict";function n(e={}){return!(!e.id||!e.name)}function i(e){return"string"==typeof e&&e.trim().length<501||"number"==typeof e}function o(e,t){if(2!==t?.harvestEndpointVersion)return{};const r=t.agentRef.runtime.appMetadata.agents[0].entityGuid;return n(e)?{"mfe.id":e.id,"mfe.name":e.name,eventSource:e.eventSource,"parent.id":e.parent?.id||r}:{"entity.guid":r,appId:t.agentRef.info.applicationID}}r.d(t,{Ux:()=>o,c7:()=>n,yo:()=>i})},5205:(e,t,r)=>{"use strict";r.d(t,{j:()=>_});var n=r(384),i=r(1741);var o=r(2555),s=r(3333);const a=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var c=r(2614),u=r(944),d=r(8122);const l="[data-nr-mask]",f=e=>(0,d.a)(e,(()=>{const e={feature_flags:[],experimental:{allow_registered_children:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},api:{get allow_registered_children(){return e.feature_flags.includes(s.$v.REGISTER)||e.experimental.allow_registered_children},set allow_registered_children(t){e.experimental.allow_registered_children=t},duplicate_registered_data:!1},browser_consent_mode:{enabled:!1},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1,capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(s.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:c.wk,inactiveMs:c.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){a(t)?e.mask_selector="".concat(t,",").concat(l):""===t||null===t?e.mask_selector=l:(0,u.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){a(t)?e.block_selector+=",".concat(t):""!==t&&(0,u.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,u.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}})());var h=r(6154),p=r(9324);let g=0;const m={buildEnv:p.F3,distMethod:p.Xs,version:p.xv,originTime:h.WN},v={consented:!1},b={appMetadata:{},get consented(){return this.session?.state?.consent||v.consented},set consented(e){v.consented=e},customTransaction:void 0,denyList:void 0,disabled:!1,harvester:void 0,isolatedBacklog:!1,isRecording:!1,loaderType:void 0,maxBytes:3e4,obfuscator:void 0,onerror:void 0,ptid:void 0,releaseIds:{},session:void 0,timeKeeper:void 0,registeredEntities:[],jsAttributesMetadata:{bytes:0},get harvestCount(){return++g}},y=e=>{const t=(0,d.a)(e,b),r=Object.keys(m).reduce((e,t)=>(e[t]={value:m[t],writable:!1,configurable:!0,enumerable:!0},e),{});return Object.defineProperties(t,r)};var w=r(5701);const R=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};var x=r(7836),T=r(3241);const E={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},A=e=>(0,d.a)(e,E),S=new Set;function _(e,t={},r,s){let{init:a,info:c,loader_config:u,runtime:d={},exposed:l=!0}=t;if(!c){const e=(0,n.pV)();a=e.init,c=e.info,u=e.loader_config}e.init=f(a||{}),e.loader_config=A(u||{}),c.jsAttributes??={},h.bv&&(c.jsAttributes.isWorker=!0),e.info=(0,o.D)(c);const p=e.init,g=[c.beacon,c.errorBeacon];S.has(e.agentIdentifier)||(p.proxy.assets&&(R(p.proxy.assets),g.push(p.proxy.assets)),p.proxy.beacon&&g.push(p.proxy.beacon),e.beacons=[...g],function(e){const t=(0,n.pV)();Object.getOwnPropertyNames(i.W.prototype).forEach(r=>{const n=i.W.prototype[r];if("function"!=typeof n||"constructor"===n)return;let o=t[r];e[r]&&!1!==e.exposed&&"micro-agent"!==e.runtime?.loaderType&&(t[r]=(...t)=>{const n=e[r](...t);return o?o(...t):n})})}(e),(0,n.US)("activatedFeatures",w.B),e.runSoftNavOverSpa&&=!0===p.soft_navigations.enabled&&p.feature_flags.includes("soft_nav")),d.denyList=[...p.ajax.deny_list||[],...p.ajax.block_internal?g:[]],d.ptid=e.agentIdentifier,d.loaderType=r,e.runtime=y(d),S.has(e.agentIdentifier)||(e.ee=x.ee.get(e.agentIdentifier),e.exposed=l,(0,T.W)({agentIdentifier:e.agentIdentifier,drained:!!w.B?.[e.agentIdentifier],type:"lifecycle",name:"initialize",feature:void 0,data:e.config})),S.add(e.agentIdentifier)}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>s,SR:()=>o,rF:()=>a});var n=r(384),i=r(7767);function o(e){return!!(0,n.dV)().o.MO&&(0,i.V)(e)&&!0===e?.session_trace.enabled}function s(e){return!0===e?.session_replay.preload&&o(e)}function a(e,t){try{if("string"==typeof t?.type){if("password"===t.type.toLowerCase())return"*".repeat(e?.length||0);if(void 0!==t?.dataset?.nrUnmask||t?.classList?.contains("nr-unmask"))return e}}catch(e){}return"string"==typeof e?e.replace(/[\S]/g,"*"):"*".repeat(e?.length||0)}},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,Qr:()=>a,sB:()=>s});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function s(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}function a(e){if(i())return e();(0,n.sp)("popstate",e)}},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},5701:(e,t,r)=>{"use strict";r.d(t,{B:()=>o,t:()=>s});var n=r(3241);const i=new Set,o={};function s(e,t){const r=t.agentIdentifier;o[r]??={},e&&"object"==typeof e&&(i.has(r)||(t.ee.emit("rumresp",[e]),o[r]=e,i.add(r),(0,n.W)({agentIdentifier:r,loaded:!0,drained:!0,type:"lifecycle",name:"load",feature:void 0,data:e})))}},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>a,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>s,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),s=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a="complete"===s?.document?.readyState,c=Boolean("hidden"===s?.document?.visibilityState),u=""+s?.location,d=/iPad|iPhone|iPod/.test(s.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=s.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,Qb:()=>l,TZ:()=>i,Ug:()=>s,Vh:()=>o,_s:()=>a,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o="errorDuringReplay",s=.12,a={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api",RESUME:"resume",SWITCH_TO_FULL:"switchToFull",INITIALIZE:"initialize",PRELOAD:"preload"}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout(()=>{i=clearTimeout(i)},t)),n||(clearTimeout(i),i=setTimeout(()=>{e.apply(this,r)},t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>s,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(a(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function s(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,s;i>0?(o=r.substring(0,i),s=r.substring(i)):(o=r,s="");let[a]=o.split(":");n.push({hostname:a,pathname:s})}}function a(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>E,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>a,wW:()=>T,xq:()=>s});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],s=999,a="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",T="cb"+R,E="jsTime",A="fetch"},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},7699:(e,t,r)=>{"use strict";r.d(t,{It:()=>o,KC:()=>a,No:()=>i,qh:()=>s});var n=r(860);const i=16e3,o=1e6,s="SESSION_ERROR",a={[n.K7.logging]:!0,[n.K7.genericEvents]:!1,[n.K7.jserrors]:!1,[n.K7.ajax]:!1}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>i});var n=r(6154);const i=e=>n.RI&&!0===e?.privacy.cookies_enabled},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>a,ee:()=>c});var n=r(384),i=r(8990),o=r(2646),s=r(5607);const a="nr@context:".concat(s.W),c=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&u.initializedAgents?.[r]?.runtime.isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(c.aborted&&!i)return;t&&o&&t.emit(e,r,n);var a=h(n);g(e).forEach(e=>{e.apply(a,r)});var u=v()[s[e]];u&&u.push([f,e,r,a]);return a},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach(([e,n])=>{s[n]=t,t in r||(r[t]=[])})},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach(e=>{delete f.backlog[e]})},isBuffering:function(e){return!!v()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof o.y?e:e?(0,i.I)(e,a,()=>new o.y(a)):new o.y(a)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),u=(0,n.Zm)();u.ee||(u.ee=c)},8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let s in o)if(void 0!==e[s])try{if(null===e[s]){r[s]=null;continue}Array.isArray(e[s])&&Array.isArray(t[s])?r[s]=Array.from(new Set([...e[s],...t[s]])):"object"==typeof e[s]&&"object"==typeof t[s]?r[s]=i(e[s],t[s]):r[s]=e[s]}catch(e){r[s]||(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),s=r(6154);const a={},c=s.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(a[t.debugId]++)return t;a[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(s.RI&&h(document,f),c&&h(c.prototype,f),h(s.gm,f)),t.on(u+"-start",function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)&&"newrelic"!==e[0]){var i=(0,o.I)(n,l,function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=e[1]=i}}),t.on(d+"-start",function(e){e[1]=this.wrapped||e[1]}),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},8154:(e,t,r)=>{"use strict";r.d(t,{z_:()=>o,XG:()=>a,TZ:()=>n,rs:()=>i,xV:()=>s});r(6154),r(9566),r(384);const n=r(860).K7.metrics,i="sm",o="cm",s="storeSupportabilityMetrics",a="storeEventMetrics"},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},9324:(e,t,r)=>{"use strict";r.d(t,{AJ:()=>s,F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.303.0",i="PROD",o="CDN",s="@newrelic/rrweb",a="1.0.1"},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>a,ZF:()=>c,bz:()=>s,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function s(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map(e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e).join("")}function a(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const s=[];for(var a=0;a<e;a++)s.push(o(r,i++).toString(16));return s.join("")}function c(){return a(16)}function u(){return a(32)}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce((t,r)=>(i.f[r](e,t),t),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.303.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.303.0.PROD:",i.l=(r,n,o,s)=>{if(e[r])e[r].push(n);else{var a,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){a=l;break}}if(!a){c=!0;var f={478:"sha512-Q1pLqcoiNmLHv0rtq3wFkJBA3kofBdRJl0ExDl0mTuAoCBd0qe/1J0XWrDlQKuNlUryL6aZfVkAMPLmoikWIoQ==",249:"sha512-695ZzudsxlMtHKnpDNvkMlJd3tdMtY03IQKVCw9SX12tjUC+f7Nrx5tnWO72Vg9RFf6DSY6wVmM3cEkRM12kkQ==",212:"sha512-18Gx1wIBsppcn0AnKFhwgw4IciNgFxiw3J74W393Ape+wtg4hlg7t6SBKsIE/Dk/tfl2yltgcgBFvYRs283AFg=="};(a=document.createElement("script")).charset="utf-8",i.nc&&a.setAttribute("nonce",i.nc),a.setAttribute("data-webpack",t+o),a.src=r,0!==a.src.indexOf(window.location.origin+"/")&&(a.crossOrigin="anonymous"),f[s]&&(a.integrity=f[s])}e[r]=[n];var h=(t,n)=>{a.onerror=a.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],a.parentNode&&a.parentNode.removeChild(a),i&&i.forEach(e=>e(n)),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:a}),12e4);a.onerror=h.bind(null,a.onerror),a.onload=h.bind(null,a.onload),c&&document.head.appendChild(a)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise((r,i)=>n=e[t]=[r,i]);r.push(n[2]=o);var s=i.p+i.u(t),a=new Error;i.l(s,r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),s=r&&r.target&&r.target.src;a.message="Loading chunk "+t+" failed.\n("+o+": "+s+")",a.name="ChunkLoadError",a.type=o,a.request=s,n[1](a)}},"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[s,a,c]=r,u=0;if(s.some(t=>0!==e[t])){for(n in a)i.o(a,n)&&(i.m[n]=a[n]);if(c)c(i)}for(t&&t(r);u<s.length;u++)o=s[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.303.0.PROD"]=self["webpackChunk:NRBA-1.303.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(9566),t=i(1741);class r extends t.W{agentIdentifier=(0,e.LA)(16)}var n=i(860);const o=Object.values(n.K7);var s=i(5205);var a=i(9908),c=i(1863),u=i(4261),d=i(3241),l=i(944),f=i(5701),h=i(8154);function p(e,t,i,o){const s=o||i;!s||s[e]&&s[e]!==r.prototype[e]||(s[e]=function(){(0,a.p)(h.xV,["API/"+e+"/called"],void 0,n.K7.metrics,i.ee),(0,d.W)({agentIdentifier:i.agentIdentifier,drained:!!f.B?.[i.agentIdentifier],type:"data",name:"api",feature:u.Pl+e,data:{}});try{return t.apply(this,arguments)}catch(e){(0,l.R)(23,e)}})}function g(e,t,r,n,i){const o=e.info;null===r?delete o.jsAttributes[t]:o.jsAttributes[t]=r,(i||null===r)&&(0,a.p)(u.Pl+n,[(0,c.t)(),t,r],void 0,"session",e.ee)}var m=i(1687),v=i(4234),b=i(5289),y=i(6154),w=i(5270),R=i(7767),x=i(6389),T=i(7699);class E extends v.W{constructor(e,t){super(e.agentIdentifier,t),this.agentRef=e,this.abortHandler=void 0,this.featAggregate=void 0,this.loadedSuccessfully=void 0,this.onAggregateImported=new Promise(e=>{this.loadedSuccessfully=e}),this.deferred=Promise.resolve(),!1===e.init[this.featureName].autoStart?this.deferred=new Promise((t,r)=>{this.ee.on("manual-start-all",(0,x.J)(()=>{(0,m.Ak)(e.agentIdentifier,this.featureName),t()}))}):(0,m.Ak)(e.agentIdentifier,t)}importAggregator(e,t,r={}){if(this.featAggregate)return;const n=async()=>{let n;await this.deferred;try{if((0,R.V)(e.init)){const{setupAgentSession:t}=await i.e(478).then(i.bind(i,8766));n=t(e)}}catch(e){(0,l.R)(20,e),this.ee.emit("internal-error",[e]),(0,a.p)(T.qh,[e],void 0,this.featureName,this.ee)}try{if(!this.#t(this.featureName,n,e.init))return(0,m.Ze)(this.agentIdentifier,this.featureName),void this.loadedSuccessfully(!1);const{Aggregate:i}=await t();this.featAggregate=new i(e,r),e.runtime.harvester.initializedAggregates.push(this.featAggregate),this.loadedSuccessfully(!0)}catch(e){(0,l.R)(34,e),this.abortHandler?.(),(0,m.Ze)(this.agentIdentifier,this.featureName,!0),this.loadedSuccessfully(!1),this.ee&&this.ee.abort()}};y.RI?(0,b.GG)(()=>n(),!0):n()}#t(e,t,r){if(this.blocked)return!1;switch(e){case n.K7.sessionReplay:return(0,w.SR)(r)&&!!t;case n.K7.sessionTrace:return!!t;default:return!0}}}var A=i(6630),S=i(2614);class _ extends E{static featureName=A.T;constructor(e){var t;super(e,A.T),this.setupInspectionEvents(e.agentIdentifier),t=e,p(u.Fw,function(e,r){"string"==typeof e&&("/"!==e.charAt(0)&&(e="/"+e),t.runtime.customTransaction=(r||"http://custom.transaction")+e,(0,a.p)(u.Pl+u.Fw,[(0,c.t)()],void 0,void 0,t.ee))},t),this.importAggregator(e,()=>i.e(478).then(i.bind(i,1983)))}setupInspectionEvents(e){const t=(t,r)=>{t&&(0,d.W)({agentIdentifier:e,timeStamp:t.timeStamp,loaded:"complete"===t.target.readyState,type:"window",name:r,data:t.target.location+""})};(0,b.sB)(e=>{t(e,"DOMContentLoaded")}),(0,b.GG)(e=>{t(e,"load")}),(0,b.Qr)(e=>{t(e,"navigate")}),this.ee.on(S.tS.UPDATE,(t,r)=>{(0,d.W)({agentIdentifier:e,type:"lifecycle",name:"session",data:r})})}}var O=i(384);var N=i(2843),I=i(3878),P=i(782);class j extends E{static featureName=P.T;constructor(e){super(e,P.T),y.RI&&((0,N.u)(()=>(0,a.p)("docHidden",[(0,c.t)()],void 0,P.T,this.ee),!0),(0,I.sp)("pagehide",()=>(0,a.p)("winPagehide",[(0,c.t)()],void 0,P.T,this.ee)),this.importAggregator(e,()=>i.e(478).then(i.bind(i,9917))))}}class k extends E{static featureName=h.TZ;constructor(e){super(e,h.TZ),y.RI&&document.addEventListener("securitypolicyviolation",e=>{(0,a.p)(h.xV,["Generic/CSPViolation/Detected"],void 0,this.featureName,this.ee)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,6555)))}}var C=i(6774),L=i(3304);class H{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,L.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function M(e){return U(e)?e:new H(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic,e?.cause)}function K(e){const t="Unhandled Promise Rejection: ";if(!e?.reason)return;if(U(e.reason)){try{e.reason.message.startsWith(t)||(e.reason.message=t+e.reason.message)}catch(e){}return M(e.reason)}const r=M(e.reason);return(r.message||"").startsWith(t)||(r.message=t+r.message),r}function D(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new H(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic,e.cause);return t.name=SyntaxError.name,t}return U(e.error)?e.error:M(e)}function U(e){return e instanceof Error&&!!e.stack}function F(e,t,r,i,o=(0,c.t)()){"string"==typeof e&&(e=new Error(e)),(0,a.p)("err",[e,o,!1,t,r.runtime.isRecording,void 0,i],void 0,n.K7.jserrors,r.ee),(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,r.ee)}var W=i(4387),B=i(993),V=i(3785);function G(e,{customAttributes:t={},level:r=B.p_.INFO}={},n,i,o=(0,c.t)()){(0,V.R)(n.ee,e,t,r,i,o)}function z(e,t,r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.hG,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function Z(e,t,r,i,o=(0,c.t)()){const{start:s,end:d,customAttributes:f}=t||{},h={customAttributes:f||{}};if("object"!=typeof h.customAttributes||"string"!=typeof e||0===e.length)return void(0,l.R)(57);const p=(e,t)=>null==e?t:"number"==typeof e?e:e instanceof PerformanceMark?e.startTime:Number.NaN;if(h.start=p(s,0),h.end=p(d,o),Number.isNaN(h.start)||Number.isNaN(h.end))(0,l.R)(57);else{if(h.duration=h.end-h.start,!(h.duration<0))return(0,a.p)(u.Pl+u.V1,[h,e,i],void 0,n.K7.genericEvents,r.ee),h;(0,l.R)(58)}}function q(e,t={},r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.fF,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function X(e){p(u.eY,function(t){return Y(e,t)},e)}function Y(e,t,r){const i={};(0,l.R)(54,"newrelic.register"),t||={},t.eventSource="MicroFrontendBrowserAgent",t.licenseKey||=e.info.licenseKey,t.blocked=!1,t.parent=r||{};let o=()=>{};const s=e.runtime.registeredEntities,u=s.find(({metadata:{target:{id:e,name:r}}})=>e===t.id);if(u)return u.metadata.target.name!==t.name&&(u.metadata.target.name=t.name),u;const d=e=>{t.blocked=!0,o=e};e.init.api.allow_registered_children||d((0,x.J)(()=>(0,l.R)(55))),(0,W.c7)(t)||d((0,x.J)(()=>(0,l.R)(48,t))),(0,W.yo)(t.id)&&(0,W.yo)(t.name)||d((0,x.J)(()=>(0,l.R)(48,t)));const f={addPageAction:(r,n={})=>m(z,[r,{...i,...n},e],t),log:(r,n={})=>m(G,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),measure:(r,n={})=>m(Z,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),noticeError:(r,n={})=>m(F,[r,{...i,...n},e],t),register:(t={})=>m(Y,[e,t],f.metadata.target),recordCustomEvent:(r,n={})=>m(q,[r,{...i,...n},e],t),setApplicationVersion:e=>g("application.version",e),setCustomAttribute:(e,t)=>g(e,t),setUserId:e=>g("enduser.id",e),metadata:{customAttributes:i,target:t}},p=()=>(t.blocked&&o(),t.blocked);p()||s.push(f);const g=(e,t)=>{p()||(i[e]=t)},m=(t,r,i)=>{if(p())return;const o=(0,c.t)();(0,a.p)(h.xV,["API/register/".concat(t.name,"/called")],void 0,n.K7.metrics,e.ee);try{return e.init.api.duplicate_registered_data&&"register"!==t.name&&t(...r,void 0,o),t(...r,i,o)}catch(e){(0,l.R)(50,e)}};return f}class J extends E{static featureName=C.T;constructor(e){var t;super(e,C.T),t=e,p(u.o5,(e,r)=>F(e,r,t),t),function(e){p(u.bt,function(t){e.runtime.onerror=t},e)}(e),function(e){let t=0;p(u.k6,function(e,r){++t>10||(this.runtime.releaseIds[e.slice(-200)]=(""+r).slice(-200))},e)}(e),X(e);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",(t,r)=>{this.abortHandler&&(0,a.p)("ierr",[M(t),(0,c.t)(),!0,{},e.runtime.isRecording,r],void 0,this.featureName,this.ee)}),y.gm.addEventListener("unhandledrejection",t=>{this.abortHandler&&(0,a.p)("err",[K(t),(0,c.t)(),!1,{unhandledPromiseRejection:1},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),y.gm.addEventListener("error",t=>{this.abortHandler&&(0,a.p)("err",[D(t),(0,c.t)(),!1,{},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,2176)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var Q=i(8990);let ee=1;function te(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===y.gm?0:(0,Q.I)(e,"nr@id",function(){return ee++})}function re(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,L.A)(e).length}catch(e){return}}}var ne=i(8139),ie=i(7836),oe=i(3434);const se={},ae=["open","send"];function ce(e){var t=e||ie.ee;const r=function(e){return(e||ie.ee).get("xhr")}(t);if(void 0===y.gm.XMLHttpRequest)return r;if(se[r.debugId]++)return r;se[r.debugId]=1,(0,ne.u)(t);var n=(0,oe.YM)(r),i=y.gm.XMLHttpRequest,o=y.gm.MutationObserver,s=y.gm.Promise,a=y.gm.setInterval,c="readystatechange",u=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],d=[],f=y.gm.XMLHttpRequest=function(e){const t=new i(e),o=r.context(t);try{r.emit("new-xhr",[t],o),t.addEventListener(c,(s=o,function(){var e=this;e.readyState>3&&!s.resolved&&(s.resolved=!0,r.emit("xhr-resolved",[],e)),n.inPlace(e,u,"fn-",b)}),(0,I.jT)(!1))}catch(e){(0,l.R)(15,e);try{r.emit("internal-error",[e])}catch(e){}}var s;return t};function h(e,t){n.inPlace(t,["onreadystatechange"],"fn-",b)}if(function(e,t){for(var r in e)t[r]=e[r]}(i,f),f.prototype=i.prototype,n.inPlace(f.prototype,ae,"-xhr-",b),r.on("send-xhr-start",function(e,t){h(e,t),function(e){d.push(e),o&&(p?p.then(v):a?a(v):(g=-g,m.data=g))}(t)}),r.on("open-xhr-start",h),o){var p=s&&s.resolve();if(!a&&!s){var g=1,m=document.createTextNode(g);new o(v).observe(m,{characterData:!0})}}else t.on("fn-end",function(e){e[0]&&e[0].type===c||v()});function v(){for(var e=0;e<d.length;e++)h(0,d[e]);d.length&&(d=[])}function b(e,t){return t}return r}var ue="fetch-",de=ue+"body-",le=["arrayBuffer","blob","json","text","formData"],fe=y.gm.Request,he=y.gm.Response,pe="prototype";const ge={};function me(e){const t=function(e){return(e||ie.ee).get("fetch")}(e);if(!(fe&&he&&y.gm.fetch))return t;if(ge[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[ie.P]&&o[ie.P].dt&&(e=o[ie.P].dt);var s=i.apply(this,r);return t.emit(n+"start",[r,e],s),s.then(function(e){return t.emit(n+"end",[null,e],s),e},function(e){throw t.emit(n+"end",[e],s),e})})}return ge[t.debugId]=1,le.forEach(e=>{r(fe[pe],e,de),r(he[pe],e,de)}),r(y.gm,"fetch",ue),t.on(ue+"end",function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(ue+"done",[null,r],n)}else t.emit(ue+"done",[e],n)}),t}var ve=i(7485);class be{constructor(e){this.agentRef=e}generateTracePayload(t){const r=this.agentRef.loader_config;if(!this.shouldGenerateTrace(t)||!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var s=(0,e.ZF)(),a=(0,e.el)(),c=Date.now(),u={spanId:s,traceId:a,timestamp:c};return(t.sameOrigin||this.isAllowedOrigin(t)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(s,a),u.traceContextStateHeader=this.generateTraceContextStateHeader(s,c,n,i,o)),(t.sameOrigin&&!this.excludeNewrelicHeader()||!t.sameOrigin&&this.isAllowedOrigin(t)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(s,a,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof y.gm?.btoa))return null;var s={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(s.d.tk=o),btoa((0,L.A)(s))}shouldGenerateTrace(e){return this.agentRef.init?.distributed_tracing?.enabled&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1;const r=this.agentRef.init?.distributed_tracing;if(e.sameOrigin)t=!0;else if(r?.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,ve.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}excludeNewrelicHeader(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.cors_use_tracecontext_headers}}var ye=i(9300),we=i(7295);function Re(e){return"string"==typeof e?e:e instanceof(0,O.dV)().o.REQ?e.url:y.gm?.URL&&e instanceof URL?e.href:void 0}var xe=["load","error","abort","timeout"],Te=xe.length,Ee=(0,O.dV)().o.REQ,Ae=(0,O.dV)().o.XHR;const Se="X-NewRelic-App-Data";class _e extends E{static featureName=ye.T;constructor(e){super(e,ye.T),this.dt=new be(e),this.handler=(e,t,r,n)=>(0,a.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};y.gm?.performance?.getEntriesByType("resource").forEach(t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},i={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};Oe(r,t.name),this.handler("xhr",[r,i,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,n.K7.ajax)}})}catch(e){}me(this.ee),ce(this.ee),function(e,t,r,i){function o(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},t.latestLongtaskEnd=0,e.addEventListener("load",function(r){A(t,e)},(0,I.jT)(!1)),y.lR||e.addEventListener("progress",function(e){t.lastSize=e.loaded},(0,I.jT)(!1))}function s(e){this.params={method:e[0]},Oe(this,e[1]),this.metrics={}}function u(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var n=i.generateTracePayload(this.parsedOrigin);if(n){var o=!1;n.newrelicHeader&&(r.setRequestHeader("newrelic",n.newrelicHeader),o=!0),n.traceContextParentHeader&&(r.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&r.setRequestHeader("tracestate",n.traceContextStateHeader),o=!0),o&&(this.dt=n)}}function d(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var s=re(i);s&&(n.txSize=s)}this.startTime=(0,c.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var a=0;a<Te;a++)r.addEventListener(xe[a],this.listener,(0,I.jT)(!1))}function l(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function f(e,t){var r=""+te(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function p(e,t){var r=""+te(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,c.t)()}function m(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function v(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function b(e,t,r){t instanceof Ae&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,c.t)()))}function w(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,c.t)()-this.xhrCbStart,this.onload,r],r)}function R(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&y.RI&&(t=""+y.gm.location.href):e[0]&&e[0].url?t=e[0].url:y.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,ve.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=i.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if(e[0]&&e[0].headers)a(e[0].headers,n)&&(this.dt=n);else{var o={};for(var s in r)o[s]=r[s];o.headers=new Headers(r.headers||{}),a(o.headers,n)&&(this.dt=n),e.length>1?e[1]=o:e.push(o)}}function a(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,c.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r=this.opts||{},n=this.target;Oe(this,Re(n));var i=(""+(n&&n instanceof Ee&&n.method||r.method||"GET")).toUpperCase();this.params.method=i,this.body=r.body,this.txSize=re(r.body)||0}function T(e,t){if(this.endTime=(0,c.t)(),this.params||(this.params={}),(0,we.iW)(this.params))return;let i;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(i=+this.rxSize);const o={txSize:this.txSize,rxSize:i,duration:(0,c.t)()-this.startTime};r("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,n.K7.ajax)}function E(e){const t=this.params,i=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<Te;t++)e.removeEventListener(xe[t],this.listener,!1);t.aborted||(0,we.iW)(t)||(i.duration=(0,c.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):A(this,e),i.cbTime=this.cbTime,r("xhr",[t,i,this.startTime,this.endTime,"xhr"],this,n.K7.ajax))}}function A(e,r){e.params.status=r.status;var i=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?re(e.response):"text"===r||""===r||void 0===r?re(e.responseText):void 0}(r,e.lastSize);if(i&&(e.metrics.rxSize=i),e.sameOrigin&&r.getAllResponseHeaders().indexOf(Se)>=0){var o=r.getResponseHeader(Se);o&&((0,a.p)(h.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,n.K7.metrics,t),e.params.cat=o.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",o),t.on("open-xhr-start",s),t.on("open-xhr-end",u),t.on("send-xhr-start",d),t.on("xhr-cb-time",l),t.on("xhr-load-added",f),t.on("xhr-load-removed",p),t.on("xhr-resolved",g),t.on("addEventListener-end",m),t.on("removeEventListener-end",v),t.on("fn-end",w),t.on("fetch-before-start",R),t.on("fetch-start",x),t.on("fn-start",b),t.on("fetch-done",T)}(e,this.ee,this.handler,this.dt),this.importAggregator(e,()=>i.e(478).then(i.bind(i,3845)))}}function Oe(e,t){var r=(0,ve.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const Ne={},Ie=["pushState","replaceState"];function Pe(e){const t=function(e){return(e||ie.ee).get("history")}(e);return!y.RI||Ne[t.debugId]++||(Ne[t.debugId]=1,(0,oe.YM)(t).inPlace(window.history,Ie,"-")),t}var je=i(3738);function ke(e){p(u.BL,function(t=Date.now()){const r=t-y.WN;r<0&&(0,l.R)(62,t),(0,a.p)(h.XG,[u.BL,{time:r}],void 0,n.K7.metrics,e.ee),e.addToTrace({name:u.BL,start:t,origin:"nr"}),(0,a.p)(u.Pl+u.hG,[r,u.BL],void 0,n.K7.genericEvents,e.ee)},e)}const{He:Ce,bD:Le,d3:He,Kp:Me,TZ:Ke,Lc:De,uP:Ue,Rz:Fe}=je;class We extends E{static featureName=Ke;constructor(e){var t;super(e,Ke),t=e,p(u.U2,function(e){if(!(e&&"object"==typeof e&&e.name&&e.start))return;const r={n:e.name,s:e.start-y.WN,e:(e.end||e.start)-y.WN,o:e.origin||"",t:"api"};r.s<0||r.e<0||r.e<r.s?(0,l.R)(61,{start:r.s,end:r.e}):(0,a.p)("bstApi",[r],void 0,n.K7.sessionTrace,t.ee)},t),ke(e);if(!(0,R.V)(e.init))return void this.deregisterDrain();const r=this.ee;let o;Pe(r),this.eventsEE=(0,ne.u)(r),this.eventsEE.on(Ue,function(e,t){this.bstStart=(0,c.t)()}),this.eventsEE.on(De,function(e,t){(0,a.p)("bst",[e[0],t,this.bstStart,(0,c.t)()],void 0,n.K7.sessionTrace,r)}),r.on(Fe+He,function(e){this.time=(0,c.t)(),this.startPath=location.pathname+location.hash}),r.on(Fe+Me,function(e){(0,a.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,n.K7.sessionTrace,r)});try{o=new PerformanceObserver(e=>{const t=e.getEntries();(0,a.p)(Ce,[t],void 0,n.K7.sessionTrace,r)}),o.observe({type:Le,buffered:!0})}catch(e){}this.importAggregator(e,()=>i.e(478).then(i.bind(i,6974)),{resourceObserver:o})}}var Be=i(6344);class Ve extends E{static featureName=Be.TZ;#n;recorder;constructor(e){var t;let r;super(e,Be.TZ),t=e,p(u.CH,function(){(0,a.p)(u.CH,[],void 0,n.K7.sessionReplay,t.ee)},t),function(e){p(u.Tb,function(){(0,a.p)(u.Tb,[],void 0,n.K7.sessionReplay,e.ee)},e)}(e);try{r=JSON.parse(localStorage.getItem("".concat(S.H3,"_").concat(S.uh)))}catch(e){}(0,w.SR)(e.init)&&this.ee.on(u.CH,()=>this.#i()),this.#o(r)&&this.importRecorder().then(e=>{e.startRecording(Be.Qb.PRELOAD,r?.sessionReplayMode)}),this.importAggregator(this.agentRef,()=>i.e(478).then(i.bind(i,6167)),this),this.ee.on("err",e=>{this.blocked||this.agentRef.runtime.isRecording&&(this.errorNoticed=!0,(0,a.p)(Be.Vh,[e],void 0,this.featureName,this.ee))})}#o(e){return e&&(e.sessionReplayMode===S.g.FULL||e.sessionReplayMode===S.g.ERROR)||(0,w.Aw)(this.agentRef.init)}importRecorder(){return this.recorder?Promise.resolve(this.recorder):(this.#n??=Promise.all([i.e(478),i.e(249)]).then(i.bind(i,4866)).then(({Recorder:e})=>(this.recorder=new e(this),this.recorder)).catch(e=>{throw this.ee.emit("internal-error",[e]),this.blocked=!0,e}),this.#n)}#i(){this.blocked||(this.featAggregate?this.featAggregate.mode!==S.g.FULL&&this.featAggregate.initializeRecording(S.g.FULL,!0,Be.Qb.API):this.importRecorder().then(()=>{this.recorder.startRecording(Be.Qb.API,S.g.FULL)}))}}var Ge=i(3962);function ze(e){const t=e.ee.get("tracer");function r(){}p(u.dT,function(e){return(new r).get("object"==typeof e?e:{})},e);const i=r.prototype={createTracer:function(r,i){var o={},s=this,d="function"==typeof i;return(0,a.p)(h.xV,["API/createTracer/called"],void 0,n.K7.metrics,e.ee),e.runSoftNavOverSpa||(0,a.p)(u.hw+"tracer",[(0,c.t)(),r,o],s,n.K7.spa,e.ee),function(){if(t.emit((d?"":"no-")+"fn-start",[(0,c.t)(),s,d],o),d)try{return i.apply(this,arguments)}catch(e){const r="string"==typeof e?new Error(e):e;throw t.emit("fn-err",[arguments,this,r],o),r}finally{t.emit("fn-end",[(0,c.t)()],o)}}}};["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach(t=>{p.apply(this,[t,function(){return(0,a.p)(u.hw+t,[(0,c.t)(),...arguments],this,e.runSoftNavOverSpa?n.K7.softNav:n.K7.spa,e.ee),this},e,i])}),p(u.PA,function(){e.runSoftNavOverSpa?(0,a.p)(u.hw+"routeName",[performance.now(),...arguments],void 0,n.K7.softNav,e.ee):(0,a.p)(u.Pl+"routeName",[(0,c.t)(),...arguments],this,n.K7.spa,e.ee)},e)}class Ze extends E{static featureName=Ge.TZ;constructor(e){if(super(e,Ge.TZ),ze(e),!y.RI||!(0,O.dV)().o.MO)return;const t=Pe(this.ee);try{this.removeOnAbort=new AbortController}catch(e){}Ge.tC.forEach(e=>{(0,I.sp)(e,e=>{s(e)},!0,this.removeOnAbort?.signal)});const r=()=>(0,a.p)("newURL",[(0,c.t)(),""+window.location],void 0,this.featureName,this.ee);t.on("pushState-end",r),t.on("replaceState-end",r),(0,I.sp)(Ge.OV,e=>{s(e),(0,a.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)},!0,this.removeOnAbort?.signal);let n=!1;const o=new((0,O.dV)().o.MO)((e,t)=>{n||(n=!0,requestAnimationFrame(()=>{(0,a.p)("newDom",[(0,c.t)()],void 0,this.featureName,this.ee),n=!1}))}),s=(0,x.s)(e=>{(0,a.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})},100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,()=>i.e(478).then(i.bind(i,4393)),{domObserver:o})}}var qe=i(7378);const Xe={},Ye=["appendChild","insertBefore","replaceChild"];function Je(e){const t=function(e){return(e||ie.ee).get("jsonp")}(e);if(!y.RI||Xe[t.debugId])return t;Xe[t.debugId]=!0;var r=(0,oe.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function s(e,t){if(!e)return t;const r=e.match(o),n=r[1];return s(r[3],t[n])}return r.inPlace(Node.prototype,Ye,"dom-"),t.on("dom-start",function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(a=e.src,c=a.match(n),c?c[1]:null);var a,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:s(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,I.jT)(!1)),e.addEventListener("error",f,(0,I.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])}),t}const $e={};function Qe(e){const t=function(e){return(e||ie.ee).get("promise")}(e);if($e[t.debugId])return t;$e[t.debugId]=!0;var r=t.context,n=(0,oe.YM)(t),i=y.gm.Promise;return i&&function(){function e(r){var o=t.context(),s=n(r,"executor-",o,null,!1);const a=Reflect.construct(i,[s],e);return t.context(a).getCtx=function(){return o},a}y.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach(function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach(e=>{this.resolve(e).then(s("all"===r),s(!1))});const o=n.apply(this,arguments);return o;function s(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}}),["resolve","reject"].forEach(function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}}),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,s=r(i);s.promise=i,e[0]=n(e[0],"cb-",s,null,!1),e[1]=n(e[1],"cb-",s,null,!1);const a=o.apply(this,e);return s.nextPromise=a,t.emit("propagate",[i,!0],a,!1,!1),a},i.prototype.then[oe.Jt]=o,t.on("executor-start",function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)}),t.on("executor-err",function(e,t,r){e[1](r)}),t.on("cb-end",function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),t.on("propagate",function(e,r,n){if(!this.getCtx||r){const r=this,n=e instanceof Promise?t.context(e):null;let i;this.getCtx=function(){return i||(i=n&&n!==r?"function"==typeof n.getCtx?n.getCtx():n:r,i)}}})}(),t}const et={},tt="setTimeout",rt="setInterval",nt="clearTimeout",it="-start",ot=[tt,"setImmediate",rt,nt,"clearImmediate"];function st(e){const t=function(e){return(e||ie.ee).get("timer")}(e);if(et[t.debugId]++)return t;et[t.debugId]=1;var r=(0,oe.YM)(t);return r.inPlace(y.gm,ot.slice(0,2),tt+"-"),r.inPlace(y.gm,ot.slice(2,3),rt+"-"),r.inPlace(y.gm,ot.slice(3),nt+"-"),t.on(rt+it,function(e,t,n){e[0]=r(e[0],"fn-",null,n)}),t.on(tt+it,function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)}),t}const at={};function ct(e){const t=function(e){return(e||ie.ee).get("mutation")}(e);if(!y.RI||at[t.debugId])return t;at[t.debugId]=!0;var r=(0,oe.YM)(t),n=y.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:ut,d3:dt,Kp:lt,$p:ft,wW:ht,e5:pt,tH:gt,uP:mt,rw:vt,Lc:bt}=qe;class yt extends E{static featureName=ut;constructor(e){if(super(e,ut),ze(e),!y.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let t,r=0;const n=this.ee.get("tracer"),o=Je(this.ee),s=Qe(this.ee),u=st(this.ee),d=ce(this.ee),l=this.ee.get("events"),f=me(this.ee),h=Pe(this.ee),p=ct(this.ee);function g(e,t){h.emit("newURL",[""+window.location,t])}function m(){r++,t=window.location.hash,this[mt]=(0,c.t)()}function v(){r--,window.location.hash!==t&&g(0,!0);var e=(0,c.t)();this[pt]=~~this[pt]+e-this[mt],this[bt]=e}function b(e,t){e.on(t,function(){this[t]=(0,c.t)()})}this.ee.on(mt,m),s.on(vt,m),o.on(vt,m),this.ee.on(bt,v),s.on(ht,v),o.on(ht,v),this.ee.on("fn-err",(...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,a.p)("function-err",[...t],void 0,this.featureName,this.ee)}),this.ee.buffer([mt,bt,"xhr-resolved"],this.featureName),l.buffer([mt],this.featureName),u.buffer(["setTimeout"+lt,"clearTimeout"+dt,mt],this.featureName),d.buffer([mt,"new-xhr","send-xhr"+dt],this.featureName),f.buffer([gt+dt,gt+"-done",gt+ft+dt,gt+ft+lt],this.featureName),h.buffer(["newURL"],this.featureName),p.buffer([mt],this.featureName),s.buffer(["propagate",vt,ht,"executor-err","resolve"+dt],this.featureName),n.buffer([mt,"no-"+mt],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),b(f,gt+dt),b(f,gt+"-done"),b(o,"new-jsonp"),b(o,"jsonp-end"),b(o,"cb-start"),h.on("pushState-end",g),h.on("replaceState-end",g),window.addEventListener("hashchange",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",function(){g(0,r>1)},(0,I.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,5592)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var wt=i(3333);class Rt extends E{static featureName=wt.TZ;constructor(e){super(e,wt.TZ);const t=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];var r;r=e,p(u.hG,(e,t)=>z(e,t,r),r),function(e){p(u.fF,(t,r)=>q(t,r,e),e)}(e),ke(e),X(e),function(e){p(u.V1,(t,r)=>Z(t,r,e),e)}(e);const o=e.init.feature_flags.includes("user_frustrations");let s;if(y.RI&&o&&(me(this.ee),ce(this.ee),s=Pe(this.ee)),y.RI){if(e.init.user_actions.enabled&&(wt.Zp.forEach(e=>(0,I.sp)(e,e=>(0,a.p)("ua",[e],void 0,this.featureName,this.ee),!0)),wt.qN.forEach(e=>{const t=(0,x.s)(e=>{(0,a.p)("ua",[e],void 0,this.featureName,this.ee)},500,{leading:!0});(0,I.sp)(e,t)}),o)){function c(t){const r=(0,ve.D)(t);return e.beacons.includes(r.hostname+":"+r.port)}function d(){s.emit("navChange")}y.gm.addEventListener("error",()=>{(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.ee.on("open-xhr-start",(e,t)=>{c(e[1])||t.addEventListener("readystatechange",()=>{2===t.readyState&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)})}),this.ee.on("fetch-start",e=>{e.length>=1&&!c(Re(e[0]))&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)}),s.on("pushState-end",d),s.on("replaceState-end",d),window.addEventListener("hashchange",d,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",d,(0,I.jT)(!0,this.removeOnAbort?.signal))}if(e.init.performance.resources.enabled&&y.gm.PerformanceObserver?.supportedEntryTypes.includes("resource")){new PerformanceObserver(e=>{e.getEntries().forEach(e=>{(0,a.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)})}).observe({type:"resource",buffered:!0})}}try{this.removeOnAbort=new AbortController}catch(l){}this.abortHandler=()=>{this.removeOnAbort?.abort(),this.abortHandler=void 0},t.some(e=>e)?this.importAggregator(e,()=>i.e(478).then(i.bind(i,8019))):this.deregisterDrain()}}var xt=i(2646);const Tt=new Map;function Et(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||ie.ee).get("logger")}(e),o=(0,oe.YM)(i),s=new xt.y(ie.P);s.level=n.level,s.customAttributes=n.customAttributes;const a=t[r]?.[oe.Jt]||t[r];return Tt.set(a,s),o.inPlace(t,[r],"wrap-logger-",()=>Tt.get(a)),i}var At=i(1910);class St extends E{static featureName=B.TZ;constructor(e){var t;super(e,B.TZ),t=e,p(u.$9,(e,r)=>G(e,r,t),t),function(e){p(u.Wb,(t,r,{customAttributes:n={},level:i=B.p_.INFO}={})=>{Et(e.ee,t,r,{customAttributes:n,level:i})},e)}(e),X(e);const r=this.ee;["log","error","warn","info","debug","trace"].forEach(e=>{(0,At.i)(y.gm.console[e]),Et(r,y.gm.console,e,{level:"log"===e?"info":e})}),this.ee.on("wrap-logger-end",function([e]){const{level:t,customAttributes:n}=this;(0,V.R)(r,e,n,t)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,5288)))}}new class extends r{constructor(e){var t;(super(),y.gm)?(this.features={},(0,O.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(_),this.runSoftNavOverSpa=[...this.desiredFeatures].some(e=>e.featureName===n.K7.softNav),(0,s.j)(this,e,e.loaderType||"agent"),t=this,p(u.cD,function(e,r,n=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof r)||null===r)return g(t,e,r,u.cD,n);(0,l.R)(40,typeof r)}else(0,l.R)(39,typeof e)},t),function(e){p(u.Dl,function(t){if("string"==typeof t||null===t)return g(e,"enduser.id",t,u.Dl,!0);(0,l.R)(41,typeof t)},e)}(this),function(e){p(u.nb,function(t){if("string"==typeof t||null===t)return g(e,"application.version",t,u.nb,!1);(0,l.R)(42,typeof t)},e)}(this),function(e){p(u.d3,function(){e.ee.emit("manual-start-all")},e)}(this),function(e){p(u.Pv,function(t=!0){if("boolean"==typeof t){if((0,a.p)(u.Pl+u.Pv,[t],void 0,"session",e.ee),e.runtime.consented=t,t){const t=e.features.page_view_event;t.onAggregateImported.then(e=>{const r=t.featAggregate;e&&!r.sentRum&&r.sendRum()})}}else(0,l.R)(65,typeof t)},e)}(this),this.run()):(0,l.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}get api(){return this}run(){try{const e=function(e){const t={};return o.forEach(r=>{t[r]=!!e[r]?.enabled}),t}(this.init),t=[...this.desiredFeatures];t.sort((e,t)=>n.P3[e.featureName]-n.P3[t.featureName]),t.forEach(t=>{if(!e[t.featureName]&&t.featureName!==n.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&t.featureName===n.K7.spa)return;if(!this.runSoftNavOverSpa&&t.featureName===n.K7.softNav)return;const r=function(e){switch(e){case n.K7.ajax:return[n.K7.jserrors];case n.K7.sessionTrace:return[n.K7.ajax,n.K7.pageViewEvent];case n.K7.sessionReplay:return[n.K7.sessionTrace];case n.K7.pageViewTiming:return[n.K7.pageViewEvent];default:return[]}}(t.featureName).filter(e=>!(e in this.features));r.length>0&&(0,l.R)(36,{targetFeature:t.featureName,missingDependencies:r}),this.features[t.featureName]=new t(this)})}catch(e){(0,l.R)(22,e);for(const e in this.features)this.features[e].abortHandler?.();const t=(0,O.Zm)();delete t.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return t.ee.get(this.agentIdentifier).abort(),!1}}}({features:[_e,_,j,We,Ve,k,J,Rt,St,Ze,yt],loaderType:"spa"})})()})();</script>
<link rel="icon" type="image/png" sizes="16x16" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png">
<meta name="apple-mobile-web-app-title" content="Frontiers | Articles">
<link rel="manifest" href="/manifest.json">
<link rel="canonical" href="https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/full">
<meta property="description" name="description" content="Patients with the fatal disorder Transthyretin Amyloidosis (ATTR) experience polyneuropathy through the progressive destruction of peripheral nervous tissue....">
<meta property="og:title" name="title" content="Frontiers | The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation">
<meta property="og:description" name="description" content="Patients with the fatal disorder Transthyretin Amyloidosis (ATTR) experience polyneuropathy through the progressive destruction of peripheral nervous tissue....">
<meta name="keywords" content="Hsp104,transthyretin,molecular chaperone,protein aggregation,transthyretin amyloidosis,Amyloid,polyneuropathy,Aging">
<meta property="og:site_name" name="site_name" content="Frontiers">
<meta property="og:image" name="image" content="https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg">
<meta property="og:type" name="type" content="article">
<meta property="og:url" name="url" content="https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/full">
<meta name="twitter:card" content="summary_large_image">
<meta name="citation_volume" content="15">
<meta name="citation_journal_title" content="Frontiers in Molecular Neuroscience">
<meta name="citation_publisher" content="Frontiers">
<meta name="citation_journal_abbrev" content="Front. Mol. Neurosci.">
<meta name="citation_issn" content="1662-5099">
<meta name="citation_doi" content="10.3389/fnmol.2022.1050472">
<meta name="citation_firstpage" content="1050472">
<meta name="citation_language" content="English">
<meta name="citation_title" content="The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation">
<meta name="citation_keywords" content="Hsp104; transthyretin; molecular chaperone; protein aggregation; transthyretin amyloidosis; Amyloid; polyneuropathy; Aging">
<meta name="citation_abstract" content="Patients with the fatal disorder Transthyretin Amyloidosis (ATTR) experience polyneuropathy through the progressive destruction of peripheral nervous tissue. In these patients, the transthyretin (TTR) protein dissociates from its functional tetrameric structure, misfolds, and aggregates into extracellular amyloid deposits that are associated with disease progression. These aggregates form large fibrillar structures as well as shorter oligomeric aggregates that are suspected to be cytotoxic. Several studies have shown that these extracellular TTR aggregates enter the cell and accumulate intracellularly, which is associated with increased proteostasis response. However, there are limited experimental models to study how proteostasis influences internalized TTR aggregates. Here, we use a humanized yeast system to recapitulate intracellular TTR aggregating protein in vivo. The yeast molecular chaperone Hsp104 is a disaggregase that has been shown to fragment amyloidogenic aggregates associated with certain yeast prions and reduce protein aggregation associated with human neurogenerative diseases. In yeast, we found that TTR forms both SDS-resistant oligomers and SDS-sensitive large molecular weight complexes. In actively dividing cultures, Hsp104 has no impact on oligomeric or large aggregate populations, yet overexpression of Hsp104 is loosely associated with an increase in overall aggregate size. Interestingly, a potentiating mutation in the middle domain of Hsp104 consistently results in an increase in overall TTR aggregate size. These data suggest a novel approach to aggregate management, where the Hsp104 variant shifts aggregate populations away from toxic oligomeric species to more inert larger aggregates. In aged cultures Hsp104 overexpression has no impact on TTR aggregation profiles suggesting that these chaperone approaches to shift aggregate populations are not effective with age, possibly due to proteostasis decline. ">
<meta name="citation_article_type" content="Original Research">
<meta name="citation_pdf_url" content="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/pdf">
<meta name="citation_xml_url" content="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/xml">
<meta name="citation_fulltext_world_readable" content="yes">
<meta name="citation_online_date" content="2022/10/19">
<meta name="citation_publication_date" content="2022/12/16">
<meta name="citation_author" content="Knier, Adam S. ">
<meta name="citation_author_institution" content="Department of Biological Sciences, Marquette University, United States">
<meta name="citation_author" content="Davis, Emily E. ">
<meta name="citation_author_institution" content="Department of Biological Sciences, Marquette University, United States">
<meta name="citation_author" content="Buchholz, Hannah E. ">
<meta name="citation_author_institution" content="Department of Biological Sciences, Marquette University, United States">
<meta name="citation_author" content="Dorweiler, Jane E. ">
<meta name="citation_author_institution" content="Department of Biological Sciences, Marquette University, United States">
<meta name="citation_author" content="Flannagan, Lauryn E. ">
<meta name="citation_author_institution" content="Department of Biological Sciences, Marquette University, United States">
<meta name="citation_author" content="Manogaran, Anita L. ">
<meta name="citation_author_institution" content="Department of Biological Sciences, Marquette University, United States">
<meta name="dc.identifier" content="doi:10.3389/fnmol.2022.1050472">
<script type="application/ld+json">{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation","author":[{"@type":"Person","name":"Adam S. Knier","affiliation":["Department of Biological Sciences, Marquette University, United States"]},{"@type":"Person","name":"Emily E. Davis","affiliation":["Department of Biological Sciences, Marquette University, United States"]},{"@type":"Person","name":"Hannah E. Buchholz","affiliation":["Department of Biological Sciences, Marquette University, United States"]},{"@type":"Person","name":"Jane E. Dorweiler","affiliation":["Department of Biological Sciences, Marquette University, United States"]},{"@type":"Person","name":"Lauryn E. Flannagan","affiliation":["Department of Biological Sciences, Marquette University, United States"]},{"@type":"Person","name":"Anita L. Manogaran","affiliation":["Department of Biological Sciences, Marquette University, United States"]}],"datePublished":"2022-12-16","dateModified":"2025-11-25","publisher":{"@type":"Organization","name":"Frontiers"},"isPartOf":{"@type":"PublicationIssue","datePublished":"2022","isPartOf":{"@type":"PublicationVolume","volumeNumber":"15","isPartOf":{"@type":"Periodical","name":"Frontiers in Molecular Neuroscience"}}},"citation":["https://doi.org/10.3389/fnmol.2022.1050472"],"inLanguage":"en"}</script>
<script type="module" src="/ap-2024/_nuxt/v1IBIWh4.js" crossorigin></script>
<script id="unhead:payload" type="application/json">{"title":"Frontiers | Articles"}</script></head><body  class="body--v3"><div id="__nuxt"><!--[--><!----><div theme="purple"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button class="Ibar__burger" aria-label="Open Menu" data-event="iBar-btn-openMenu"></button><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/molecular-neuroscience" class="Ibar__journalName" data-event="iBar-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Molecular Neuroscience</span></div></div></a><div class="Ibar__dropdown--aboutUs" parent-data-event="iBar"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=171&amp;specialtyid=0&amp;entitytype=2&amp;entityid=2031" data-event="iBar-a-submit">Submit your research</a><div class="Ibar__spacer"></div><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><div><div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div></div><button class="Ibar__close" aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu"></button></div><div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.frontiersin.org/journals/molecular-neuroscience" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Molecular Neuroscience</span></div></div></a><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/brain-disease-mechanisms" data-event="iBarJournal-sections-a_id_2032">Brain Disease Mechanisms</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/methods-and-model-organisms" data-event="iBarJournal-sections-a_id_2034">Methods and Model Organisms</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/molecular-neuroscience-archive" data-event="iBarJournal-sections-a_id_2">Molecular Neuroscience Archive</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/molecular-signalling-and-pathways" data-event="iBarJournal-sections-a_id_2033">Molecular Signalling and Pathways</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/neuroplasticity-and-development" data-event="iBarJournal-sections-a_id_2036">Neuroplasticity and Development</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/pain-mechanisms-and-modulators" data-event="iBarJournal-sections-a_id_2035">Pain Mechanisms and Modulators</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-neuroscience/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-neuroscience/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-neuroscience/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div></div><div class="Ibar__dropdown--aboutUs" parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><!----><!----><!----><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=171&amp;specialtyid=0&amp;entitytype=2&amp;entityid=2031" data-event="iBarMenu-a-submit">Submit your research</a></div></div></div><!--[--><div class="Ibar__journal Ibar__journal--main"><div class="Ibar__wrapper Ibar__wrapper--journal"><a href="//www.frontiersin.org/journals/molecular-neuroscience" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Molecular Neuroscience</span></div></div></a><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/brain-disease-mechanisms" data-event="iBarJournal-sections-a_id_2032">Brain Disease Mechanisms</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/methods-and-model-organisms" data-event="iBarJournal-sections-a_id_2034">Methods and Model Organisms</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/molecular-neuroscience-archive" data-event="iBarJournal-sections-a_id_2">Molecular Neuroscience Archive</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/molecular-signalling-and-pathways" data-event="iBarJournal-sections-a_id_2033">Molecular Signalling and Pathways</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/neuroplasticity-and-development" data-event="iBarJournal-sections-a_id_2036">Neuroplasticity and Development</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/pain-mechanisms-and-modulators" data-event="iBarJournal-sections-a_id_2035">Pain Mechanisms and Modulators</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-neuroscience/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-neuroscience/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-neuroscience/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div></div></div><div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/molecular-neuroscience" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Molecular Neuroscience</span></div></div></a><div class="Ibar__spacer"></div><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/brain-disease-mechanisms" data-event="iBarJournal-sections-a_id_2032">Brain Disease Mechanisms</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/methods-and-model-organisms" data-event="iBarJournal-sections-a_id_2034">Methods and Model Organisms</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/molecular-neuroscience-archive" data-event="iBarJournal-sections-a_id_2">Molecular Neuroscience Archive</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/molecular-signalling-and-pathways" data-event="iBarJournal-sections-a_id_2033">Molecular Signalling and Pathways</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/neuroplasticity-and-development" data-event="iBarJournal-sections-a_id_2036">Neuroplasticity and Development</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/molecular-neuroscience/sections/pain-mechanisms-and-modulators" data-event="iBarJournal-sections-a_id_2035">Pain Mechanisms and Modulators</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-neuroscience/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-neuroscience/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/molecular-neuroscience/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=171&amp;specialtyid=0&amp;entitytype=2&amp;entityid=2031" data-event="iBarJournal-a-submit"><span>Submit</span><span>your research</span></a><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><!--]--></nav><div class="ArticlePage"><!--[--><div class="Layout Layout--withAside Layout--withIbarMix"><div class="Alert Alert--info Alert--noInfo ArticleTemplateBanner"><div class="Alert__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" class="FeedbackIcon"><path fill="#fff" d="M10 10h28v28H10z"></path><path fill="var(--blue50)" d="M24 2.88a21.12 21.12 0 1 0 0 42.24 21.12 21.12 0 0 0 0-42.24ZM22.08 13.4a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96h-1.92a.96.96 0 0 1-.96-.96V13.4Zm5.76 21.2a.96.96 0 0 1-.96.97h-5.76a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h.96v-7.68h-.96a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h3.84a.96.96 0 0 1 .96.96v10.56h.96a.96.96 0 0 1 .96.96v1.92Z"></path></svg></div><div class="Alert__main"><p class="Alert__message">Your new experience awaits. Try the new design now and help us make it even better</p><!--[--><button type="button" class="Button Button--outline Button--grey80 Button--small ArticleTemplateBanner__switchButton" data-event="btn-action"><span>Switch to the new experience</span></button><!--]--><!----></div><ol class="Alert__info"><!--[--><!--]--></ol></div><!----><main class="Layout__main"><!----><div class="ArticleDetails"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><p class="ArticleLayoutHeader__info__title">ORIGINAL RESEARCH article</p><p class="ArticleLayoutHeader__info__journalDate"><span>Front. Mol. Neurosci.</span><span>, 16 December 2022</span></p><p class="ArticleLayoutHeader__info__journalDate"> Sec. Methods and Model Organisms</p><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 15 - 2022 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/fnmol.2022.1050472">https://doi.org/10.3389/fnmol.2022.1050472</a></p><!----></div><!----><p class="ArticleLayoutHeader__isPartOfRT"><span class="ArticleLayoutHeader__isPartOfRT__label">This article is part of the Research Topic</span><span class="ArticleLayoutHeader__isPartOfRT__title">Rising Stars in Molecular Neuroscience - Methods and Model Organisms: 2022</span><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View all 4 articles" href="https://www.frontiersin.org/research-topics/46432/rising-stars-in-molecular-neuroscience---methods-and-model-organisms-2022/magazine" target="_self" data-event="customLink-linkType-a_viewAll4Articles"><span>View all 4 articles</span></a></span></p></div><div class="ArticleDetails__main__content"><div class="ArticleDetails__main__content__main ArticleDetails__main__content__main--fullArticle"><div class="JournalAbstract"><div class="JournalAbstract__titleWrapper"><h1>The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation</h1><!----></div><!----></div><div class="JournalFullText"><div class="JournalAbstract"> <a id="h1" name="h1"></a>
 <div class="authors"><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/2003445" class="user-id-2003445"><img class="pr5" src="https://loop.frontiersin.org/images/profile/2003445/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Adam S. Knier">Adam S. Knier</a></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Emily E. Davis" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Emily E. Davis</span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/2026336" class="user-id-2026336"><img class="pr5" src="https://loop.frontiersin.org/images/profile/2026336/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Hannah E. Buchholz">Hannah E. Buchholz</a></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Jane E. Dorweiler" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Jane E. Dorweiler</span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Lauryn E. Flannagan" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Lauryn E. Flannagan</span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/497140" class="user-id-497140"><img class="pr5" src="https://loop.frontiersin.org/images/profile/497140/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Anita L. Manogaran&#xA;">Anita L. Manogaran</a><sup>&#x0002A;</sup></span></div> <ul class="notes"> <li>Department of Biological Sciences, Marquette University, Milwaukee, WI, United States</li> </ul>
<p>Patients with the fatal disorder Transthyretin Amyloidosis (ATTR) experience polyneuropathy through the progressive destruction of peripheral nervous tissue. In these patients, the transthyretin (TTR) protein dissociates from its functional tetrameric structure, misfolds, and aggregates into extracellular amyloid deposits that are associated with disease progression. These aggregates form large fibrillar structures as well as shorter oligomeric aggregates that are suspected to be cytotoxic. Several studies have shown that these extracellular TTR aggregates enter the cell and accumulate intracellularly, which is associated with increased proteostasis response. However, there are limited experimental models to study how proteostasis influences internalized TTR aggregates. Here, we use a humanized yeast system to recapitulate intracellular TTR aggregating protein <i>in vivo</i>. The yeast molecular chaperone Hsp104 is a disaggregase that has been shown to fragment amyloidogenic aggregates associated with certain yeast prions and reduce protein aggregation associated with human neurogenerative diseases. In yeast, we found that TTR forms both SDS-resistant oligomers and SDS-sensitive large molecular weight complexes. In actively dividing cultures, Hsp104 has no impact on oligomeric or large aggregate populations, yet overexpression of Hsp104 is loosely associated with an increase in overall aggregate size. Interestingly, a potentiating mutation in the middle domain of Hsp104 consistently results in an increase in overall TTR aggregate size. These data suggest a novel approach to aggregate management, where the Hsp104 variant shifts aggregate populations away from toxic oligomeric species to more inert larger aggregates. In aged cultures Hsp104 overexpression has no impact on TTR aggregation profiles suggesting that these chaperone approaches to shift aggregate populations are not effective with age, possibly due to proteostasis decline.</p> <div class="clear"></div> </div> <div class="JournalFullText"> <a id="h2" name="h2"></a>
<h2>Introduction</h2>
<p class="mb15">Onset of the progressively fatal disease Transthyretin Amyloidosis (ATTR) is associated with the amyloidogenic aggregation of the human transthyretin (TTR) protein. As a functional tetramer, TTR shuttles hormone and proteins within the bloodstream and CNS. However, the tetramer can dissociate with age, leading to the misfolding and subsequent aggregation of the TTR monomer. It is the tetramer dissociation that is considered the rate limiting step of the aggregation process (<a href="#ref22">Hammarstrom et al., 2003</a>). The misfolded monomer can assemble into small oligomeric species or large amyloid. <i>In vitro</i> evidence suggests that these small oligomeric TTR aggregates are cytotoxic (<a href="#ref8">Dasari et al., 2019</a>). Over time, the circulating TTR aggregates are deposited into the heart and peripheral nerves, leading to system organ failure and death (<a href="#ref17">Gertz et al., 2015</a>). Interestingly, approaches that shift the equilibrium away from cytotoxic oligomeric species and towards either monomeric protein or large amyloid may be a means to delay the disease.</p>
<p class="mb15">Transthyretin aggregates have been observed within cells, detected as intracellular cytoplasmic deposits (<a href="#ref4">Brett et al., 1999</a>; <a href="#ref36">Misumi et al., 2013</a>). Cells with internalized TTR also display an upregulation of the HSF1 protein, a master regulator for heat shock related chaperones (<a href="#ref44">Santos et al., 2010</a>). Furthermore, the levels of several molecular chaperones appear to be increased in ATTR patients (<a href="#ref36">Misumi et al., 2013</a>; <a href="#ref7">da Costa et al., 2015</a>) suggesting a correlation between internalization and an <i>in vivo</i> molecular chaperone response.</p>
<p class="mb15">Molecular chaperones play an important role in maintaining protein homeostasis by facilitating proper polypeptide folding while managing the accumulation of excess aberrantly folded proteins (<a href="#ref37">Mogk et al., 2018</a>). Elevated chaperone activity not only is associated with ATTR, but chaperones have been shown to contribute to the prevention of neurodegenerative disease onset, such as Alzheimer&#x2019;s and Prion disease (<a href="#ref55">Wentink et al., 2019</a>; <a href="#ref53">Tittelmeier et al., 2020</a>). However, as cells age, the ability for chaperones to maintain intracellular proteostasis declines, resulting in protein aggregation and associated disease onset (<a href="#ref26">Klaips et al., 2018</a>).</p>
<p class="mb15">The study of protein aggregation and chaperones in yeast has greatly advanced our mechanistic understanding of how chaperones influence protein aggregates in humans (<a href="#ref52">Surguchov, 2021</a>). The AAA+ hexameric ATPase, Hsp104, interacts with highly conserved Hsp70 and Hsp40 co-chaperones to fragment several yeast prions that are amyloidogenic. The Hsp104/70/40 complex extracts monomeric subunits from the middle of prion fibrils, thus fragmenting the aggregate into smaller pieces (<a href="#ref41">Parsell et al., 1994</a>; <a href="#ref18">Glover and Lindquist, 1998</a>; <a href="#ref50">Shorter and Lindquist, 2004</a>; <a href="#ref45">Satpute-Krishnan et al., 2007</a>; <a href="#ref10">DeSantis et al., 2012</a>). While Hsp104 is not found in metazoans, <i>in vitro</i> studies show that wildtype-Hsp104 can disassemble human amyloidogenic aggregating proteins (<a href="#ref32">Lo Bianco et al., 2008</a>; <a href="#ref31">Liu et al., 2011</a>; <a href="#ref10">DeSantis et al., 2012</a>; <a href="#ref34">March et al., 2019</a>). In contrast, <i>in vivo</i> studies indicate that wildtype-Hsp104 has little effect on aggregate disassembly, while mutations within the regulatory middle-domain can potentiate Hsp104 function resulting in aggregate disaggregation and suppression of cellular toxicity (<a href="#ref23">Jackrel et al., 2014</a>; <a href="#ref35">March et al., 2020</a>).</p>
<p class="mb0">Several labs have used a yeast-based system in which intracellular TTR is expressed as a monomer, thus bypassing the rate limiting step of conversion from tetrameric to monomeric form, which allows for rapid TTR aggregation (<a href="#ref9">Derkatch et al., 2004</a>; <a href="#ref19">Gomes et al., 2012</a>; <a href="#ref54">Verma et al., 2018</a>). The aggregated TTR displays hallmarks of amyloidogenic protein including detection of SDS-resistant complexes (<a href="#ref19">Gomes et al., 2012</a>) and fluorescent puncta when fused to GFP (<a href="#ref9">Derkatch et al., 2004</a>; <a href="#ref54">Verma et al., 2018</a>). Here, we use this yeast-based system to explore how Hsp104 influences the formation of TTR aggregates <i>in vivo</i>. We find that TTR forms both SDS-resistant oligomers and aggregates of larger sizes. However, it appears that these SDS-resistant species also make up larger aggregates held together by SDS-sensitive bonds. While loss of Hsp104 reduces the abundance of detergent resistant TTR populations, it does not impact the size of SDS-resistant oligomers. While overexpression of wildtype Hsp104 is loosely associated with an increase in overall TTR aggregate size, a Hsp104 middle domain mutant containing a A503S substitution is associated with a more definitive increase in aggregate size. We suspect that this mutation plays an important role in shifting the equilibrium away from the oligomeric species towards larger aggregates. However, any Hsp104 specific influence observed on TTR aggregates during logarithmic growth no longer occurs in saturated cultures, suggesting that Hsp104 alone cannot overcome age-related proteostasis decline.</p> <a id="h3" name="h3"></a>
<h2>Materials and methods</h2>
<h3>Strains, plasmids, and cultivation procedures</h3>
<p class="mb15">All yeast strains are derivatives of the 74-D694 background and listed in <a href="#SM1">Supplementary Table 1</a>. <i>hsp104&#x0394;</i> 74-D694 strains were generated by standard homologous recombination as described in <a href="#ref33">Manogaran et al. (2011)</a>. Primers to generate this strain (M515) are listed in <a href="#SM1">Supplementary Table 2</a>. Plasmids used in this study are listed in <a href="#SM1">Supplementary Table 3</a>. Note that centromeric plasmids are usually held at 2&#x2013;10 copies per cell and 2 micron plasmids are held at 20&#x2013;50 copies per cell (<a href="#ref24">Karim et al., 2013</a>). <i>hsp104&#x0394;</i> strains transformed with the TTR-GFP plasmid (p3146) were also co-transformed with plasmids containing an Hsp104 promoter (<i>HSE</i>) driving either empty vector (EV; p3168), wildtype Hsp104 (Hsp104<sup>OE</sup>; p3169), Hsp104 with a A503V mutation (Hsp104<sup>A503V</sup>; p3170), or Hsp104 with a A503S mutation (Hsp104<sup>A503S</sup>; p3171).</p>
<p class="mb0">Yeast strains were grown using standard media and cultivation procedures (<a href="#ref49">Sherman et al., 1986</a>). Nutrient rich media (YPD) or synthetic complete media containing the required amino acids and 2% dextrose (SD) was used. Growth of involved fresh transformants patched onto solid selective media and grown overnight at 30&#x000B0;C before inoculating liquid cultures. Liquid cultures were grown to log phase (OD<sub>600</sub> =&#x2009;0.4&#x2013;0.8; approximately 24&#x2009;h), or until saturation (OD<sub>600</sub> =&#x2009;1.6 or higher; approximately 48&#x2009;h).</p>
<h3>Microscopy</h3>
<p class="mb0">For co-localization experiments, strains were transformed with TTR-eGFP (p3146) and mCherry (p3197) or Hsp104-mCherry (p3172). 3D images were captured with a 63X (oil immersion, N.A. 1.4) objective on a DMI600 Leica inverted microscope using Leica K5 camera and LasX software. For print, images were subjected to 3D deconvolution, using AutoQuant deconvolution software and shown as maximum projection images. For quantifying the number of cells with TTR-eGFP puncta, strains were transformed with TTR-eGFP (p3146) and either empty vector (p3168), Hsp104<sup>OE</sup> (p3169), Hsp104<sup>A503V</sup> (p3170), or Hsp104<sup>A503S</sup> (p3171). Strains were grown to log or saturation, and 3D images of independent transformants were captured and quantified for the number of cells that contained GFP puncta compared to all cells expressing GFP.</p>
<h3>Biochemical analysis of yeast lysates</h3>
<p class="mb0">Cell lysates were prepared from 50&#x2009;ml cultures by glass bead lysis with 1x lysis buffer (50&#x2009;mM Tris&#x2013;HCl, 100&#x2009;mM KCl, 20&#x2009;mM, MgCl<sub>2</sub>&#x2022;6H<sub>2</sub>0, 2&#x2009;mM EDTA, 10% glycerol; pH 7.5), protease inhibitor cocktail (Sigma) and PMSF (Sigma), while kept on ice to prevent protease degradation, as described in <a href="#ref48">Sharma et al. (2017)</a>. To analyze protein steady state levels, 75&#x2013;125&#x2009;&#x03BC;g of crude cell extracts were treated with 2% SDS sample buffer (25&#x2009;mM Tris pH 6.8, 200&#x2009;mM glycine, 5% glycerol, and 0.025% bromophenol blue) and boiled for 8&#x2009;min at 98&#x000B0;C before electrophoretically resolved on 10% acrylamide gel. Gels were transferred to PVDF membrane, blocked using Tropix&#x000AE; I-Block&#x02122; solution (Applied Biosystems, Ref: T2015) before antibody exposure (<a href="#SM1">Supplementary Table 4</a>). Blots were subjected to standard Western blot procedures. Given signal proximity, TTR antibody was detected with horse radish peroxidase using a luminol stubstrate, while PGK antibody was detected with alkaline phosphatase using a CDP-STAR Tropix&#x000AE; substrate. Antibody signal was captured by the Amersham Imager 600 and images quantified by ImageJ. Well-trap assays (<a href="#ref30">Liebman et al., 2006</a>) were performed similarly to above, except unboiled samples were incubated at room temperature for 8&#x2009;min instead of boiling.</p>
<h3>Sucrose gradient fractionation</h3>
<p class="mb0">Discontinuous sucrose gradients were performed as previously described <a href="#ref12">Dorweiler et al. (2020)</a>. Briefly, gradients consisting of 10, 40, and 60% sucrose (w/vol) were made in 1&#x000D7; lysis buffer and stored at-80&#x000B0;C. Gradients were thawed on ice, and an aliquot containing 6&#x2013;8&#x2009;mg of protein was loaded onto the gradient. Samples were spun at 16,000&#x000D7; <i>g</i> 4&#x000B0;C for 120&#x2009;min in a swinging bucket rotor. 10 fractions of 180&#x2009;&#x03BC;l each were collected per sample. Equivalent volumes of fractions were loaded onto SDS-PAGE and subjected to standard Western blot procedures. The intensity of individual fractions was compared to total intensity of combined fractions from each trial to derive a percent value of resolvable protein per fraction. These values per fraction were then binned according to sucrose layer to derive the percent of total protein: fractions 1&#x2013;4 representing the 10% layer, fractions 5&#x2013;7 representing the 40% layer, and fractions 8&#x2013;10 and the pellet representing the 60% layer.</p>
<h3>SDD-AGE</h3>
<p class="mb0">To analyze SDS-resistant oligomers by SDD-AGE, 230&#x2009;&#x03BC;g of crude lysate, or a 1:1 ratio of sucrose gradient fraction to 1&#x000D7; lysis buffer, was treated with 2% SDS loading buffer and incubated at room temperature for a minimum of 5&#x2009;min prior to loading into a 1.5% agarose gel containing 0.1% SDS. Protein was transferred to nitrocellulose membrane <i>via</i> capillary transfer, as described in <a href="#ref21">Halfmann and Lindquist (2008)</a>. Blots were subjected to standard Western blot procedures and probed with polyclonal TTR antibody.</p> <a id="h4" name="h4"></a>
<h2>Results</h2>
<h3>Hsp104 colocalizes with visible TTR puncta</h3>
<p class="mb0">To begin to understand how Hsp104 influences TTR aggregation <i>in vivo</i>, we assessed whether Hsp104 co-localized with TTR fluorescent puncta. Using <i>hsp104</i>&#x2206; strains, where the only source of Hsp104 was from a plasmid expressing Hsp104-mCherry, TTR puncta consistently colocalized with Hsp104-mCherry in all images (<a href="#fig1">Figure 1A</a>). These data suggest that Hsp104 may potentially interact with TTR-GFP aggregates and influence their formation.</p>
<div class="DottedLine"></div> <div class="Imageheaders">FIGURE 1</div> <div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg" name="figure1" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg" alt="www.frontiersin.org" id="fig1" loading="lazy">
  </picture>
</a>
<p><b>Figure 1</b>. TTR-GFP forms fluorescent puncta that co-localizes with Hsp104. <b>(A)</b> <i>hsp104</i>&#x2206; cells were transformed with the indicated plasmid combinations and grown for approximately 48&#x2009;h. Representative fluorescent microscopy images with the indicated proteins are shown. <b>(B)</b> Cells in wildtype strains (WT; containing a genomic copy of <i>HSP104</i>), <i>hsp104</i>&#x2206; strains, and <i>hsp104</i>&#x2206; strains with a plasmid moderately overexpressing Hsp104 (Hsp104<sup>OE</sup>) were grown to log (OD<sub>600</sub>&#x2009;=&#x2009;0.4&#x2013;0.8, approximately 24&#x2009;h). The percentage of GFP expressing cells containing puncta was plotted from 3 independent experiments. Total number of cells counted of the three experiments is reported above. Data is shown as means and standard deviation.</p></div> <div class="clear"></div> <div class="DottedLine"></div>
<p class="mb15">Previous work used visual aggregates to track TTR aggregation, well after cultures reached saturation, reporting approximately 5&#x2013;7% of cells exhibit TTR-GFP as visible puncta after 72&#x2009;h of growth (<a href="#ref54">Verma et al., 2018</a>). To determine whether incubation time correlated with the number of cells with visible puncta, we assessed the percent of cells containing puncta in mid-log (OD<sub>600</sub> =&#x2009;0.4&#x2013;0.8) growth after 24&#x2009;h. Wildtype strains with an endogenous copy of Hsp104 (WT) exhibited on average less than 0.5% of cells with puncta, while strains lacking <i>HSP104</i> (<i>hsp104&#x0394;</i>) had almost three times as many cells with puncta (<a href="#fig1">Figure 1B</a>) suggesting that Hsp104 appears to play a role in limiting the formation of visible aggregates. In addition, considering results from <a href="#ref54">Verma et al. (2018)</a>, the number of cells containing visible TTR puncta appear to increase over time.</p>
<p class="mb0">It has been shown that increased levels of Hsp104 result in the loss of an endogenous yeast amyloid called the [<i>PSI</i><sup>+</sup>] prion (<a href="#ref5">Chernoff et al., 1995</a>). A plasmid containing wildtype <i>HSP104</i> driven by the <i>HSP104</i> promoter on a centromeric plasmid increases steady state Hsp104 levels approximately 8-10-fold more when compared to endogenous levels (<a href="#SM1">Supplementary Figure 1</a>). When this same plasmid was introduced in a <i>hsp104</i>&#x2206; strain (Hsp104<sup>OE</sup>; see materials and methods), we found that cells did not have any detectable TTR-GFP puncta after 24&#x2009;h of growth (<a href="#fig1">Figure 1B</a>). It is important to note that the presence or absence of Hsp104 in log cultures does not impact TTR steady state levels (<a href="#SM1">Supplementary Figure 2A</a>), and TTR expression does not impact endogenous or plasmid-derived Hsp104 steady state levels (<a href="#SM1">Supplementary Figures 2B,C</a>). We also verified that these plasmids produced more than endogenous levels of Hsp104 by an independent prion-curing assay, since excess Hsp104 cures the [<i>PSI</i><sup>+</sup>] prion. Using weak [<i>PSI</i><sup>+</sup>] log cultures, we show that the plasmid derived Hsp104<sup>OE</sup> resulted in 5-fold more [<i>PSI</i><sup>+</sup>] loss compared to strains with empty vector plasmids (<a href="#SM1">Supplementary Figure 3</a>).</p>
<h3>Hsp104 increases the abundance of SDS-resistant TTR populations</h3>
<p class="mb0">If the low percentage of cells with visible TTR puncta correlates with the amount of aggregated TTR, then biochemical analysis should detect high amounts of soluble monomeric TTR in all strains. Previous work has shown that TTR expressed in yeast forms SDS-resistant aggregates (<a href="#ref54">Verma et al., 2018</a>). Similarly, amyloidogenic proteins are commonly detergent resistant and only enter an SDS-PAGE gel upon boiling (<a href="#ref25">Kazantsev et al., 1999</a>; <a href="#ref27">Kryndushkin et al., 2003</a>; <a href="#ref40">Nizhnikov et al., 2014</a>; <a href="#ref1">Andrich et al., 2017</a>). To determine the percentage of TTR protein that is SDS-resistant, well-trap assays were performed. In this assay, large SDS-resistant aggregates are trapped in the well in unboiled lysates and are broken and resolved as a monomer in boiled lysates. Roughly 50% of TTR from WT log cultures are SDS-resistant (<a href="#fig2">Figure 2A</a>). We also found that a L55P TTR mutation, which has previously considered to be amyloidogenic in yeast (<a href="#ref19">Gomes et al., 2012</a>), as well as a L110Q mutation show similar aggregation compared to wildtype TTR (<a href="#SM1">Supplementary Figure 4</a>). Interestingly, there is a 5-fold reduction of SDS-resistant TTR populations in <i>hsp104&#x2206;,</i> suggesting that Hsp104 may play a role in facilitating the formation of SDS-resistant populations. Conversely, increased levels of Hsp104 through plasmid expression in Hsp104<sup>OE</sup> showed a 2-fold reduction in SDS-resistant aggregates compared to WT strains expressing endogenous Hsp104. It is important to note that the amount of TTR that is not visible in unboiled WT strains is well beyond the percentage of cells that contain visible puncta (<a href="#fig1">Figure 1B</a>), indicating that these SDS-resistant populations are likely not visible as fluorescent puncta.</p>
<div class="DottedLine"></div> <div class="Imageheaders">FIGURE 2</div> <div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg" name="figure2" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg" alt="www.frontiersin.org" id="fig2" loading="lazy">
  </picture>
</a>
<p><b>Figure 2</b>. Hsp104 enhances the formation of SDS-resistant populations, but oligomer size appears to be unaffected <b>(A)</b> (Top) Lysates from WT or <i>hsp104</i>&#x2206; strains co-transformed with TTR-GFP and HSE-EV, or <i>hsp104&#x2206;</i> strains co-transformed with TTR-GFP and HSE-Hsp104 (Hsp104<sup>OE</sup>) were incubated at room temperature (&#x02212;) or boiled (+). Representative Western blots using anti-TTR or anti-PGK antibody, captured with different detection methods (see Materials and Methods), is shown. PGK was used to confirm even sample loading and quantification of the amount of SDS-resistant aggregated protein was determined by calculating the ratio of unboiled to boiled sample (Bottom). Quantification is from 3 Independent trials. Data is shown as means and ranges. &#x0002A;<i>p</i>&#x2009;&#x02264;&#x2009;0.05, &#x0002A;&#x0002A;<i>p</i>&#x2009;&#x02264;&#x2009;0.01, by unpaired two-tailed <i>t</i>-test. <b>(B)</b> SDD-AGE analysis was used to resolve SDS-resistant oligomers. Lysates from [<i>psi</i><sup>&#x02212;</sup>] or weak[<i>PSI<sup>+</sup></i>] strains (left) or TTR expressing lysates from the indicated (right) were subjected to SDD-AGE analysis and visualized with anti-Sup35 and anti-TTR, respectively. Arrows denote monomeric Sup35 (Left) or TTR-GFP (right). It is important to note that lysates from strains are loaded in a different order than <b>(A)</b>. Representative images are shown.</p></div> <div class="clear"></div> <div class="DottedLine"></div>
<p class="mb0">Semi-denaturing agarose gels (SDD-AGE; <a href="#ref27">Kryndushkin et al., 2003</a>; <a href="#ref2">Bagriantsev et al., 2006</a>; <a href="#ref21">Halfmann and Lindquist, 2008</a>) can resolve SDS-resistant oligomer populations that may be too large to enter a SDS-PAGE gel. In the case of the [<i>PSI</i><sup>+</sup>] prion, SDS-resistant oligomers consisting of approximately 9&#x2013;50 monomers of Sup35 can be detected (<a href="#ref27">Kryndushkin et al., 2003</a>). We find TTR forms SDS-resistant oligomeric species in unboiled wildtype lysates (<a href="#fig2">Figure 2B</a>). These TTR protein smears are resolved closer to the bottom of the gel when compared to weak [<i>PSI</i><sup>+</sup>], indicating that TTR oligomers are smaller than [<i>PSI</i><sup>+</sup>] oligomers. Given that TTR is unable to maintain its tetrameric structure in the presence of SDS (<a href="#ref6">Colon and Kelly, 1992</a>), and little to no dimers or tetramers were detected by SDS-PAGE and Western blots (<a href="#SM1">Supplementary Figure 5</a>), the size range of these smears, as well as their disappearance upon boiling (<a href="#fig2">Figure 2B</a>), suggest TTR forms SDS-resistant oligomers and not tetramers. Interestingly, the SDS-resistant oligomer did not change size when Hsp104 was absent or overexpressed, suggesting that Hsp104 does not impact the formation of these SDS-resistant oligomers.</p>
<h3>TTR aggregate size changes in Hsp104<sup>OE</sup> strains</h3>
<p class="mb0">TTR expression in our yeast model yields both monomeric and aggregated TTR protein. While SDS-treatment shows that oligomers and aggregates are SDS-resistant, it is unclear whether the monomers generated by SDS-treatment are normally associated in higher molecular weight complexes in the absence of SDS. To answer this question, we employed a different approach to assess the general distribution of TTR aggregate sizes in all three strains. A discontinuous sucrose gradient (10, 40, and 60% sucrose, <i>w/w</i>) can trap protein complexes and aggregates of different sizes within the interface between different sucrose concentrations (<a href="#ref12">Dorweiler et al., 2020</a>). Crude lysates were directly loaded onto a discontinuous gradient and collected in 10 fractions and subjected to Western blot using anti-TTR antibody (<a href="#fig3">Figure 3A</a>). To quantify protein sedimentation, we combined TTR signal intensity from the top (soluble protein or small size complexes: fractions 1&#x2013;4; &#x201C;10%&#x201D;), middle (moderate size complexes: fractions 5&#x2013;7; &#x201C;40%&#x201D;), and bottom and pellet (high molecular weight complexes; fractions 8&#x2013;10 and pellet; &#x201C;60%&#x201D;; <a href="#fig3">Figure 3A</a>) fractions of the gradient.</p>
<div class="DottedLine"></div> <div class="Imageheaders">FIGURE 3</div> <div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg" name="figure3" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg" alt="www.frontiersin.org" id="fig3" loading="lazy">
  </picture>
</a>
<p><b>Figure 3</b>. TTR sediments with higher molecular weight complexes in Hsp104<sup>OE</sup> log cultures. <b>(A)</b> Lysates from the indicated strains were loaded onto a discontinuous sucrose gradient (10, 40, 60% sucrose, <i>w/w</i>). 10 fractions were collected, with fractions 1&#x2013;4 equivalent to the supernatant and 10% sucrose, fractions 5&#x2013;7 equivalent to 40% sucrose, and fractions 8&#x2013;10 equivalent to the 60% sucrose layers. P indicates pellet and L indicates separately loaded whole cell lysates. (Top) Representative blots of TTR sedimentation in log cultures are shown. (Bottom) Quantification of sedimented TTR signal in fractions 1&#x2013;4 (10%), fractions 5&#x2013;7 (40%), or fractions 8-P (60%) compared to total protein in all fractions. All quantification represents 4&#x2013;6 independent cultures per strain. Data is shown as means and ranges. &#x0002A;<i>p</i>&#x2009;&#x02264;&#x2009;0.05 by unpaired two-tailed <i>t</i>-test. <b>(B)</b> The lysates of WT strain in log growth were either treated in the presence or absence of 2.0% SDS prior to centrifugation on discontinuous sucrose gradients. Gradients were spun at 25&#x000B0;C to prevent SDS precipitation. <b>(C)</b> Untreated lysates were subjected to sucrose gradient sedimentation, and lysates were resolved by SDD-AGE and visualized with anti-TTR. Note that L <b>(B)</b> indicates crude lysate that were boiled prior to loading. Arrows denote TTR monomers. Representative images are shown.</p></div> <div class="clear"></div> <div class="DottedLine"></div>
<p class="mb0">In wildtype log cultures, the bulk of sedimented protein is in the 10% fractions (<a href="#fig3">Figures 3A</a>,<a href="#fig3">B</a>). Conversely, there is a large difference in sedimentation patterns between Hsp104<sup>OE</sup> and the other strains. While WT and <i>hsp104&#x2206;</i> strains show the bulk of TTR fractionate to 10% (<a href="#fig3">Figure 3A</a>; <a href="#SM1">Supplementary Figure 6A</a>), the overexpression of Hsp104 (Hsp104<sup>OE</sup>) shows TTR preferentially fractionating to either the 10% or 60% fractions (<a href="#fig3">Figure 3A</a>; <a href="#SM1">Supplementary Figure 6B</a>). The inconsistent TTR sedimentation pattern from Hsp104<sup>OE</sup> strains is unlikely a product of variable Hsp104 expression from the centromeric plasmid since Hsp104 steady state levels appeared to be similar (<a href="#SM1">Supplementary Figure 6B</a>). Closer analysis of individual trials show that an increase in TTR sedimentation in the 60% sucrose fractions is associated with a decrease in 10% sucrose fractions and vice versa (<a href="#SM1">Supplementary Figure 6B</a>). Interestingly, there is no dramatic change in TTR sedimentation in the 40% fractions. Taking the SDS-treatment and sucrose gradient results together, our data show that while SDS-resistant oligomer formation is Hsp104 independent (<a href="#fig5">Figure 5B</a>), the formation of SDS-resistant populations and overall TTR aggregation is influenced by Hsp104 overexpression (<a href="#fig3">Figures 3A</a>, <a href="#fig2">2A</a>).</p>
<div class="DottedLine"></div> <div class="Imageheaders">FIGURE 5</div> <div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg" name="figure5" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg" alt="www.frontiersin.org" id="fig4" loading="lazy">
  </picture>
</a>
<p><b>Figure 5</b>. The effect of Hsp104 on aggregating TTR is muted in saturated cultures. All cultures were grown to saturation (OD<sub>600</sub>&#x2009;&#x02265;&#x2009;2.0) over 48&#x2009;h. <b>(A)</b> (Top) Representative blots from lysates were incubated at room temperature (&#x02212;) or boiled (+). (Bottom) Quantification of SDS-resistant aggregated protein. Quantification is from at least 3 independent trials. Data is shown as means and ranges. <b>(B)</b> Lysates subjected to discontinuous sucrose gradient centrifugation and detected with anti-TTR antibody. (Top) Representative blots of TTR sedimentation. (Bottom) Quantification of sedimented TTR signal. All quantification represents 4&#x2013;6 independent cultures per strain. Data is shown as means and ranges. <b>(C)</b> Sucrose gradient fractions of indicated strains from saturated cultures were resolved by SDD-AGE and visualized with anti-TTR. Note that L <b>(B)</b> indicates crude lysate that were boiled prior to loading. Arrows denote TTR monomers. Representative images are shown.</p></div> <div class="clear"></div> <div class="DottedLine"></div>
<p class="mb0">To better understand the relationship between SDS-resistant populations, oligomers resolved by SDD-AGE, and TTR aggregates resolved by sucrose gradient, we performed two experiments. In the first experiment, we wanted to determine whether TTR associated with the high molecular weight fractions of a sucrose gradient are involved in SDS-sensitive associations. Based on the relatively smaller size of SDS-resistant oligomers resolved by SDD-AGE, and TTR sedimentation in high molecular weight fractions, we suspected that SDS treatment of crude lysates would dissolve larger SDS-sensitive structures into smaller SDS-resistant oligomers. Therefore, crude lysates were treated with SDS prior to fractionation on the sucrose gradient. SDS-treated crude lysates result in a TTR sedimentation pattern to only the top 3 fractions of the gradient (<a href="#fig3">Figure 3B</a>), suggesting that TTR protein in higher gradient fractions are held together by SDS-sensitive associations. In the second experiment, we wanted to confirm whether SDS-resistant oligomers were found in higher molecular weight TTR fractions. Untreated fractionated lysates were run on SDD-AGE gels. We found that SDS-resistant oligomers are associated with all fractions regardless of sedimentation patterns or Hsp104 levels (<a href="#fig3">Figure 3C</a>). Taken together, these data support an aggregate model comprised of smaller SDS-resistant oligomers held together as higher ordered structures by SDS-sensitive associations.</p>
<h3>Hsp104<sup>A503S</sup> mutant maintains SDS-resistant TTR oligomer sizes but lead to larger TTR aggregates</h3>
<p class="mb15">The middle domain of Hsp104 has been shown to be important for regulating disaggregase activity and co-chaperone interaction during aggregate disassembly (<a href="#ref46">Schirmer et al., 2004</a>; <a href="#ref29">Lee et al., 2010</a>; <a href="#ref51">Sielaff and Tsai, 2010</a>; <a href="#ref11">Desantis and Shorter, 2012</a>; <a href="#ref14">Dulle et al., 2014</a>; <a href="#ref23">Jackrel et al., 2014</a>). Several mutations within the middle domain of Hsp104 have been shown to reduce aggregation and toxicity associated with aggregated amyloidogenic human protein <i>in vivo</i> (<a href="#ref23">Jackrel et al., 2014</a>; <a href="#ref35">March et al., 2020</a>), and potentiate the disaggregase activity with co-chaperones <i>in vitro</i> (<a href="#ref23">Jackrel et al., 2014</a>). We asked whether middle domain mutations would also reduce TTR protein aggregation. Middle domain mutants A503V or A503S in a <i>hsp104&#x2206;</i> background, to create Hsp104<sup>A503V</sup> and Hsp104<sup>A503S</sup> strains, were tested. Steady state levels of these Hsp104 mutants were similar to Hsp104<sup>OE</sup> strain at 8&#x2013;10 times higher concentration than endogenous levels (<a href="#SM1">Supplementary Figure 1</a>). Similarly, TTR steady state levels and the percentage of cells exhibiting TTR puncta were similar in Hsp104<sup>OE</sup>, Hsp104<sup>A503V</sup>, or Hsp104<sup>A503S</sup> log cultures (<a href="#SM1">Supplementary Figures 2A, 7A</a>).</p>
<p class="mb0">Well-trap and SDD-AGE experiments show that the Hsp104<sup>A503V</sup> and Hsp104<sup>A503S</sup> mutants show similar percent SDS-resistant TTR populations and size of SDS-resistant TTR oligomers compared with Hsp104<sup>OE</sup> (<a href="#fig4">Figures 4A</a>,<a href="#fig4">B</a>). Sucrose gradient fractionation of TTR in Hsp104<sup>A503V</sup> sedimented similarly to <i>hsp104&#x2206;</i> strains with the bulk of the protein found in 10% fractions. Interestingly, Hsp104<sup>A503S</sup> shows strong sedimentation of TTR to the bottom of the gradient, much more consistently than Hsp104<sup>OE</sup>. The dichotomy of how each Hsp104 mutant sediments TTR populations, despite maintaining TTR oligomer sizes in all fractions (<a href="#fig4">Figure 4D</a>), suggests a functional difference between the two variants.</p>
<div class="DottedLine"></div> <div class="Imageheaders">FIGURE 4</div> <div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg" name="figure4" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg" alt="www.frontiersin.org" id="fig5" loading="lazy">
  </picture>
</a>
<p><b>Figure 4</b>. Strains expressing Hsp104<sup>A503V</sup> show different sedimentation profiles compared to strains expressing Hsp104<sup>OE</sup>. <b>(A)</b> Similar to <a href="#fig2">Figure 2A</a>, TTR expressing <i>hsp104&#x2206;</i> strains co-transformed with either Hsp104<sup>OE</sup>, Hsp104<sup>A503V</sup>, or Hsp104<sup>A503S</sup>. (Top) Representative Western blots. (Bottom) Quantification is from 3 independent trials. <i>hsp104&#x2206;</i> and Hsp104<sup>OE</sup> data from <a href="#fig2">Figure 2A</a>. Data is shown as means and ranges. <b>(B)</b> Log culture lysates of indicated strains were resolved by SDD-AGE. The arrow denotes TTR monomers. Representative images are shown. <b>(C)</b> Western blot of lysates from the indicated log strains subjected to a discontinuous sucrose gradient. (Top) Representative blots of TTR sedimentation from lysates, and (Bottom) quantification of TTR signal as percent of total protein, as in <a href="#fig3">Figure 3A</a>. <i>hsp104&#x2206;</i> and Hsp104<sup>OE</sup> data from <a href="#fig3">Figure 3A</a>. All quantification represents 4&#x2013;5 independent cultures per strain. Data is shown as means and ranges. <b>(D)</b> Sucrose gradient fractions of indicated strains were resolved by SDD-AGE as in <a href="#fig3">Figure 3B</a>. Arrows denote TTR monomers. Representative images are shown.</p></div> <div class="clear"></div> <div class="DottedLine"></div>
<h3>Hsp104 related changes to TTR aggregation are not observed in saturated cultures</h3>
<p class="mb15">Since visible TTR aggregates are more abundant in saturated cultures (<a href="#ref54">Verma et al., 2018</a>) compared to log cultures (<a href="#fig1">Figure 1B</a>), we asked how TTR aggregation changes when cultures are in saturation. Cells in saturated culture have slower cell cycles, increased chronological aging, undergo metabolic shifts in response to diminishing nutrient availability, and have reduced ATP (<a href="#ref3">Bilinski et al., 2017</a>; <a href="#ref58">Zimmermann et al., 2018</a>). In saturated cultures, percentage of cells with fluorescent puncta increased in both WT and <i>hsp104&#x0394;</i> strains compared to log cultures (<a href="#SM1">Supplementary Figure 7</a>), confirming that the number of cells with visible aggregates increase with time. Surprisingly, increasing wildtype or mutant Hsp104 levels did not impact the number of cells with fluorescent puncta (<a href="#SM1">Supplementary Figure 7B</a>), suggesting that any potential effect that Hsp104 overexpression has on puncta formation in log cultures is lost in saturation. Interestingly, Hsp104<sup>OE</sup> does not seem to be completely inactive in saturated cultures since a slight but significant increase in prion loss is observed when compared to log cultures (<a href="#SM1">Supplementary Figure 3</a>). However, saturated cultures showed decreased plasmid derived Hsp104 steady state levels in the presence of TTR (<a href="#SM1">Supplementary Figures 2B,C</a>) and a modest increase in cell death when compared to log cultures (<a href="#SM1">Supplementary Figure 8</a>).</p>
<p class="mb15">The aggregation state of TTR in saturated cultures showed no difference when comparing the percent of protein in SDS-resistant aggregates (<a href="#fig5">Figure 5A</a>) or the size of oligomers (<a href="#SM1">Supplementary Figure 9</a>) between strains. Similarly, sucrose gradient sedimentation showed TTR fractionating to the top two-thirds of the sucrose gradient in all strains (<a href="#fig5">Figure 5B</a>). SDS-resistant oligomers persist in all sucrose gradient fractions (<a href="#fig5">Figure 5C</a>), similar to log cultures. However, while log cultures showed monomeric protein found in fractions 1&#x2013;3 in all strains (<a href="#fig3">Figures 3D</a>, <a href="#fig4">4D</a>), the monomeric protein was absent in saturated cultures in these fractions (<a href="#fig5">Figure 5C</a>).</p>
<p class="mb0">Nutrient availability declines in saturated cultures due to exhaustion of resources and buildup of waste material. To ensure that our observed TTR results from saturated cultures was not a simple product of limited nutrients, we refreshed the culture media every six hours between reaching mid-log growth to 48&#x2009;h. After 48&#x2009;h, we found that refreshing media had no effect on the percentage of TTR in SDS-resistant aggregates (<a href="#SM1">Supplementary Figure 10</a>). Taken together, our saturation data indicates that aggregating TTR populations change between log and saturated cultures, but TTR aggregates do not respond to altered levels of Hsp104 in saturated cultures.</p> <a id="h5" name="h5"></a>
<h2>Discussion</h2>
<p class="mb0">Here, we used a yeast-based system to understand TTR aggregate formation and how the molecular disaggregase, Hsp104, influences this process. Our study shows that fluorescently labeled Hsp104 colocalizes with visible TTR puncta (<a href="#fig1">Figure 1A</a>), but fluorescent puncta are not fully representative of TTR aggregation (<a href="#fig1">Figures 1B</a>, <a href="#fig2">2A</a>). Instead, this co-localization between TTR and Hsp104 suggest a molecular interaction <i>in vivo</i> and is the impetus for studying whether altering levels of Hsp104 influences aggregating TTR. Increased amount of SDS-resistant TTR protein form in the presence of Hsp104 (<a href="#fig2">Figure 2A</a>), yet SDS-resistant TTR oligomers and higher order structures containing SDS-sensitive associations form independently of Hsp104 (<i>hsp104&#x0394;</i>, <a href="#fig2">Figures 2B</a>,<a href="#fig3">3A</a>, <a href="#fig3">B</a>). These results suggest that the structure of higher order TTR aggregates is comprised of smaller SDS-resistant oligomeric populations held together by SDS-sensitive bonds (<a href="#fig6">Figure 6</a>). Introduction of the Hsp104<sup>A503S</sup> mutant shows TTR aggregates consistently sediment in higher molecular weight fractions (<a href="#fig4">Figure 4C</a>), which is consistent with previous studies that show Hsp104 middle domain mutations are more influential in the formation of human amyloidogenic protein aggregates compared to wildtype Hsp104 (<a href="#ref23">Jackrel et al., 2014</a>; <a href="#ref35">March et al., 2020</a>). Lastly, our work shows that Hsp104 exerts an effect on TTR aggregate populations during log phase growth, but not in saturated cultures. Given that media replacement does not change SDS-resistant TTR populations in saturated conditions (<a href="#fig5">Figure 5A</a>; <a href="#SM1">Supplementary Figure 10</a>), it is possible that the inability to respond to elevated Hsp104 levels is due to proteostasis collapse (<a href="#ref28">Labbadia and Morimoto, 2015</a>; <a href="#ref26">Klaips et al., 2018</a>).</p>
<div class="DottedLine"></div> <div class="Imageheaders">FIGURE 6</div> <div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg" name="figure6" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg" alt="www.frontiersin.org" id="fig6" loading="lazy">
  </picture>
</a>
<p><b>Figure 6</b>. Model of TTR aggregate growth by excess Hsp104. Red diamonds represent SDS-resistant TTR oligomers and blue rectangles represent SDS-sensitive associations to depict large TTR aggregates. (Top) Co-chaperones, possibly along with Hsp104, play a role in maintaining smaller sized aggregates. (Bottom) Excess Hsp104, or Hsp104<sup>A503S</sup>, increases aggregate size by possibly titrating chaperones away from the TTR aggregate.</p></div> <div class="clear"></div> <div class="DottedLine"></div>
<h3>TTR aggregate organization in yeast</h3>
<p class="mb0">Amyloid is commonly resistant to detergent solubilization (<a href="#ref25">Kazantsev et al., 1999</a>; <a href="#ref27">Kryndushkin et al., 2003</a>; <a href="#ref40">Nizhnikov et al., 2014</a>; <a href="#ref1">Andrich et al., 2017</a>) and therefore can be used to detect whether a protein aggregate is in an amyloidogenic state. Using well-trap assays, we show that a portion of the TTR population is in large SDS-resistant populations. Further analysis using semi-denaturing gels (SDD-AGE) shows both oligomeric and monomeric protein are detected. Tetrameric TTR-GFP is approximately 160&#x2009;kDa but is unlikely to be stable in the presence of 2% SDS (<a href="#ref6">Colon and Kelly, 1992</a>). Little or no high molecular weight TTR signal is detected in our SDS-PAGE gels (<a href="#SM1">Supplementary Figure 5</a>). Given the SDS-PAGE system is able to resolve proteins under 400&#x2009;kDa, the observation of larger molecule weight smears by SDD-AGE indicate a SDS-resistant TTR population larger than the tetramer.</p>
<h3>The formation of the TTR aggregate and the role of Hsp104</h3>
<p class="mb15">Hsp104&#x2019;s fragmentation activity has been well characterized in its role in prion propagation by fragmenting aggregates and generating smaller transmissible particles that can be inherited by daughter cells (<a href="#ref5">Chernoff et al., 1995</a>; <a href="#ref42">Paushkin et al., 1996</a>; <a href="#ref50">Shorter and Lindquist, 2004</a>; <a href="#ref45">Satpute-Krishnan et al., 2007</a>). Overexpression of Hsp104 leads to prion loss, however the mechanism of how overexpressed Hsp104 acts on the prion aggregate is still under debate. There are two prominent models that can explain prion loss: trimming and malpartition. The trimming model suggests that excess Hsp104 facilitates the disassembly of the prion aggregate fibril from the ends (<a href="#ref57">Zhao et al., 2017</a>; <a href="#ref20">Greene et al., 2020</a>). This model is largely supported by fluorescently labeled prion protein and the observed changes in generated fluorescent puncta (<a href="#ref57">Zhao et al., 2017</a>). In the malpartition model, aggregates become so large they are asymmetrically retained in the mother cell, unable to pass through the bud neck (<a href="#ref39">Ness et al., 2017</a>; <a href="#ref20">Greene et al., 2020</a>). It has been suggested that excess Hsp104 results in aggregate stability (<a href="#ref39">Ness et al., 2017</a>). Conversely, Hsp104 overexpression could unbalance the proper co-chaperone stoichiometric ratio required to form functional Hsp104/70/40 complexes, thereby decreasing fragmentation necessary for prion propagation (<a href="#ref56">Winkler et al., 2012</a>; <a href="#ref38">Naeimi and Serio, 2022</a>).</p>
<p class="mb15">We show that TTR aggregates sediment in higher molecular weight fractions occasionally with Hsp104<sup>OE</sup> (<a href="#fig3">Figure 3A</a>) and consistently with Hsp104<sup>A503S</sup> (<a href="#fig4">Figure 4C</a>). It is important to recognize that SDS-resistant oligomers form in the absence of Hsp104 (<a href="#fig2">Figure 2B</a>), and TTR aggregate sedimentation patterns are similar between <i>hsp104&#x2206;</i> and WT strains (<a href="#fig3">Figure 3A</a>). Therefore, while Hsp104 appears to co-localize with visible aggregates (<a href="#fig1">Figure 1</a>), it is unclear whether the chaperone is needed for aggregate formation, remodeling, or maintenance. In the case of TTR aggregates, it is possible that co-chaperones such as Hsp70 and Hsp40 work independently from Hsp104. This idea is supported by <i>in vitro</i> studies that show homologous human chaperone combinations disassemble and remodel human aggregating amyloidogenic proteins in the absence of Hsp104 (<a href="#ref13">Duennwald et al., 2012</a>; <a href="#ref47">Scior et al., 2018</a>; <a href="#ref16">Franco et al., 2021</a>).</p>
<p class="mb15">Overexpression of Hsp104<sup>A503S</sup> results in the sedimentation of TTR to the lowest fractions of the gradient (<a href="#fig4">Figure 4C</a>), suggesting that excess Hsp104<sup>A503S</sup> increases aggregate size. This increase in size is consistent with the malpartition model. It has been shown that this potentiated Hsp104 variant has increased ATP hydrolysis, has activity independent of the Hsp70 and altered substrate translocation (<a href="#ref23">Jackrel et al., 2014</a>; <a href="#ref15">Durie et al., 2019</a>). Given the relationship between excess Hsp104<sup>A503S</sup> and increased TTR aggregate size, it is possible that the middle domain mutant may impact co-chaperones interactions that are required for maintaining smaller aggregate populations in log cultures (<a href="#fig6">Figure 6</a>).</p>
<p class="mb0">In humans, the TTR monomer assembles into small oligomers and larger aggregates. These small oligomeric species are toxic (<a href="#ref43">Reixach et al., 2004</a>; <a href="#ref8">Dasari et al., 2019</a>) and have implications associated with poor patient outcomes. We show that in yeast, TTR forms both SDS-resistant oligomeric species and large aggregates, and overexpression of Hsp104<sup>A503S</sup> appears to shift the equilibrium of TTR to larger aggregates. This shift suggests that chaperone titration may be a novel approach to ameliorating cells of toxic TTR oligomers and delay disease progression. Future studies focusing on the relationship between chaperones and their ability to shift aggregate populations away from oligomeric species may hold promise for therapeutic interventions to combat the onset and progression of ATTR, and potentially other fatal neurodegenerative diseases.</p> <a id="h6" name="h6"></a>
<h2>Data availability statement</h2>
<p class="mb0">The raw data supporting the conclusions of this article are included in the article/supplementary material, further inquiries can be directed to the corresponding author.</p> <a id="h7" name="h7"></a>
<h2>Author contributions</h2>
<p class="mb0">ASK and ALM contributed to the conceptual design of the study, ASK, EED, HEB, JED, LEF, and ALM contributed to the acquisition, analysis, and/or interpretation of the data, and ASK and ALM have written the manuscript.</p> <a id="h8" name="h8"></a>
<h2>Funding</h2>
<p class="mb0">This work was supported by the Greater Milwaukee Foundation (20172483) and the National Institutes of Health (NIH) grant (GM131365) to AM, and the Schmitt Leadership Fellowship to AK.</p> <a id="h9" name="h9"></a>
<h2>Acknowledgments</h2>
<p class="mb0">The authors would like to thank Jim Shorter, Tiago Outiero, and Susan Lindquist for plasmids used in this study. Strains were a kind gift from Susan Liebman, and the BE4 (Sup35) antibody was a gift from Viravan Prapapanich and Susan Liebman. Images were created by Biorender.</p> <a id="h10" name="h10"></a>
<h2>Conflict of interest</h2>
<p class="mb0">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p> <a id="h11" name="h11"></a>
<h2>Publisher&#x2019;s note</h2>
<p class="mb0">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p> <a id="h12" name="h12"></a>
<h2>Supplementary material</h2>
<p class="mb0" id="SM1">The Supplementary material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fnmol.2022.1050472/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fnmol.2022.1050472/full#supplementary-material</a></p> <a id="h13" name="h13"></a>
<h2>References</h2>
<div class="References">
<p class="ReferencesCopy1"><a name="ref1" id="ref1"></a>Andrich, K., Hegenbart, U., Kimmich, C., Kedia, N., Bergen, H. R. 3rd, Schonland, S., et al. (2017). Aggregation of full-length immunoglobulin light chains from systemic light chain amyloidosis (AL) patients is remodeled by epigallocatechin-3-gallate. <i>J. Biol. Chem.</i> 292, 2328&#x2013;2344. doi: 10.1074/jbc.M116.750323 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28031465" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1074/jbc.M116.750323" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=K.+Andrich&#x00026;author=U.+Hegenbart&#x00026;author=C.+Kimmich&#x00026;author=N.+Kedia&#x00026;author=H.+R.+Bergen&#x00026;author=S.+Schonland&#x00026;publication_year=2017&#x00026;title=Aggregation+of+full-length+immunoglobulin+light+chains+from+systemic+light+chain+amyloidosis+(AL)+patients+is+remodeled+by+epigallocatechin-3-gallate&#x00026;journal=J.+Biol.+Chem.&#x00026;volume=292&#x00026;pages=2328-2344" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref2" id="ref2"></a>Bagriantsev, S. N., Kushnirov, V. V., and Liebman, S. W. (2006). Analysis of amyloid aggregates using agarose gel electrophoresis. <i>Methods Enzymol.</i> 412, 33&#x2013;48. doi: 10.1016/S0076-6879(06)12003-0 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/17046650" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/S0076-6879(06)12003-0" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S.+N.+Bagriantsev&#x00026;author=V.+V.+Kushnirov&#x00026;author=S.+W.+Liebman&#x00026;publication_year=2006&#x00026;title=Analysis+of+amyloid+aggregates+using+agarose+gel+electrophoresis&#x00026;journal=Methods+Enzymol.&#x00026;volume=412&#x00026;pages=33-48" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref3" id="ref3"></a>Bilinski, T., Bylak, A., and Zadrag-Tecza, R. (2017). The budding yeast <i>Saccharomyces cerevisiae</i> as a model organism: possible implications for gerontological studies. <i>Biogerontology</i> 18, 631&#x2013;640. doi: 10.1007/s10522-017-9712-x </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28573416" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s10522-017-9712-x" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=T.+Bilinski&#x00026;author=A.+Bylak&#x00026;author=R.+Zadrag-Tecza&#x00026;publication_year=2017&#x00026;title=The+budding+yeast+Saccharomyces+cerevisiae+as+a+model+organism:+possible+implications+for+gerontological+studies&#x00026;journal=Biogerontology&#x00026;volume=18&#x00026;pages=631-640" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref4" id="ref4"></a>Brett, M., Persey, M. R., Reilly, M. M., Revesz, T., Booth, D. R., Booth, S. E., et al. (1999). Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. <i>Brain</i> 122, 183&#x2013;190. doi: 10.1093/brain/122.2.183 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/10071047" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/brain/122.2.183" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Brett&#x00026;author=M.+R.+Persey&#x00026;author=M.+M.+Reilly&#x00026;author=T.+Revesz&#x00026;author=D.+R.+Booth&#x00026;author=S.+E.+Booth&#x00026;publication_year=1999&#x00026;title=Transthyretin+Leu12Pro+is+associated+with+systemic+neuropathic+and+leptomeningeal+amyloidosis&#x00026;journal=Brain&#x00026;volume=122&#x00026;pages=183-190" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref5" id="ref5"></a>Chernoff, Y. O., Lindquist, S. L., Ono, B., Inge-Vechtomov, S. G., and Liebman, S. W. (1995). Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. <i>Science</i> 268, 880&#x2013;884. doi: 10.1126/science.7754373 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/7754373" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1126/science.7754373" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y.+O.+Chernoff&#x00026;author=S.+L.+Lindquist&#x00026;author=B.+Ono&#x00026;author=S.+G.+Inge-Vechtomov&#x00026;author=S.+W.+Liebman&#x00026;publication_year=1995&#x00026;title=Role+of+the+chaperone+protein+Hsp104+in+propagation+of+the+yeast+prion-like+factor+[psi+]&#x00026;journal=Science&#x00026;volume=268&#x00026;pages=880-884" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref6" id="ref6"></a>Colon, W., and Kelly, J. W. (1992). Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. <i>Biochemistry</i> 31, 8654&#x2013;8660. doi: 10.1021/bi00151a036 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/1390650" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1021/bi00151a036" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=W.+Colon&#x00026;author=J.+W.+Kelly&#x00026;publication_year=1992&#x00026;title=Partial+denaturation+of+transthyretin+is+sufficient+for+amyloid+fibril+formation+in+vitro&#x00026;journal=Biochemistry&#x00026;volume=31&#x00026;pages=8654-8660" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref7" id="ref7"></a>da Costa, G., Ribeiro-Silva, C., Ribeiro, R., Gilberto, S., Gomes, R. A., Ferreira, A., et al. (2015). Transthyretin amyloidosis: chaperone concentration changes and increased proteolysis in the pathway to disease. <i>PLoS One</i> 10:e0125392. doi: 10.1371/journal.pone.0125392 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26147092" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0125392" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=G.+da+Costa&#x00026;author=C.+Ribeiro-Silva&#x00026;author=R.+Ribeiro&#x00026;author=S.+Gilberto&#x00026;author=R.+A.+Gomes&#x00026;author=A.+Ferreira&#x00026;publication_year=2015&#x00026;title=Transthyretin+amyloidosis:+chaperone+concentration+changes+and+increased+proteolysis+in+the+pathway+to+disease&#x00026;journal=PLoS+One&#x00026;volume=10&#x00026;pages=e0125392" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref8" id="ref8"></a>Dasari, A. K. R., Hughes, R. M., Wi, S., Hung, I., Gan, Z., Kelly, J. W., et al. (2019). Transthyretin aggregation pathway toward the formation of distinct cytotoxic oligomers. <i>Sci. Rep.</i> 9:33. doi: 10.1038/s41598-018-37230-1 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30631096" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41598-018-37230-1" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+K.+R.+Dasari&#x00026;author=R.+M.+Hughes&#x00026;author=S.+Wi&#x00026;author=I.+Hung&#x00026;author=Z.+Gan&#x00026;author=J.+W.+Kelly&#x00026;publication_year=2019&#x00026;title=Transthyretin+aggregation+pathway+toward+the+formation+of+distinct+cytotoxic+oligomers&#x00026;journal=Sci.+Rep.&#x00026;volume=9&#x00026;pages=33" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref9" id="ref9"></a>Derkatch, I. L., Uptain, S. M., Outeiro, T. F., Krishnan, R., Lindquist, S. L., and Liebman, S. W. (2004). Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. <i>Proc. Natl. Acad. Sci. U. S. A.</i> 101, 12934&#x2013;12939. doi: 10.1073/pnas.0404968101 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/15326312" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1073/pnas.0404968101" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=I.+L.+Derkatch&#x00026;author=S.+M.+Uptain&#x00026;author=T.+F.+Outeiro&#x00026;author=R.+Krishnan&#x00026;author=S.+L.+Lindquist&#x00026;author=S.+W.+Liebman&#x00026;publication_year=2004&#x00026;title=Effects+of+Q/N-rich+polyQ+and+non-polyQ+amyloids+on+the+de+novo+formation+of+the+[PSI+]+prion+in+yeast+and+aggregation+of+Sup35+in+vitro&#x00026;journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&#x00026;volume=101&#x00026;pages=12934-12939" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref10" id="ref10"></a>DeSantis, M. E., Leung, E. H., Sweeny, E. A., Jackrel, M. E., Cushman-Nick, M., Neuhaus-Follini, A., et al. (2012). Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients. <i>Cells</i> 151, 778&#x2013;793. doi: 10.1016/j.cell.2012.09.038 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23141537" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cell.2012.09.038" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+E.+DeSantis&#x00026;author=E.+H.+Leung&#x00026;author=E.+A.+Sweeny&#x00026;author=M.+E.+Jackrel&#x00026;author=M.+Cushman-Nick&#x00026;author=A.+Neuhaus-Follini&#x00026;publication_year=2012&#x00026;title=Operational+plasticity+enables+hsp104+to+disaggregate+diverse+amyloid+and+nonamyloid+clients&#x00026;journal=Cells&#x00026;volume=151&#x00026;pages=778-793" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref11" id="ref11"></a>Desantis, M. E., and Shorter, J. (2012). The elusive middle domain of Hsp104 and ClpB: location and function. <i>Biochim. Biophys. Acta</i> 1823, 29&#x2013;39. doi: 10.1016/j.bbamcr.2011.07.014 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/21843558" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.bbamcr.2011.07.014" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+E.+Desantis&#x00026;author=J.+Shorter&#x00026;publication_year=2012&#x00026;title=The+elusive+middle+domain+of+Hsp104+and+ClpB:+location+and+function&#x00026;journal=Biochim.+Biophys.+Acta&#x00026;volume=1823&#x00026;pages=29-39" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref12" id="ref12"></a>Dorweiler, J. E., Oddo, M. J., Lyke, D. R., Reilly, J. A., Wisniewski, B. T., Davis, E. E., et al. (2020). The actin cytoskeletal network plays a role in yeast prion transmission and contributes to prion stability. <i>Mol. Microbiol.</i> 114, 480&#x2013;494. doi: 10.1111/mmi.14528 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32426863" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/mmi.14528" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+E.+Dorweiler&#x00026;author=M.+J.+Oddo&#x00026;author=D.+R.+Lyke&#x00026;author=J.+A.+Reilly&#x00026;author=B.+T.+Wisniewski&#x00026;author=E.+E.+Davis&#x00026;publication_year=2020&#x00026;title=The+actin+cytoskeletal+network+plays+a+role+in+yeast+prion+transmission+and+contributes+to+prion+stability&#x00026;journal=Mol.+Microbiol.&#x00026;volume=114&#x00026;pages=480-494" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref13" id="ref13"></a>Duennwald, M. L., Echeverria, A., and Shorter, J. (2012). Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans. <i>PLoS Biol.</i> 10:e1001346. doi: 10.1371/journal.pbio.1001346 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22723742" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pbio.1001346" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+L.+Duennwald&#x00026;author=A.+Echeverria&#x00026;author=J.+Shorter&#x00026;publication_year=2012&#x00026;title=Small+heat+shock+proteins+potentiate+amyloid+dissolution+by+protein+disaggregases+from+yeast+and+humans&#x00026;journal=PLoS+Biol.&#x00026;volume=10&#x00026;pages=e1001346" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref14" id="ref14"></a>Dulle, J. E., Stein, K. C., and True, H. L. (2014). Regulation of the Hsp104 middle domain activity is critical for yeast prion propagation. <i>PLoS One</i> 9:e87521. doi: 10.1371/journal.pone.0087521 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/24466354" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0087521" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+E.+Dulle&#x00026;author=K.+C.+Stein&#x00026;author=H.+L.+True&#x00026;publication_year=2014&#x00026;title=Regulation+of+the+Hsp104+middle+domain+activity+is+critical+for+yeast+prion+propagation&#x00026;journal=PLoS+One&#x00026;volume=9&#x00026;pages=e87521" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref15" id="ref15"></a>Durie, C. L., Lin, J., Scull, N. W., Mack, K. L., Jackrel, M. E., Sweeny, E. A., et al. (2019). Hsp104 and potentiated variants can operate as distinct nonprocessive translocases. <i>Biophys. J.</i> 116, 1856&#x2013;1872. doi: 10.1016/j.bpj.2019.03.035 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31027887" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.bpj.2019.03.035" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C.+L.+Durie&#x00026;author=J.+Lin&#x00026;author=N.+W.+Scull&#x00026;author=K.+L.+Mack&#x00026;author=M.+E.+Jackrel&#x00026;author=E.+A.+Sweeny&#x00026;publication_year=2019&#x00026;title=Hsp104+and+potentiated+variants+can+operate+as+distinct+nonprocessive+translocases&#x00026;journal=Biophys.+J.&#x00026;volume=116&#x00026;pages=1856-1872" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref16" id="ref16"></a>Franco, A., Gracia, P., Colom, A., Camino, J. D., Fernandez-Higuero, J. A., Orozco, N., et al. (2021). All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of alpha-synuclein toxic species. <i>Proc. Natl. Acad. Sci. U. S. A.</i> 118:e2105548118. doi: 10.1073/pnas.2105548118</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1073/pnas.2105548118" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Franco&#x00026;author=P.+Gracia&#x00026;author=A.+Colom&#x00026;author=J.+D.+Camino&#x00026;author=J.+A.+Fernandez-Higuero&#x00026;author=N.+Orozco&#x00026;publication_year=2021&#x00026;title=All-or-none+amyloid+disassembly+via+chaperone-triggered+fibril+unzipping+favors+clearance+of+alpha-synuclein+toxic+species&#x00026;journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&#x00026;volume=118&#x00026;pages=e2105548118" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref17" id="ref17"></a>Gertz, M. A., Benson, M. D., Dyck, P. J., Grogan, M., Coelho, T., Cruz, M., et al. (2015). Diagnosis, prognosis, and therapy of transthyretin amyloidosis. <i>J. Am. Coll. Cardiol.</i> 66, 2451&#x2013;2466. doi: 10.1016/j.jacc.2015.09.075</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.jacc.2015.09.075" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+A.+Gertz&#x00026;author=M.+D.+Benson&#x00026;author=P.+J.+Dyck&#x00026;author=M.+Grogan&#x00026;author=T.+Coelho&#x00026;author=M.+Cruz&#x00026;publication_year=2015&#x00026;title=Diagnosis+prognosis+and+therapy+of+transthyretin+amyloidosis&#x00026;journal=J.+Am.+Coll.+Cardiol.&#x00026;volume=66&#x00026;pages=2451-2466" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref18" id="ref18"></a>Glover, J. R., and Lindquist, S. (1998). Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. <i>Cells</i> 94, 73&#x2013;82. doi: 10.1016/S0092-8674(00)81223-4</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1016/S0092-8674(00)81223-4" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+R.+Glover&#x00026;author=S.+Lindquist&#x00026;publication_year=1998&#x00026;title=Hsp104+Hsp70+and+Hsp40:+a+novel+chaperone+system+that+rescues+previously+aggregated+proteins&#x00026;journal=Cells&#x00026;volume=94&#x00026;pages=73-82" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref19" id="ref19"></a>Gomes, R. A., Franco, C., Da Costa, G., Planchon, S., Renaut, J., Ribeiro, R. M., et al. (2012). The proteome response to amyloid protein expression in vivo. <i>PLoS One</i> 7:e50123. doi: 10.1371/journal.pone.0050123 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23185553" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0050123" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+A.+Gomes&#x00026;author=C.+Franco&#x00026;author=G.+Da+Costa&#x00026;author=S.+Planchon&#x00026;author=J.+Renaut&#x00026;author=R.+M.+Ribeiro&#x00026;publication_year=2012&#x00026;title=The+proteome+response+to+amyloid+protein+expression+in+vivo&#x00026;journal=PLoS+One&#x00026;volume=7&#x00026;pages=e50123" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref20" id="ref20"></a>Greene, L. E., Saba, F., Silberman, R. E., and Zhao, X. (2020). Mechanisms for curing yeast prions. <i>Int. J. Mol. Sci.</i> 21:6536. doi: 10.3390/ijms21186536 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32906758" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/ijms21186536" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=L.+E.+Greene&#x00026;author=F.+Saba&#x00026;author=R.+E.+Silberman&#x00026;author=X.+Zhao&#x00026;publication_year=2020&#x00026;title=Mechanisms+for+curing+yeast+prions&#x00026;journal=Int.+J.+Mol.+Sci.&#x00026;volume=21&#x00026;pages=6536" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref21" id="ref21"></a>Halfmann, R., and Lindquist, S. (2008). Screening for amyloid aggregation by semi-denaturing detergent-agarose gel electrophoresis. <i>J. Vis. Exp.</i> 17:838. doi: 10.3791/838 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/19066511" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3791/838" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Halfmann&#x00026;author=S.+Lindquist&#x00026;publication_year=2008&#x00026;title=Screening+for+amyloid+aggregation+by+semi-denaturing+detergent-agarose+gel+electrophoresis&#x00026;journal=J.+Vis.+Exp.&#x00026;volume=17&#x00026;pages=838" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref22" id="ref22"></a>Hammarstrom, P., Wiseman, R. L., Powers, E. T., and Kelly, J. W. (2003). Prevention of transthyretin amyloid disease by changing protein misfolding energetics. <i>Science</i> 299, 713&#x2013;716. doi: 10.1126/science.1079589 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/12560553" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1126/science.1079589" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=P.+Hammarstrom&#x00026;author=R.+L.+Wiseman&#x00026;author=E.+T.+Powers&#x00026;author=J.+W.+Kelly&#x00026;publication_year=2003&#x00026;title=Prevention+of+transthyretin+amyloid+disease+by+changing+protein+misfolding+energetics&#x00026;journal=Science&#x00026;volume=299&#x00026;pages=713-716" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref23" id="ref23"></a>Jackrel, M. E., DeSantis, M. E., Martinez, B. A., Castellano, L. M., Stewart, R. M., Caldwell, K. A., et al. (2014). Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. <i>Cells</i> 156, 170&#x2013;182. doi: 10.1016/j.cell.2013.11.047 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/24439375" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cell.2013.11.047" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+E.+Jackrel&#x00026;author=M.+E.+DeSantis&#x00026;author=B.+A.+Martinez&#x00026;author=L.+M.+Castellano&#x00026;author=R.+M.+Stewart&#x00026;author=K.+A.+Caldwell&#x00026;publication_year=2014&#x00026;title=Potentiated+Hsp104+variants+antagonize+diverse+proteotoxic+misfolding+events&#x00026;journal=Cells&#x00026;volume=156&#x00026;pages=170-182" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref24" id="ref24"></a>Karim, A. S., Curran, K. A., and Alper, H. S. (2013). Characterization of plasmid burden and copy number in Saccharomyces cerevisiae for optimization of metabolic engineering applications. <i>FEMS Yeast Res.</i> 13, 107&#x2013;116. doi: 10.1111/1567-1364.12016 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23107142" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/1567-1364.12016" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+S.+Karim&#x00026;author=K.+A.+Curran&#x00026;author=H.+S.+Alper&#x00026;publication_year=2013&#x00026;title=Characterization+of+plasmid+burden+and+copy+number+in+Saccharomyces+cerevisiae+for+optimization+of+metabolic+engineering+applications&#x00026;journal=FEMS+Yeast+Res.&#x00026;volume=13&#x00026;pages=107-116" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref25" id="ref25"></a>Kazantsev, A., Preisinger, E., Dranovsky, A., Goldgaber, D., and Housman, D. (1999). Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. <i>Proc. Natl. Acad. Sci. U. S. A.</i> 96, 11404&#x2013;11409. doi: 10.1073/pnas.96.20.11404 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/10500189" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1073/pnas.96.20.11404" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Kazantsev&#x00026;author=E.+Preisinger&#x00026;author=A.+Dranovsky&#x00026;author=D.+Goldgaber&#x00026;author=D.+Housman&#x00026;publication_year=1999&#x00026;title=Insoluble+detergent-resistant+aggregates+form+between+pathological+and+nonpathological+lengths+of+polyglutamine+in+mammalian+cells&#x00026;journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&#x00026;volume=96&#x00026;pages=11404-11409" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref26" id="ref26"></a>Klaips, C. L., Jayaraj, G. G., and Hartl, F. U. (2018). Pathways of cellular proteostasis in aging and disease. <i>J. Cell Biol.</i> 217, 51&#x2013;63. doi: 10.1083/jcb.201709072 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29127110" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1083/jcb.201709072" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C.+L.+Klaips&#x00026;author=G.+G.+Jayaraj&#x00026;author=F.+U.+Hartl&#x00026;publication_year=2018&#x00026;title=Pathways+of+cellular+proteostasis+in+aging+and+disease&#x00026;journal=J.+Cell+Biol.&#x00026;volume=217&#x00026;pages=51-63" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref27" id="ref27"></a>Kryndushkin, D. S., Alexandrov, I. M., Ter-Avanesyan, M. D., and Kushnirov, V. V. (2003). Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. <i>J. Biol. Chem.</i> 278, 49636&#x2013;49643. doi: 10.1074/jbc.M307996200 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/14507919" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1074/jbc.M307996200" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+S.+Kryndushkin&#x00026;author=I.+M.+Alexandrov&#x00026;author=M.+D.+Ter-Avanesyan&#x00026;author=V.+V.+Kushnirov&#x00026;publication_year=2003&#x00026;title=Yeast+[PSI+]+prion+aggregates+are+formed+by+small+Sup35+polymers+fragmented+by+Hsp104&#x00026;journal=J.+Biol.+Chem.&#x00026;volume=278&#x00026;pages=49636-49643" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref28" id="ref28"></a>Labbadia, J., and Morimoto, R. I. (2015). The biology of proteostasis in aging and disease. <i>Annu. Rev. Biochem.</i> 84, 435&#x2013;464. doi: 10.1146/annurev-biochem-060614-033955 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25784053" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1146/annurev-biochem-060614-033955" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+Labbadia&#x00026;author=R.+I.+Morimoto&#x00026;publication_year=2015&#x00026;title=The+biology+of+proteostasis+in+aging+and+disease&#x00026;journal=Annu.+Rev.+Biochem.&#x00026;volume=84&#x00026;pages=435-464" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref29" id="ref29"></a>Lee, S., Sielaff, B., Lee, J., and Tsai, F. T. (2010). CryoEM structure of Hsp104 and its mechanistic implication for protein disaggregation. <i>Proc. Natl. Acad. Sci. U. S. A.</i> 107, 8135&#x2013;8140. doi: 10.1073/pnas.1003572107 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20404203" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1073/pnas.1003572107" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S.+Lee&#x00026;author=B.+Sielaff&#x00026;author=J.+Lee&#x00026;author=F.+T.+Tsai&#x00026;publication_year=2010&#x00026;title=CryoEM+structure+of+Hsp104+and+its+mechanistic+implication+for+protein+disaggregation&#x00026;journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&#x00026;volume=107&#x00026;pages=8135-8140" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref30" id="ref30"></a>Liebman, S. W., Bagriantsev, S. N., and Derkatch, I. L. (2006). Biochemical and genetic methods for characterization of [PIN+] prions in yeast. <i>Methods</i> 39, 23&#x2013;34. doi: 10.1016/j.ymeth.2006.04.010 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/16793281" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.ymeth.2006.04.010" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S.+W.+Liebman&#x00026;author=S.+N.+Bagriantsev&#x00026;author=I.+L.+Derkatch&#x00026;publication_year=2006&#x00026;title=Biochemical+and+genetic+methods+for+characterization+of+[PIN+]+prions+in+yeast&#x00026;journal=Methods&#x00026;volume=39&#x00026;pages=23-34" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref31" id="ref31"></a>Liu, Y. H., Han, Y. L., Song, J., Wang, Y., Jing, Y. Y., Shi, Q., et al. (2011). Heat shock protein 104 inhibited the fibrillization of prion peptide 106-126 and disassembled prion peptide 106-126 fibrils in vitro. <i>Int. J. Biochem. Cell Biol.</i> 43, 768&#x2013;774. doi: 10.1016/j.biocel.2011.01.022 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/21296677" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.biocel.2011.01.022" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y.+H.+Liu&#x00026;author=Y.+L.+Han&#x00026;author=J.+Song&#x00026;author=Y.+Wang&#x00026;author=Y.+Y.+Jing&#x00026;author=Q.+Shi&#x00026;publication_year=2011&#x00026;title=Heat+shock+protein+104+inhibited+the+fibrillization+of+prion+peptide+106-126+and+disassembled+prion+peptide+106-126+fibrils+in+vitro&#x00026;journal=Int.+J.+Biochem.+Cell+Biol.&#x00026;volume=43&#x00026;pages=768-774" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref32" id="ref32"></a>Lo Bianco, C., Shorter, J., Regulier, E., Lashuel, H., Iwatsubo, T., Lindquist, S., et al. (2008). Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease. <i>J. Clin. Invest.</i> 118, 3087&#x2013;3097. doi: 10.1172/JCI35781 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/18704197" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1172/JCI35781" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C.+Lo+Bianco&#x00026;author=J.+Shorter&#x00026;author=E.+Regulier&#x00026;author=H.+Lashuel&#x00026;author=T.+Iwatsubo&#x00026;author=S.+Lindquist&#x00026;publication_year=2008&#x00026;title=Hsp104+antagonizes+alpha-synuclein+aggregation+and+reduces+dopaminergic+degeneration+in+a+rat+model+of+Parkinson+disease&#x00026;journal=J.+Clin.+Invest.&#x00026;volume=118&#x00026;pages=3087-3097" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref33" id="ref33"></a>Manogaran, A. L., Hong, J. Y., Hufana, J., Tyedmers, J., Lindquist, S., and Liebman, S. W. (2011). Prion formation and polyglutamine aggregation are controlled by two classes of genes. <i>PLoS Genet.</i> 7:e1001386. doi: 10.1371/journal.pgen.1001386 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/21625618" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pgen.1001386" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+L.+Manogaran&#x00026;author=J.+Y.+Hong&#x00026;author=J.+Hufana&#x00026;author=J.+Tyedmers&#x00026;author=S.+Lindquist&#x00026;author=S.+W.+Liebman&#x00026;publication_year=2011&#x00026;title=Prion+formation+and+polyglutamine+aggregation+are+controlled+by+two+classes+of+genes&#x00026;journal=PLoS+Genet.&#x00026;volume=7&#x00026;pages=e1001386" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref34" id="ref34"></a>March, Z. M., Mack, K. L., and Shorter, J. (2019). AAA+ protein-based technologies to counter neurodegenerative disease. <i>Biophys. J.</i> 116, 1380&#x2013;1385. doi: 10.1016/j.bpj.2019.03.007 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30952364" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.bpj.2019.03.007" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Z.+M.+March&#x00026;author=K.+L.+Mack&#x00026;author=J.+Shorter&#x00026;publication_year=2019&#x00026;title=AAA++protein-based+technologies+to+counter+neurodegenerative+disease&#x00026;journal=Biophys.+J.&#x00026;volume=116&#x00026;pages=1380-1385" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref35" id="ref35"></a>March, Z. M., Sweeney, K., Kim, H., Yan, X., Castellano, L. M., Jackrel, M. E., et al. (2020). Therapeutic genetic variation revealed in diverse Hsp104 homologs. <i>eLife</i> 9:e57457.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?author=Z.+M.+March&#x00026;author=K.+Sweeney&#x00026;author=H.+Kim&#x00026;author=X.+Yan&#x00026;author=L.+M.+Castellano&#x00026;author=M.+E.+Jackrel&#x00026;publication_year=2020&#x00026;title=Therapeutic+genetic+variation+revealed+in+diverse+Hsp104+homologs&#x00026;journal=eLife&#x00026;volume=9&#x00026;pages=e57457" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref36" id="ref36"></a>Misumi, Y., Ando, Y., Goncalves, N. P., and Saraiva, M. J. (2013). Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis. <i>Lab. Investig.</i> 93, 911&#x2013;920. doi: 10.1038/labinvest.2013.83 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23817086" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/labinvest.2013.83" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y.+Misumi&#x00026;author=Y.+Ando&#x00026;author=N.+P.+Goncalves&#x00026;author=M.+J.+Saraiva&#x00026;publication_year=2013&#x00026;title=Fibroblasts+endocytose+and+degrade+transthyretin+aggregates+in+transthyretin-related+amyloidosis&#x00026;journal=Lab.+Investig.&#x00026;volume=93&#x00026;pages=911-920" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref37" id="ref37"></a>Mogk, A., Bukau, B., and Kampinga, H. H. (2018). Cellular handling of protein aggregates by disaggregation machines. <i>Mol. Cell</i> 69, 214&#x2013;226. doi: 10.1016/j.molcel.2018.01.004 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29351843" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.molcel.2018.01.004" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Mogk&#x00026;author=B.+Bukau&#x00026;author=H.+H.+Kampinga&#x00026;publication_year=2018&#x00026;title=Cellular+handling+of+protein+aggregates+by+disaggregation+machines&#x00026;journal=Mol.+Cell&#x00026;volume=69&#x00026;pages=214-226" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref38" id="ref38"></a>Naeimi, W. R., and Serio, T. R. (2022). Beyond amyloid fibers: accumulation, biological relevance, and regulation of higher-order prion architectures. <i>Viruses</i> 14:1635. doi: 10.3390/v14081635 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/35893700" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/v14081635" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=W.+R.+Naeimi&#x00026;author=T.+R.+Serio&#x00026;publication_year=2022&#x00026;title=Beyond+amyloid+fibers:+accumulation+biological+relevance+and+regulation+of+higher-order+prion+architectures&#x00026;journal=Viruses&#x00026;volume=14&#x00026;pages=1635" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref39" id="ref39"></a>Ness, F., Cox, B. S., Wongwigkarn, J., Naeimi, W. R., and Tuite, M. F. (2017). Over-expression of the molecular chaperone Hsp104 in Saccharomyces cerevisiae results in the malpartition of [PSI(+)] propagons. <i>Mol. Microbiol.</i> 104, 125&#x2013;143. doi: 10.1111/mmi.13617 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28073182" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/mmi.13617" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=F.+Ness&#x00026;author=B.+S.+Cox&#x00026;author=J.+Wongwigkarn&#x00026;author=W.+R.+Naeimi&#x00026;author=M.+F.+Tuite&#x00026;publication_year=2017&#x00026;title=Over-expression+of+the+molecular+chaperone+Hsp104+in+Saccharomyces+cerevisiae+results+in+the+malpartition+of+[PSI(+)]+propagons&#x00026;journal=Mol.+Microbiol.&#x00026;volume=104&#x00026;pages=125-143" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref40" id="ref40"></a>Nizhnikov, A. A., Alexandrov, A. I., Ryzhova, T. A., Mitkevich, O. V., Dergalev, A. A., Ter-Avanesyan, M. D., et al. (2014). Proteomic screening for amyloid proteins. <i>PLoS One</i> 9:e116003. doi: 10.1371/journal.pone.0116003 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25549323" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0116003" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+A.+Nizhnikov&#x00026;author=A.+I.+Alexandrov&#x00026;author=T.+A.+Ryzhova&#x00026;author=O.+V.+Mitkevich&#x00026;author=A.+A.+Dergalev&#x00026;author=M.+D.+Ter-Avanesyan&#x00026;publication_year=2014&#x00026;title=Proteomic+screening+for+amyloid+proteins&#x00026;journal=PLoS+One&#x00026;volume=9&#x00026;pages=e116003" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref41" id="ref41"></a>Parsell, D. A., Kowal, A. S., Singer, M. A., and Lindquist, S. (1994). Protein disaggregation mediated by heat-shock protein Hsp104. <i>Nature</i> 372, 475&#x2013;478. doi: 10.1038/372475a0 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/7984243" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/372475a0" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+A.+Parsell&#x00026;author=A.+S.+Kowal&#x00026;author=M.+A.+Singer&#x00026;author=S.+Lindquist&#x00026;publication_year=1994&#x00026;title=Protein+disaggregation+mediated+by+heat-shock+protein+Hsp104&#x00026;journal=Nature&#x00026;volume=372&#x00026;pages=475-478" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref42" id="ref42"></a>Paushkin, S. V., Kushnirov, V. V., Smirnov, V. N., and Ter-Avanesyan, M. D. (1996). Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. <i>EMBO J.</i> 15, 3127&#x2013;3134. doi: 10.1002/j.1460-2075.1996.tb00675.x </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/8670813" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/j.1460-2075.1996.tb00675.x" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S.+V.+Paushkin&#x00026;author=V.+V.+Kushnirov&#x00026;author=V.+N.+Smirnov&#x00026;author=M.+D.+Ter-Avanesyan&#x00026;publication_year=1996&#x00026;title=Propagation+of+the+yeast+prion-like+[psi+]+determinant+is+mediated+by+oligomerization+of+the+SUP35-encoded+polypeptide+chain+release+factor&#x00026;journal=EMBO+J.&#x00026;volume=15&#x00026;pages=3127-3134" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref43" id="ref43"></a>Reixach, N., Deechongkit, S., Jiang, X., Kelly, J. W., and Buxbaum, J. N. (2004). Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. <i>Proc. Natl. Acad. Sci. U. S. A.</i> 101, 2817&#x2013;2822. doi: 10.1073/pnas.0400062101 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/14981241" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1073/pnas.0400062101" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=N.+Reixach&#x00026;author=S.+Deechongkit&#x00026;author=X.+Jiang&#x00026;author=J.+W.+Kelly&#x00026;author=J.+N.+Buxbaum&#x00026;publication_year=2004&#x00026;title=Tissue+damage+in+the+amyloidoses:+transthyretin+monomers+and+nonnative+oligomers+are+the+major+cytotoxic+species+in+tissue+culture&#x00026;journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&#x00026;volume=101&#x00026;pages=2817-2822" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref44" id="ref44"></a>Santos, S. D., Fernandes, R., and Saraiva, M. J. (2010). The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems. <i>Neurobiol. Aging</i> 31, 280&#x2013;289. doi: 10.1016/j.neurobiolaging.2008.04.001 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/18485534" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.neurobiolaging.2008.04.001" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S.+D.+Santos&#x00026;author=R.+Fernandes&#x00026;author=M.+J.+Saraiva&#x00026;publication_year=2010&#x00026;title=The+heat+shock+response+modulates+transthyretin+deposition+in+the+peripheral+and+autonomic+nervous+systems&#x00026;journal=Neurobiol.+Aging&#x00026;volume=31&#x00026;pages=280-289" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref45" id="ref45"></a>Satpute-Krishnan, P., Langseth, S. X., and Serio, T. R. (2007). Hsp104-dependent remodeling of prion complexes mediates protein-only inheritance. <i>PLoS Biol.</i> 5:e24. doi: 10.1371/journal.pbio.0050024 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/17253904" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pbio.0050024" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=P.+Satpute-Krishnan&#x00026;author=S.+X.+Langseth&#x00026;author=T.+R.+Serio&#x00026;publication_year=2007&#x00026;title=Hsp104-dependent+remodeling+of+prion+complexes+mediates+protein-only+inheritance&#x00026;journal=PLoS+Biol.&#x00026;volume=5&#x00026;pages=e24" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref46" id="ref46"></a>Schirmer, E. C., Homann, O. R., Kowal, A. S., and Lindquist, S. (2004). Dominant gain-of-function mutations in Hsp104p reveal crucial roles for the middle region. <i>Mol. Biol. Cell</i> 15, 2061&#x2013;2072. doi: 10.1091/mbc.e02-08-0502 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/14978213" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1091/mbc.e02-08-0502" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=E.+C.+Schirmer&#x00026;author=O.+R.+Homann&#x00026;author=A.+S.+Kowal&#x00026;author=S.+Lindquist&#x00026;publication_year=2004&#x00026;title=Dominant+gain-of-function+mutations+in+Hsp104p+reveal+crucial+roles+for+the+middle+region&#x00026;journal=Mol.+Biol.+Cell&#x00026;volume=15&#x00026;pages=2061-2072" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref47" id="ref47"></a>Scior, A., Buntru, A., Arnsburg, K., Ast, A., Iburg, M., Juenemann, K., et al. (2018). Complete suppression of Htt fibrilization and disaggregation of Htt fibrils by a trimeric chaperone complex. <i>EMBO J.</i> 37, 282&#x2013;299. doi: 10.15252/embj.201797212 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29212816" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.15252/embj.201797212" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Scior&#x00026;author=A.+Buntru&#x00026;author=K.+Arnsburg&#x00026;author=A.+Ast&#x00026;author=M.+Iburg&#x00026;author=K.+Juenemann&#x00026;publication_year=2018&#x00026;title=Complete+suppression+of+Htt+fibrilization+and+disaggregation+of+Htt+fibrils+by+a+trimeric+chaperone+complex&#x00026;journal=EMBO+J.&#x00026;volume=37&#x00026;pages=282-299" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref48" id="ref48"></a>Sharma, J., Wisniewski, B. T., Paulson, E., Obaoye, J. O., Merrill, S. J., and Manogaran, A. L. (2017). De novo [PSI +] prion formation involves multiple pathways to form infectious oligomers. <i>Sci. Rep.</i> 7:76. doi: 10.1038/s41598-017-00135-6 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28250435" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41598-017-00135-6" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+Sharma&#x00026;author=B.+T.+Wisniewski&#x00026;author=E.+Paulson&#x00026;author=J.+O.+Obaoye&#x00026;author=S.+J.+Merrill&#x00026;author=A.+L.+Manogaran&#x00026;publication_year=2017&#x00026;title=De+novo+[PSI++]+prion+formation+involves+multiple+pathways+to+form+infectious+oligomers&#x00026;journal=Sci.+Rep.&#x00026;volume=7&#x00026;pages=76" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref49" id="ref49"></a>Sherman, F., Fink, G.R., and Hicks, J.B. (1986). <i>Methods in Yeast Genetics.</i> Plainview, New York: Cold Spring Harbor Lab.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?author=F.+Sherman&#x00026;author=G.R.+Fink&#x00026;author=J.B.+Hicks&#x00026;publication_year=1986&#x00026;journal=Methods+in+Yeast+Genetics.&#x00026;" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref50" id="ref50"></a>Shorter, J., and Lindquist, S. (2004). Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. <i>Science</i> 304, 1793&#x2013;1797. doi: 10.1126/science.1098007 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/15155912" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1126/science.1098007" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+Shorter&#x00026;author=S.+Lindquist&#x00026;publication_year=2004&#x00026;title=Hsp104+catalyzes+formation+and+elimination+of+self-replicating+Sup35+prion+conformers&#x00026;journal=Science&#x00026;volume=304&#x00026;pages=1793-1797" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref51" id="ref51"></a>Sielaff, B., and Tsai, F. T. (2010). The M-domain controls Hsp104 protein remodeling activity in an Hsp70/Hsp40-dependent manner. <i>J. Mol. Biol.</i> 402, 30&#x2013;37. doi: 10.1016/j.jmb.2010.07.030 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20654624" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.jmb.2010.07.030" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=B.+Sielaff&#x00026;author=F.+T.+Tsai&#x00026;publication_year=2010&#x00026;title=The+M-domain+controls+Hsp104+protein+remodeling+activity+in+an+Hsp70/Hsp40-dependent+manner&#x00026;journal=J.+Mol.+Biol.&#x00026;volume=402&#x00026;pages=30-37" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref52" id="ref52"></a>Surguchov, A. (2021). Invertebrate models untangle the mechanism of neurodegeneration in Parkinson's disease. <i>Cells</i> 10:407. doi: 10.3390/cells10020407 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33669308" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/cells10020407" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Surguchov&#x00026;publication_year=2021&#x00026;title=Invertebrate+models+untangle+the+mechanism+of+neurodegeneration+in+Parkinson's+disease&#x00026;journal=Cells&#x00026;volume=10&#x00026;pages=407" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref53" id="ref53"></a>Tittelmeier, J., Nachman, E., and Nussbaum-Krammer, C. (2020). Molecular chaperones: a double-edged sword in neurodegenerative diseases. <i>Front. Aging Neurosci.</i> 12:581374. doi: 10.3389/fnagi.2020.581374 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33132902" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fnagi.2020.581374" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+Tittelmeier&#x00026;author=E.+Nachman&#x00026;author=C.+Nussbaum-Krammer&#x00026;publication_year=2020&#x00026;title=Molecular+chaperones:+a+double-edged+sword+in+neurodegenerative+diseases&#x00026;journal=Front.+Aging+Neurosci.&#x00026;volume=12&#x00026;pages=581374" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref54" id="ref54"></a>Verma, M., Girdhar, A., Patel, B., Ganguly, N. K., Kukreti, R., and Taneja, V. (2018). Q-rich yeast prion [PSI(+)] accelerates aggregation of transthyretin, a non-Q-rich human protein. <i>Front. Mol. Neurosci.</i> 11:75. doi: 10.3389/fnmol.2018.00075 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29593496" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fnmol.2018.00075" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Verma&#x00026;author=A.+Girdhar&#x00026;author=B.+Patel&#x00026;author=N.+K.+Ganguly&#x00026;author=R.+Kukreti&#x00026;author=V.+Taneja&#x00026;publication_year=2018&#x00026;title=Q-rich+yeast+prion+[PSI(+)]+accelerates+aggregation+of+transthyretin+a+non-Q-rich+human+protein&#x00026;journal=Front.+Mol.+Neurosci.&#x00026;volume=11&#x00026;pages=75" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref55" id="ref55"></a>Wentink, A., Nussbaum-Krammer, C., and Bukau, B. (2019). Modulation of amyloid states by molecular chaperones. <i>Cold Spring Harb. Perspect Biol.</i> 11:a033969. doi: 10.1101/cshperspect.a033969</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1101/cshperspect.a033969" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Wentink&#x00026;author=C.+Nussbaum-Krammer&#x00026;author=B.+Bukau&#x00026;publication_year=2019&#x00026;title=Modulation+of+amyloid+states+by+molecular+chaperones&#x00026;journal=Cold+Spring+Harb.+Perspect+Biol.&#x00026;volume=11&#x00026;pages=a033969" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref56" id="ref56"></a>Winkler, J., Tyedmers, J., Bukau, B., and Mogk, A. (2012). Hsp70 targets Hsp100 chaperones to substrates for protein disaggregation and prion fragmentation. <i>J. Cell Biol.</i> 198, 387&#x2013;404. doi: 10.1083/jcb.201201074 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22869599" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1083/jcb.201201074" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+Winkler&#x00026;author=J.+Tyedmers&#x00026;author=B.+Bukau&#x00026;author=A.+Mogk&#x00026;publication_year=2012&#x00026;title=Hsp70+targets+Hsp100+chaperones+to+substrates+for+protein+disaggregation+and+prion+fragmentation&#x00026;journal=J.+Cell+Biol.&#x00026;volume=198&#x00026;pages=387-404" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref57" id="ref57"></a>Zhao, X., Rodriguez, R., Silberman, R. E., Ahearn, J. M., Saidha, S., Cummins, K. C., et al. (2017). Heat shock protein 104 (Hsp104)-mediated curing of [PSI(+)] yeast prions depends on both [PSI(+)] conformation and the properties of the Hsp104 homologs. <i>J. Biol. Chem.</i> 292, 8630&#x2013;8641. doi: 10.1074/jbc.M116.770719 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28373280" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1074/jbc.M116.770719" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=X.+Zhao&#x00026;author=R.+Rodriguez&#x00026;author=R.+E.+Silberman&#x00026;author=J.+M.+Ahearn&#x00026;author=S.+Saidha&#x00026;author=K.+C.+Cummins&#x00026;publication_year=2017&#x00026;title=Heat+shock+protein+104+(Hsp104)-mediated+curing+of+[PSI(+)]+yeast+prions+depends+on+both+[PSI(+)]+conformation+and+the+properties+of+the+Hsp104+homologs&#x00026;journal=J.+Biol.+Chem.&#x00026;volume=292&#x00026;pages=8630-8641" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref58" id="ref58"></a>Zimmermann, A., Hofer, S., Pendl, T., Kainz, K., Madeo, F., and Carmona-Gutierrez, D. (2018). Yeast as a tool to identify anti-aging compounds. <i>FEMS Yeast Res.</i> 18:foy020. doi: 10.1093/femsyr/foy020 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29905792" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/femsyr/foy020" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Zimmermann&#x00026;author=S.+Hofer&#x00026;author=T.+Pendl&#x00026;author=K.+Kainz&#x00026;author=F.+Madeo&#x00026;author=D.+Carmona-Gutierrez&#x00026;publication_year=2018&#x00026;title=Yeast+as+a+tool+to+identify+anti-aging+compounds&#x00026;journal=FEMS+Yeast+Res.&#x00026;volume=18&#x00026;pages=foy020" target="_blank">Google Scholar</a></p></div>
</div> <div class="thinLineM20"></div> <div class="AbstractSummary">
<p><span>Keywords:</span> Hsp104, transthyretin, molecular chaperone, protein aggregation, transthyretin amyloidosis, amyloid, polyneuropathy, aging</p>
<p><span>Citation:</span> Knier AS, Davis EE, Buchholz HE, Dorweiler JE, Flannagan LE and Manogaran AL (2022) The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation. <i>Front. Mol. Neurosci</i>. 15:1050472. doi: 10.3389/fnmol.2022.1050472</p>
<p class="timestamps"><span>Received:</span> 21 September 2022; <span>Accepted:</span> 19 October 2022;<br> <span>Published:</span> 16 December 2022.</p> <div>
<p>Edited by:</p> <a href="https://loop.frontiersin.org/people/122913/overview">Andrei Surguchov</a>, University of Kansas Medical Center, United States</div> <div>
<p>Reviewed by:</p> <a href="https://loop.frontiersin.org/people/363601/overview">Irina G. Sourgoutcheva</a>, University of Kansas Medical Center, United States<br> <a href="https://loop.frontiersin.org/people/608012/overview">Maria Ros&#x00E1;rio Almeida</a>, Universidade do Porto, Portugal</div>
<p><span>Copyright</span> &#x000A9; 2022 Knier, Davis, Buchholz, Dorweiler, Flannagan and Manogaran. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY)</a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<p><span>&#x0002A;Correspondence:</span> Anita L. Manogaran, <a id="encmail">YW5pdGEubWFub2dhcmFuQG1hcnF1ZXR0ZS5lZHU=</a></p> <div class="clear"></div> </div></div></div><p class="AbstractSummary__disclaimer"><span>Disclaimer: </span> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div><!----></main><aside class="Layout__aside"><div class="ArticleDetails__wrapper"><div class="ArticleDetails__aside"><div class="ArticleDetails__aside__responsiveButtons"><div class="ActionsDropDown" id="FloatingButtonsEl"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--icon ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fnmol.2022.1050472" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="ArticleDetails__aside__responsiveButtons__items"><span></span><div class="ArticleDetailsShare__responsive"><button class="ArticleDetailsShare__trigger" aria-label="Open share options"></button><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div></div><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeIconButton ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><!----></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Export citation</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div></div></div><div class="TotalViews"><div class="TotalViews__data"><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">6K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Total views</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">1,2K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Downloads</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">3</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Citations</div></div></div><div class="ImpactMetricsInfoPopover"><button aria-label="Open impact metrics info" class="ImpactMetricsInfoPopover__button"></button><div class="ImpactMetricsInfoPopover__tooltip"><button aria-label="Close impact metrics info" class="ImpactMetricsInfoPopover__tooltip__closeButton"></button><div class="ImpactMetricsInfoPopover__tooltip__text"> Citation numbers are available from Dimensions </div></div></div></div><div class="TotalViews__viewImpactLink"><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View article impact" href="http://loop-impact.frontiersin.org/impact/article/1050472#totalviews/views" target="_blank" data-event="customLink-link-a_viewArticleImpact"><span>View article impact</span></a></span></div><div class="TotalViews__altmetric"><div data-badge-popover="bottom" data-badge-type="donut" data-doi="10.3389/fnmol.2022.1050472" data-condensed="true" data-link-target="new" class="altmetric-embed"></div><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View altmetric score" href="https://www.altmetric.com/details/doi/10.3389/fnmol.2022.1050472" target="_blank" data-event="customLink-link-a_viewAltmetricScore"><span>View altmetric score</span></a></span></div></div><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Edited by</div><!--[--><a href="https://loop.frontiersin.org/people/122913/overview" data-event="editorInfo-a-andreiSurguchov" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">A</span><span class="notranslate">S</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Andrei  Surguchov</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">University of Kansas Medical Center, United States</div></div></a><!--]--></div></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Reviewed by</div><!--[--><a href="https://loop.frontiersin.org/people/363601/overview" data-event="editorInfo-a-irinaGSourgoutcheva" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">I</span><span class="notranslate">G</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Irina  G Sourgoutcheva</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">University of Kansas Medical Center, United States</div></div></a><a href="https://loop.frontiersin.org/people/608012/overview" data-event="editorInfo-a-mariaRosrioAlmeida" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">M</span><span class="notranslate">R</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Maria  Rosrio Almeida</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal</div></div></a><!--]--></div></div><div class="ArticleDetailsGlossary ArticleDetailsGlossary--open"><button class="ArticleDetailsGlossary__header"><div class="ArticleDetailsGlossary__header__title">Table of contents</div><div class="ArticleDetailsGlossary__header__arrow"></div></button><div class="ArticleDetailsGlossary__content"><ul class="flyoutJournal"> <li><a href="#h1">Abstract</a></li> <li><a href="#h2">Introduction</a></li> <li><a href="#h3">Materials and methods</a></li> <li><a href="#h4">Results</a></li> <li><a href="#h5">Discussion</a></li> <li><a href="#h6">Data availability statement</a></li> <li><a href="#h7">Author contributions</a></li> <li><a href="#h8">Funding</a></li> <li><a href="#h9">Acknowledgments</a></li> <li><a href="#h10">Conflict of interest</a></li> <li><a href="#h11">Publisher&#x2019;s note</a></li> <li><a href="#h12">Supplementary material</a></li> <li><a href="#h13">References</a></li> </ul></div></div><span></span><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeOutline ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Export citation</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="CheckForUpdates"><button data-target="crossmark" class="CheckForUpdates__link" data-event="checkForUpdates-btn-openModal"><img class="CheckForUpdates__link__img" src="/ap-2024/images/crossmark.svg" alt="Crossmark icon"><div class="CheckForUpdates__link__text">Check for updates</div></button></div><div class="AnnouncementCard"><p class="AnnouncementCard__title">Frontiers&#39; impact</p><article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><!--[--><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><!--]--><img src="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" class="is-inside-mask" alt loading="eager"></picture><!----></figure><div class="CardA__info"><!--[--><h2 class="CardA__title">Articles published with Frontiers have received 12 million total citations</h2><p class="CardA__text">Your research is the real superpower - learn how we maximise its impact through our leading community journals</p><br><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right" aria-label="Explore our impact metrics" href="https://www.frontiersin.org/about/impact" target="_self" data-event="customLink-linkType-a_exploreOurImpactMe"><span>Explore our impact metrics</span></a></span><!--]--></div></div></article></div><!----><!----></div><div><div class="Modal Modal--noFooter"><button aria-label="Close modal" class="Modal__overlay" data-event="modal-overlay-close"></button><div class="Modal__container"><div class="Modal__header"><p class="Modal__title">Supplementary Material</p><button aria-label="Close modal" class="Modal__close" data-event="modal-button-close"></button></div><div class="Modal__body"><!--[--><div class="SupplementalData"><ul class="SupplementalData__list"><!--[--><!--]--></ul></div><!--]--><!----></div><!----><!----></div></div></div><div><div class="FloatingButtons"><!----><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--iconDownload ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Download</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fnmol.2022.1050472" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><!----></div></div></div></aside></div><div class=""><!----></div><!--]--></div><!----><footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><!--[--><!--[--><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Guidelines</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/guidelines/author-guidelines" target="_self" data-event="footer-block_0-a_authorGuidelines">Author guidelines</a></li><li><a href="https://www.frontiersin.org/for-authors/author-services" target="_self" data-event="footer-block_0-a_servicesForAuthors">Services for authors</a></li><li><a href="https://www.frontiersin.org/guidelines/policies-and-publication-ethics" target="_self" data-event="footer-block_0-a_policiesAndPublicationE">Policies and publication ethics</a></li><li><a href="https://www.frontiersin.org/guidelines/editor-guidelines" target="_self" data-event="footer-block_0-a_editorGuidelines">Editor guidelines</a></li><li><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="footer-block_0-a_feePolicy">Fee policy</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Explore</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/articles" target="_self" data-event="footer-block_1-a_articles">Articles</a></li><li><a href="https://www.frontiersin.org/research-topics" target="_self" data-event="footer-block_1-a_researchTopics">Research Topics </a></li><li><a href="https://www.frontiersin.org/journals" target="_self" data-event="footer-block_1-a_journals">Journals</a></li><li><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="footer-block_1-a_howWePublish">How we publish</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Outreach</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://forum.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForum">Frontiers Forum </a></li><li><a href="https://policylabs.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersPolicyLabs">Frontiers Policy Labs </a></li><li><a href="https://kids.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForYoungMinds">Frontiers for Young Minds</a></li><li><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="footer-block_2-a_frontiersPlanetPrize">Frontiers Planet Prize</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Connect</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://helpcenter.frontiersin.org" target="_blank" data-event="footer-block_3-a_helpCenter">Help center</a></li><li><a href="https://subscription-management.frontiersin.org/emails/preferences#block0" target="_blank" data-event="footer-block_3-a_emailsAndAlerts">Emails and alerts </a></li><li><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="footer-block_3-a_contactUs">Contact us </a></li><li><a href="https://www.frontiersin.org/submission/submit" target="_self" data-event="footer-block_3-a_submit">Submit</a></li><li><a href="https://careers.frontiersin.org/" target="_blank" data-event="footer-block_3-a_careerOpportunities">Career opportunities</a></li><!--]--></ul><!--]--></div></li><!--]--><!--]--></ul><div class="Footer__socialLinks"><div class="Footer__socialLinks__title">Follow us</div><!--[--><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--facebook Link--right" aria-label="Frontiers Facebook" href="https://www.facebook.com/Frontiersin" target="_blank" data-event="footer-facebook-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--twitter Link--right" aria-label="Frontiers Twitter" href="https://twitter.com/frontiersin" target="_blank" data-event="footer-twitter-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--linkedin Link--right" aria-label="Frontiers LinkedIn" href="https://www.linkedin.com/company/frontiers" target="_blank" data-event="footer-linkedIn-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--instagram Link--right" aria-label="Frontiers Instagram" href="https://www.instagram.com/frontiersin_" target="_blank" data-event="footer-instagram-a_true"><span></span></a></span><!--]--></div></div><div class="Footer__copyright"><div><span> 2025 Frontiers Media SA. All rights reserved.</span></div><div><a href="https://www.frontiersin.org/legal/privacy-policy" target="_blank">Privacy policy</a><span>|</span><a href="https://www.frontiersin.org/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer><div class="SnackbarWrapper"><div class="SnackbarManager"><!--[--><!--]--></div></div></div><noscript><iframe
            src="https://tag-manager.frontiersin.org/ns.html?id=GTM-M322FV2&gtm_auth=owVbWxfaJr21yQv1fe1cAQ&gtm_preview=env-1&gtm_cookies_win=x"
            height="0"
            width="0"
            style="display: none; visibility: hidden">
          </iframe></noscript><!--]--></div><div id="teleports"></div><script type="application/json" id="__NUXT_DATA__" data-ssr="true">[["ShallowReactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverRendered":13,"path":14,"pinia":15},["ShallowReactive",3],{},["Reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","Frontiers articles","https://article-pages-2024.frontiersin.org/",["Set"],["ShallowReactive",12],{},true,"/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/full",["Reactive",16],{"main":17,"user":502,"article":503,"articleHub":774,"mainHeader":778},{"ibar":18,"footer":212,"newsletterComponent":-1,"snackbarItem":294,"toggleShowSnackbar":295,"contentfulJournal":296,"graphJournal":402,"settingsFeaturesSwitchers":406,"templateToggleBanner":407,"tenantConfig":467},{"tenantLogo":19,"journalLogo":19,"aboutUs":20,"submitUrl":113,"showSubmitButton":13,"journal":114,"sectionTerm":143,"aboutJournal":144,"mainLinks":193,"journalLinks":200,"helpCenterLink":209},"",[21,38,47,71,87],{"title":22,"links":23},"Who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"ariaLabel":28},"Mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"ariaLabel":28},"History","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"ariaLabel":28},"Leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"ariaLabel":28},"Awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"Impact and progress",[41,44],{"text":42,"url":43,"target":27,"ariaLabel":28},"Frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"ariaLabel":28},"Our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"Publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"ariaLabel":28},"How we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"ariaLabel":28},"Open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"ariaLabel":28},"Peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"ariaLabel":28},"Research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"ariaLabel":28},"Research Topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"ariaLabel":28},"FAIR Data Management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"ariaLabel":28},"Fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"Services",[74,78,81,84],{"text":75,"url":76,"target":77,"ariaLabel":28},"Societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"ariaLabel":28},"National consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"ariaLabel":28},"Institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"ariaLabel":28},"Collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"More from Frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"ariaLabel":93},"Frontiers Forum","https://forum.frontiersin.org/","this link will take you to the Frontiers Forum website",{"text":95,"url":96,"target":27,"ariaLabel":28},"Frontiers Planet Prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"ariaLabel":100},"Press office","https://pressoffice.frontiersin.org/","this link will take you to the Frontiers press office website",{"text":102,"url":103,"target":27,"ariaLabel":104},"Sustainability","https://www.frontiersin.org/about/sustainability","link to information about Frontiers' sustainability",{"text":106,"url":107,"target":77,"ariaLabel":108},"Career opportunities","https://careers.frontiersin.org/","this link will take you to the Frontiers careers website",{"text":110,"url":111,"target":27,"ariaLabel":112},"Contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=1&fieldid=171&specialtyid=0&entitytype=2&entityid=2031",{"id":115,"name":116,"slug":117,"sections":118},2031,"Frontiers in Molecular Neuroscience","molecular-neuroscience",[119,123,127,131,135,139],{"id":120,"name":121,"slug":122},2032,"Brain Disease Mechanisms","brain-disease-mechanisms",{"id":124,"name":125,"slug":126},2034,"Methods and Model Organisms","methods-and-model-organisms",{"id":128,"name":129,"slug":130},2,"Molecular Neuroscience Archive","molecular-neuroscience-archive",{"id":132,"name":133,"slug":134},2033,"Molecular Signalling and Pathways","molecular-signalling-and-pathways",{"id":136,"name":137,"slug":138},2036,"Neuroplasticity and Development","neuroplasticity-and-development",{"id":140,"name":141,"slug":142},2035,"Pain Mechanisms and Modulators","pain-mechanisms-and-modulators","Sections",[145,169],{"title":146,"links":147},"Scope",[148,151,154,157,160,163,166],{"text":149,"url":150,"target":27,"ariaLabel":28},"Field chief editors","https://www.frontiersin.org/journals/molecular-neuroscience/about#about-editors",{"text":152,"url":153,"target":27,"ariaLabel":28},"Mission & scope","https://www.frontiersin.org/journals/molecular-neuroscience/about#about-scope",{"text":155,"url":156,"target":27,"ariaLabel":28},"Facts","https://www.frontiersin.org/journals/molecular-neuroscience/about#about-facts",{"text":158,"url":159,"target":27,"ariaLabel":28},"Journal sections","https://www.frontiersin.org/journals/molecular-neuroscience/about#about-submission",{"text":161,"url":162,"target":27,"ariaLabel":28},"Open access statement","https://www.frontiersin.org/journals/molecular-neuroscience/about#about-open",{"text":164,"url":165,"target":27,"ariaLabel":28},"Copyright statement","https://www.frontiersin.org/journals/molecular-neuroscience/about#copyright-statement",{"text":167,"url":168,"target":27,"ariaLabel":28},"Quality","https://www.frontiersin.org/journals/molecular-neuroscience/about#about-quality",{"title":170,"links":171},"For authors",[172,175,178,181,184,187,190],{"text":173,"url":174,"target":27,"ariaLabel":28},"Why submit?","https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/why-submit",{"text":176,"url":177,"target":27,"ariaLabel":28},"Article types","https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/article-types",{"text":179,"url":180,"target":27,"ariaLabel":28},"Author guidelines","https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/author-guidelines",{"text":182,"url":183,"target":27,"ariaLabel":28},"Editor guidelines","https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/editor-guidelines",{"text":185,"url":186,"target":27,"ariaLabel":28},"Publishing fees","https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/publishing-fees",{"text":188,"url":189,"target":27,"ariaLabel":28},"Submission checklist","https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/submission-checklist",{"text":191,"url":192,"target":27,"ariaLabel":28},"Contact editorial office","https://www.frontiersin.org/journals/molecular-neuroscience/for-authors/contact-editorial-office",[194,197],{"text":195,"url":196,"target":27,"ariaLabel":28},"All journals","https://www.frontiersin.org/journals",{"text":198,"url":199,"target":27,"ariaLabel":28},"All articles","https://www.frontiersin.org/articles",[201,204,206],{"text":202,"url":203,"target":27,"ariaLabel":28},"Articles","articles",{"text":63,"url":205,"target":27,"ariaLabel":28},"research-topics",{"text":207,"url":208,"target":27,"ariaLabel":28},"Editorial board","editors",{"text":210,"url":211,"target":77,"ariaLabel":210},"Help center","https://helpcenter.frontiersin.org",{"blocks":213,"socialLinks":267,"copyright":291,"termsAndConditionsUrl":292,"privacyPolicyUrl":293},[214,228,238,252],{"title":215,"links":216},"Guidelines",[217,219,222,225,227],{"text":179,"url":218,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":220,"url":221,"target":27,"ariaLabel":28},"Services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":223,"url":224,"target":27,"ariaLabel":28},"Policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":182,"url":226,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"ariaLabel":28},{"title":229,"links":230},"Explore",[231,232,235,237],{"text":202,"url":199,"target":27,"ariaLabel":28},{"text":233,"url":234,"target":27,"ariaLabel":28},"Research Topics ","https://www.frontiersin.org/research-topics",{"text":236,"url":196,"target":27,"ariaLabel":28},"Journals",{"text":51,"url":52,"target":27,"ariaLabel":28},{"title":239,"links":240},"Outreach",[241,244,247,251],{"text":242,"url":92,"target":77,"ariaLabel":243},"Frontiers Forum ","Frontiers Forum website",{"text":245,"url":246,"target":77,"ariaLabel":28},"Frontiers Policy Labs ","https://policylabs.frontiersin.org/",{"text":248,"url":249,"target":77,"ariaLabel":250},"Frontiers for Young Minds","https://kids.frontiersin.org/","Frontiers for Young Minds journal",{"text":95,"url":96,"target":27,"ariaLabel":28},{"title":253,"links":254},"Connect",[255,256,260,263,266],{"text":210,"url":211,"target":77,"ariaLabel":210},{"text":257,"url":258,"target":77,"ariaLabel":259},"Emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","Subscribe to Frontiers emails",{"text":261,"url":111,"target":27,"ariaLabel":262},"Contact us ","Subscribe to newsletter",{"text":264,"url":265,"target":27,"ariaLabel":28},"Submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"ariaLabel":28},[268,276,281,286],{"link":269,"type":272,"color":273,"icon":274,"size":275,"hiddenText":13},{"text":270,"url":271,"target":77,"ariaLabel":270},"Frontiers Facebook","https://www.facebook.com/Frontiersin","Link","Grey","Facebook","Medium",{"link":277,"type":272,"color":273,"icon":280,"size":275,"hiddenText":13},{"text":278,"url":279,"target":77,"ariaLabel":28},"Frontiers Twitter","https://twitter.com/frontiersin","Twitter",{"link":282,"type":272,"color":273,"icon":285,"size":275,"hiddenText":13},{"text":283,"url":284,"target":77,"ariaLabel":28},"Frontiers LinkedIn","https://www.linkedin.com/company/frontiers","LinkedIn",{"link":287,"type":272,"color":273,"icon":290,"size":275,"hiddenText":13},{"text":288,"url":289,"target":77,"ariaLabel":28},"Frontiers Instagram","https://www.instagram.com/frontiersin_","Instagram","Frontiers Media SA. All rights reserved.","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":297,"identifier":115,"name":116,"slug":117,"banner":298,"description":395,"mission":396,"palette":397,"impactFactor":398,"citeScore":399,"citations":400,"showTagline":28,"twitter":401},"Journal",[299],{"id":300,"src":301,"name":302,"tags":303,"type":354,"width":355,"height":356,"idHash":357,"archive":358,"brandId":359,"limited":358,"fileSize":360,"isPublic":361,"original":362,"copyright":19,"extension":363,"thumbnails":365,"dateCreated":373,"description":374,"orientation":375,"userCreated":376,"watermarked":358,"dateModified":373,"datePublished":377,"ecsArchiveFiles":378,"propertyOptions":379,"property_Channel":384,"property_Sub-Type":386,"property_Asset_Type":388,"activeOriginalFocusPoint":390,"property_Office_Department":393},"915C603D-8627-48C8-9ADC6859F133F72E","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/915C603D-8627-48C8-9ADC6859F133F72E/webimage-FF824A5C-14ED-4DCD-93CACD22B3645CEB.png","FNMOL_Main Visual_Purple_Website",[304,305,306,307,308,309,310,311,312,313,314,315,316,317,318,319,320,321,322,323,324,325,326,327,328,329,330,331,332,333,334,335,336,337,338,339,340,341,342,343,344,345,346,347,348,349,350,351,352,353],"signal","memory","medical","hormone","rendering","transfer","network","white","tissue","function","electrical","axon","think","impulse","nerve","nervous","brain","bio","receptor","health","system","blue","anatomy","neural","concept","biology","data","intelligence","chemical","loss","science","microscopic","connection","abstract","communication","background","nucleus","synapse","neuron","dendrite","inside","illustration","medicine","3d","cell","human","neurotransmitter","immunological","neurology","cognitive","image",4500,3000,"33456db75c2e9caf",0,"22C10171-81B3-4DA6-99342F272A32E8BB",3650002,1,"https://brand.frontiersin.org/m/33456db75c2e9caf/original/FNMOL_Main-Visual_Purple_Website.jpg",[364],"jpg",{"mini":366,"thul":367,"webimage":301,"Guidelines":368,"WebsiteJpg_XL":369,"WebsiteWebP_L":370,"WebsiteWebP_M":371,"WebsiteWebP_XL":372},"https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/915C603D-8627-48C8-9ADC6859F133F72E/mini-2DF1B922-ADBF-4B3A-9EDD58E05B5A72E3.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/915C603D-8627-48C8-9ADC6859F133F72E/thul-D2F90508-80E0-452C-AE61AD64775B5DEB.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/915C603D-8627-48C8-9ADC6859F133F72E/6194DC60-82DA-4989-984FDC66CE7BA15C/Guidelines-FNMOL_Main Visual_Purple_Website.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/915C603D-8627-48C8-9ADC6859F133F72E/6194DC60-82DA-4989-984FDC66CE7BA15C/WebsiteJpg_XL-FNMOL_Main Visual_Purple_Website.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/915C603D-8627-48C8-9ADC6859F133F72E/6194DC60-82DA-4989-984FDC66CE7BA15C/WebsiteWebP_L-FNMOL_Main Visual_Purple_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/915C603D-8627-48C8-9ADC6859F133F72E/6194DC60-82DA-4989-984FDC66CE7BA15C/WebsiteWebP_M-FNMOL_Main Visual_Purple_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/915C603D-8627-48C8-9ADC6859F133F72E/6194DC60-82DA-4989-984FDC66CE7BA15C/WebsiteWebP_XL-FNMOL_Main Visual_Purple_Website.webp","2022-06-27T10:00:30Z","Receptors sending electrochemical signals. Impulse in human brain on a molecular level. 3d rendering; Shutterstock ID 1210864027; purchase_order: Main Visual; job: ; client: ; other:","landscape","Caroline Sutter","2022-06-27T09:27:09Z",[],[380,381,382,383],"414FB2D4-2283-43FD-BE14E534ECA67928","6C18119B-14BD-4951-B437696F4357BD33","7C692885-DB25-4858-B1FB4FF47B241E9B","D88C0047-EC30-4506-A7DF28A4D765E1CF",[385],"frontiersin_org",[387],"Main_Visual",[389],"Photography",{"x":391,"y":392},2250,1500,[394],"Publishing","Part of the most cited neuroscience series, this journal explores and identifies key molecules underlying the structure, design and function of the brain across all levels.","\u003Cp>Frontiers in Molecular Neuroscience is a PubMed Central, Scopus, and SCIE-indexed journal, that explores the brain's molecular structure, design, and function.\u003C/p>\n\n\u003Cp>Frontiers in Molecular Neuroscience is led by Field Chief Editors Robert J. Harvey (University of the Sunshine Coast, Queensland, Australia) and Jochen C. Meier (Technische Universitat Braunschweig, Germany). This multidisciplinary journal seeks to identify how key molecules function and interact to understand the brain's structure, design, and function across all levels. Topics of interest include:\u003C/p>\n\n\u003Cul>\n  \u003Cli>brain disease mechanisms\u003C/li>\n  \u003Cli>coding and non-coding RNA\u003C/li>\n  \u003Cli>methods and model organisms\u003C/li>\n  \u003Cli>molecular mechanisms regulating cellular and dendritic RNA trafficking and translation\u003C/li>\n  \u003Cli>molecular signaling and pathways\u003C/li>\n  \u003Cli>neuroplasticity and development\u003C/li>\n  \u003Cli>pain mechanisms and modulators\u003C/li>\n  \u003Cli>synaptic and cellular proteins.\u003C/li>\n\u003C/ul>\n\n\u003Cp>Frontiers in Molecular Neuroscience is particularly interested in submissions on human brain diseases, and genetically engineered model organisms  such as C. elegans, Drosophila, zebrafish, and rodents  in which alterations in key molecules underlying cellular and synaptic function and plasticity produce defined anatomical, physiological or behavioral changes. Research on genetic alterations in specific neural circuits (e.g., olfactory bulb, motor cortex, cortical layers, hippocampal subfields, cerebellum, brainstem, spinal cord) and compensatory or homeostatic mechanisms are of particular interest.\u003C/p>\n\n\u003Cp>Equally important, the journal encourages submissions that advance the UN's Sustainable Development Goals (SDGs), specifically SDG 3: good health and well-being, promoting our biological understanding of brain health.\u003C/p>\n\n\u003Cp>Manuscripts that focus on clinical practice, genetics, neurological function, cognitive function, and cell proliferation without a clear connection to molecular neuroscience are not suitable for publication in this journal. Similarly, studies on complementary/alternative medicine, e.g., acupuncture/electroacupuncture will not be considered. Studies that do not provide novel insights into the molecular mechanisms underlying neurological processes are also out of scope. For example, research on stem cells or genetic causes of disease without a direct link to molecular neuroscience will not be considered.\u003C/p>\n\n\u003Cp>Frontiers journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the \u003Ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,Standards%20for%20research%20methodology,-Experiments\">Frontiers Standards for research methodology policy\u003C/a>, for more information. Manuscripts not adhering to these standards will not be considered.\u003Cp>\n\n\u003Cp>Frontiers in Molecular Neuroscience is also committed to advancing research in the field of molecular neuroscience by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public to enable future scientific breakthroughs.\u003C/p>\n\n\u003Cp>---------\u003C/p>\n\n\u003Cp>Ethics statement\u003C/p>\n\n\u003Cp>All manuscripts submitted toFrontiers in Molecular Neuroscience that have been conducted in human subjects must conform with current regulations and the Declaration of Helsinki. Ethics committee approval and informed patient consent are required for studies involving human subjects. Ethics committee approval is also needed for studies involving animals. Phase I - Phase IV clinical trials submitted for publication inFrontiers in Molecular Neuroscience must have been registered with an appropriate public trials registry at the time or before the first patient enrolment. The information on the clinical trial registration (Unique Identifier and URL) must be included in the abstract. Authors are required to disclose all apparent or potential conflicts of interest according to the ICMJE guidelines and those of Frontiers.\u003C/p>\n\n\u003Cp>Frontiers endeavors to follow the guidelines and best practice recommendations published by the Committee on Publication Ethics (COPE). Authors should refer to theauthor guidelinesfor full details.\u003C/p>\n","purple","4.8","6.7","114113","@FrontNeurosci",{"id":115,"name":116,"slug":117,"abbreviation":403,"isOnline":13,"isOpenForSubmissions":13,"citeScore":404,"impactFactor":405},"fnmol",6.8,3.8,{"displayTitlePillLabels":13,"displayRelatedArticlesBox":13,"showEditors":13,"showReviewers":13,"showLoopImpactLink":13,"enableFigshare":295},{"isPublic":13,"allowCompanyUsers":295,"whiteListEmails":408,"enableAllJournals":13,"whiteListJournals":430},[409,410,411,412,413,414,415,416,417,414,418,419,420,421,422,423,424,425,426,427,428,429],"Y2FybG9zLmxvcmNhQGZyb250aWVyc2luLm9yZw==","ZGFuaWVsLmx1ekBmcm9udGllcnNpbi5vcmc=","bGF1cmEudGVuYUBmcm9udGllcnNpbi5vcmc=","cmFmYWVsLnJpYW5jaG9AZnJvbnRpZXJzaW4ub3Jn","amFtZXMuc21hbGxib25lQGZyb250aWVyc2luLm9yZw==","ZnJhbi5tb3Jlbm9AZnJvbnRpZXJzaW4ub3Jn","c2FtdWVsLmZlcm5hbmRlekBmcm9udGllcnNpbi5vcmc=","YmFyYmFyYS5jYXJjYW5naXVAZnJvbnRpZXJzaW4ub3Jn","aXZhbi5zYW50YW1hcmlhQGZyb250aWVyc2luLm9yZw==","aHVlLnRyYW5AZnJvbnRpZXJzaW4ub3Jn","Z29uY2Fsby52YXJnYXNAZnJvbnRpZXJzaW4ub3Jn","bHVjaWUuc2VubkBmcm9udGllcnNpbi5vcmc=","bG9ybi5mcmFzZXJAZnJvbnRpZXJzaW4ub3Jn","ZWxzYS5jYXJyb25AZnJvbnRpZXJzaW4ub3Jn","bWFhcnRlbi52YW5kaWpja0Bmcm9udGllcnNpbi5vcmc=","YmluZGh1LmtyaXNobmFuQGZyb250aWVyc2luLm9yZw==","bWF0dGhldy5hdHR3YXRlcnNAZnJvbnRpZXJzaW4ub3Jn","Z2l1bGlhLnZhbHNlY2NoaUBmcm9udGllcnNpbi5vcmc=","ZmFiaWFuLmRlbGxhbW9ydGVAZnJvbnRpZXJzaW4ub3Jn","dmlqYXlhbi5wcEBwaXRzb2x1dGlvbnMuY29t","Z3VpbGxhdW1lLnNldXJhdEBmcm9udGllcnNpbi5vcmc=",[431,432,433,434,435,436,361,437,438,439,440,441,442,443,444,445,446,447,448,449,450,451,452,453,454,455,456,457,458,459,460,461,462,463,464,465,466],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,141,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceId":361,"name":361,"availableJournalPages":468,"announcement":472},[203,208,205,469,470,471],"volumes","about","community-reviewers",{"__typename":473,"sys":474,"preHeader":42,"title":476,"description":477,"image":478,"link":500},"Announcement",{"id":475},"5ITtnTtQgAzPPGH6rX0AlM","Articles published with Frontiers have received 12 million total citations","Your research is the real superpower - learn how we maximise its impact through our leading community journals",[479],{"archive":358,"brandId":359,"copyright":28,"dateCreated":480,"dateModified":481,"datePublished":482,"description":28,"extension":483,"fileSize":485,"height":486,"id":487,"isPublic":358,"limited":358,"name":488,"orientation":375,"original":28,"thumbnails":489,"type":354,"watermarked":358,"width":496,"videoPreviewURLs":497,"tags":498,"textMetaproperties":499,"src":490},"2025-06-18T12:58:01Z","2025-06-18T14:15:34Z","2025-06-18T12:57:32Z",[484],"png",1365026,920,"7C5269C4-3C83-4591-951A74D15B95DAEA","Impact metrics banner for article pages",{"webimage":490,"thul":491,"mini":492,"WebsiteWebP_L":493,"WebsiteWebP_M":494,"Guidelines":495},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_L/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_M/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/Guidelines/Impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":501,"url":43,"target":27,"ariaLabel":28},"Explore our impact metrics",{"loggedUserInfo":-1},{"currentArticle":504,"isPreviewPage":295,"hasSupplementalData":295,"showCrossmarkWidget":13,"articleTemplate":647,"currentArticlePageMetaInfo":648,"xmlParsedArticleContent":-1,"xmlParsingError":-1},{"id":505,"doi":506,"title":507,"acceptanceDate":508,"receptionDate":509,"publicationDate":510,"lastModifiedDate":511,"isPublished":13,"abstract":512,"researchTopic":513,"articleType":519,"stage":522,"keywords":524,"authors":533,"editors":575,"reviewers":584,"journal":603,"section":610,"impactMetrics":612,"volume":616,"articleVolume":617,"relatedArticles":618,"isPublishedV2":295,"contents":619,"files":622},1050472,"10.3389/fnmol.2022.1050472","The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation",["Date","2022-10-19T21:20:30.000Z"],["Date","2022-09-21T16:58:19.000Z"],["Date","2022-12-16T00:00:00.000Z"],["Date","2025-11-25T03:35:14.072Z"],"Patients with the fatal disorder Transthyretin Amyloidosis (ATTR) experience polyneuropathy through the progressive destruction of peripheral nervous tissue. In these patients, the transthyretin (TTR) protein dissociates from its functional tetrameric structure, misfolds, and aggregates into extracellular amyloid deposits that are associated with disease progression. These aggregates form large fibrillar structures as well as shorter oligomeric aggregates that are suspected to be cytotoxic. Several studies have shown that these extracellular TTR aggregates enter the cell and accumulate intracellularly, which is associated with increased proteostasis response. However, there are limited experimental models to study how proteostasis influences internalized TTR aggregates. Here, we use a humanized yeast system to recapitulate intracellular TTR aggregating protein in vivo. The yeast molecular chaperone Hsp104 is a disaggregase that has been shown to fragment amyloidogenic aggregates associated with certain yeast prions and reduce protein aggregation associated with human neurogenerative diseases. In yeast, we found that TTR forms both SDS-resistant oligomers and SDS-sensitive large molecular weight complexes. In actively dividing cultures, Hsp104 has no impact on oligomeric or large aggregate populations, yet overexpression of Hsp104 is loosely associated with an increase in overall aggregate size. Interestingly, a potentiating mutation in the middle domain of Hsp104 consistently results in an increase in overall TTR aggregate size. These data suggest a novel approach to aggregate management, where the Hsp104 variant shifts aggregate populations away from toxic oligomeric species to more inert larger aggregates. In aged cultures Hsp104 overexpression has no impact on TTR aggregation profiles suggesting that these chaperone approaches to shift aggregate populations are not effective with age, possibly due to proteostasis decline. ",{"id":514,"title":515,"articlesCount":516,"isMagazinePage":13,"slug":517,"isOpenForSubmission":295,"views":518},46432,"Rising Stars in Molecular Neuroscience - Methods and Model Organisms: 2022",4,"rising-stars-in-molecular-neuroscience---methods-and-model-organisms-2022",23419,{"id":520,"name":521},24,"Original Research",{"id":523,"name":19},18,[525,526,527,528,529,530,531,532],"Hsp104","transthyretin","molecular chaperone","protein aggregation","transthyretin amyloidosis","Amyloid","polyneuropathy","Aging",[534,543,549,556,562,568],{"id":535,"firstName":536,"middleName":19,"lastName":537,"givenNames":538,"isCorresponding":295,"isProfilePublic":13,"userId":535,"email":-1,"affiliations":539},2003445,"Adam S.","Knier","Adam S. ",[540],{"organizationName":541,"countryName":542,"cityName":19,"stateName":19,"zipCode":19},"Department of Biological Sciences, Marquette University","United States",{"id":358,"firstName":544,"middleName":19,"lastName":545,"givenNames":546,"isCorresponding":295,"isProfilePublic":295,"userId":358,"email":-1,"affiliations":547},"Emily E.","Davis","Emily E. ",[548],{"organizationName":541,"countryName":542,"cityName":19,"stateName":19,"zipCode":19},{"id":550,"firstName":551,"middleName":19,"lastName":552,"givenNames":553,"isCorresponding":295,"isProfilePublic":13,"userId":550,"email":-1,"affiliations":554},2026336,"Hannah E.","Buchholz","Hannah E. ",[555],{"organizationName":541,"countryName":542,"cityName":19,"stateName":19,"zipCode":19},{"id":358,"firstName":557,"middleName":19,"lastName":558,"givenNames":559,"isCorresponding":295,"isProfilePublic":295,"userId":358,"email":-1,"affiliations":560},"Jane E.","Dorweiler","Jane E. ",[561],{"organizationName":541,"countryName":542,"cityName":19,"stateName":19,"zipCode":19},{"id":358,"firstName":563,"middleName":19,"lastName":564,"givenNames":565,"isCorresponding":295,"isProfilePublic":295,"userId":358,"email":-1,"affiliations":566},"Lauryn E.","Flannagan","Lauryn E. ",[567],{"organizationName":541,"countryName":542,"cityName":19,"stateName":19,"zipCode":19},{"id":569,"firstName":570,"middleName":19,"lastName":571,"givenNames":572,"isCorresponding":295,"isProfilePublic":13,"userId":569,"email":-1,"affiliations":573},497140,"Anita L.","Manogaran","Anita L. ",[574],{"organizationName":541,"countryName":542,"cityName":19,"stateName":19,"zipCode":19},[576],{"id":577,"firstName":578,"middleName":19,"lastName":579,"givenNames":580,"isCorresponding":295,"isProfilePublic":13,"userId":577,"email":-1,"affiliations":581},122913,"Andrei","Surguchov","Andrei ",[582],{"organizationName":583,"countryName":542,"cityName":19,"stateName":19,"zipCode":19},"University of Kansas Medical Center",[585,593],{"id":586,"firstName":587,"middleName":588,"lastName":589,"givenNames":590,"isCorresponding":295,"isProfilePublic":13,"userId":586,"email":-1,"affiliations":591},363601,"Irina","G","Sourgoutcheva","Irina  G",[592],{"organizationName":583,"countryName":542,"cityName":19,"stateName":19,"zipCode":19},{"id":594,"firstName":595,"middleName":596,"lastName":597,"givenNames":598,"isCorresponding":295,"isProfilePublic":13,"userId":594,"email":-1,"affiliations":599},608012,"Maria","Rosrio","Almeida","Maria  Rosrio",[600],{"organizationName":601,"countryName":602,"cityName":19,"stateName":19,"zipCode":19},"Institute of Biomedical Sciences Abel Salazar, University of Porto","Portugal",{"id":115,"slug":117,"name":116,"shortName":604,"electronicISSN":605,"field":606,"specialtyId":28,"journalSectionPaths":608},"Front. Mol. Neurosci.","1662-5099",{"id":607,"domainId":361},171,[609],{"section":610},{"id":124,"name":125,"slug":126,"specialtyId":611},2475,{"views":613,"downloads":614,"citations":615},6000,1185,3,15,"Volume 15 - 2022",[],{"titleHtml":507,"fullTextHtml":620,"menuHtml":621},"\u003Cdiv class=\"JournalAbstract\"> \u003Ca id=\"h1\" name=\"h1\">\u003C/a>\n \u003Cdiv class=\"authors\">\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/2003445\" class=\"user-id-2003445\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/2003445/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Adam S. Knier\">Adam S. Knier\u003C/a>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Emily E. Davis\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Emily E. Davis\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/2026336\" class=\"user-id-2026336\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/2026336/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Hannah E. Buchholz\">Hannah E. Buchholz\u003C/a>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Jane E. Dorweiler\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Jane E. Dorweiler\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Lauryn E. Flannagan\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Lauryn E. Flannagan\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/497140\" class=\"user-id-497140\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/497140/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Anita L. Manogaran&#xA;\">Anita L. Manogaran\u003C/a>\u003Csup>&#x0002A;\u003C/sup>\u003C/span>\u003C/div> \u003Cul class=\"notes\"> \u003Cli>Department of Biological Sciences, Marquette University, Milwaukee, WI, United States\u003C/li> \u003C/ul>\n\u003Cp>Patients with the fatal disorder Transthyretin Amyloidosis (ATTR) experience polyneuropathy through the progressive destruction of peripheral nervous tissue. In these patients, the transthyretin (TTR) protein dissociates from its functional tetrameric structure, misfolds, and aggregates into extracellular amyloid deposits that are associated with disease progression. These aggregates form large fibrillar structures as well as shorter oligomeric aggregates that are suspected to be cytotoxic. Several studies have shown that these extracellular TTR aggregates enter the cell and accumulate intracellularly, which is associated with increased proteostasis response. However, there are limited experimental models to study how proteostasis influences internalized TTR aggregates. Here, we use a humanized yeast system to recapitulate intracellular TTR aggregating protein \u003Ci>in vivo\u003C/i>. The yeast molecular chaperone Hsp104 is a disaggregase that has been shown to fragment amyloidogenic aggregates associated with certain yeast prions and reduce protein aggregation associated with human neurogenerative diseases. In yeast, we found that TTR forms both SDS-resistant oligomers and SDS-sensitive large molecular weight complexes. In actively dividing cultures, Hsp104 has no impact on oligomeric or large aggregate populations, yet overexpression of Hsp104 is loosely associated with an increase in overall aggregate size. Interestingly, a potentiating mutation in the middle domain of Hsp104 consistently results in an increase in overall TTR aggregate size. These data suggest a novel approach to aggregate management, where the Hsp104 variant shifts aggregate populations away from toxic oligomeric species to more inert larger aggregates. In aged cultures Hsp104 overexpression has no impact on TTR aggregation profiles suggesting that these chaperone approaches to shift aggregate populations are not effective with age, possibly due to proteostasis decline.\u003C/p> \u003Cdiv class=\"clear\">\u003C/div> \u003C/div> \u003Cdiv class=\"JournalFullText\"> \u003Ca id=\"h2\" name=\"h2\">\u003C/a>\n\u003Ch2>Introduction\u003C/h2>\n\u003Cp class=\"mb15\">Onset of the progressively fatal disease Transthyretin Amyloidosis (ATTR) is associated with the amyloidogenic aggregation of the human transthyretin (TTR) protein. As a functional tetramer, TTR shuttles hormone and proteins within the bloodstream and CNS. However, the tetramer can dissociate with age, leading to the misfolding and subsequent aggregation of the TTR monomer. It is the tetramer dissociation that is considered the rate limiting step of the aggregation process (\u003Ca href=\"#ref22\">Hammarstrom et al., 2003\u003C/a>). The misfolded monomer can assemble into small oligomeric species or large amyloid. \u003Ci>In vitro\u003C/i> evidence suggests that these small oligomeric TTR aggregates are cytotoxic (\u003Ca href=\"#ref8\">Dasari et al., 2019\u003C/a>). Over time, the circulating TTR aggregates are deposited into the heart and peripheral nerves, leading to system organ failure and death (\u003Ca href=\"#ref17\">Gertz et al., 2015\u003C/a>). Interestingly, approaches that shift the equilibrium away from cytotoxic oligomeric species and towards either monomeric protein or large amyloid may be a means to delay the disease.\u003C/p>\n\u003Cp class=\"mb15\">Transthyretin aggregates have been observed within cells, detected as intracellular cytoplasmic deposits (\u003Ca href=\"#ref4\">Brett et al., 1999\u003C/a>; \u003Ca href=\"#ref36\">Misumi et al., 2013\u003C/a>). Cells with internalized TTR also display an upregulation of the HSF1 protein, a master regulator for heat shock related chaperones (\u003Ca href=\"#ref44\">Santos et al., 2010\u003C/a>). Furthermore, the levels of several molecular chaperones appear to be increased in ATTR patients (\u003Ca href=\"#ref36\">Misumi et al., 2013\u003C/a>; \u003Ca href=\"#ref7\">da Costa et al., 2015\u003C/a>) suggesting a correlation between internalization and an \u003Ci>in vivo\u003C/i> molecular chaperone response.\u003C/p>\n\u003Cp class=\"mb15\">Molecular chaperones play an important role in maintaining protein homeostasis by facilitating proper polypeptide folding while managing the accumulation of excess aberrantly folded proteins (\u003Ca href=\"#ref37\">Mogk et al., 2018\u003C/a>). Elevated chaperone activity not only is associated with ATTR, but chaperones have been shown to contribute to the prevention of neurodegenerative disease onset, such as Alzheimer&#x2019;s and Prion disease (\u003Ca href=\"#ref55\">Wentink et al., 2019\u003C/a>; \u003Ca href=\"#ref53\">Tittelmeier et al., 2020\u003C/a>). However, as cells age, the ability for chaperones to maintain intracellular proteostasis declines, resulting in protein aggregation and associated disease onset (\u003Ca href=\"#ref26\">Klaips et al., 2018\u003C/a>).\u003C/p>\n\u003Cp class=\"mb15\">The study of protein aggregation and chaperones in yeast has greatly advanced our mechanistic understanding of how chaperones influence protein aggregates in humans (\u003Ca href=\"#ref52\">Surguchov, 2021\u003C/a>). The AAA+ hexameric ATPase, Hsp104, interacts with highly conserved Hsp70 and Hsp40 co-chaperones to fragment several yeast prions that are amyloidogenic. The Hsp104/70/40 complex extracts monomeric subunits from the middle of prion fibrils, thus fragmenting the aggregate into smaller pieces (\u003Ca href=\"#ref41\">Parsell et al., 1994\u003C/a>; \u003Ca href=\"#ref18\">Glover and Lindquist, 1998\u003C/a>; \u003Ca href=\"#ref50\">Shorter and Lindquist, 2004\u003C/a>; \u003Ca href=\"#ref45\">Satpute-Krishnan et al., 2007\u003C/a>; \u003Ca href=\"#ref10\">DeSantis et al., 2012\u003C/a>). While Hsp104 is not found in metazoans, \u003Ci>in vitro\u003C/i> studies show that wildtype-Hsp104 can disassemble human amyloidogenic aggregating proteins (\u003Ca href=\"#ref32\">Lo Bianco et al., 2008\u003C/a>; \u003Ca href=\"#ref31\">Liu et al., 2011\u003C/a>; \u003Ca href=\"#ref10\">DeSantis et al., 2012\u003C/a>; \u003Ca href=\"#ref34\">March et al., 2019\u003C/a>). In contrast, \u003Ci>in vivo\u003C/i> studies indicate that wildtype-Hsp104 has little effect on aggregate disassembly, while mutations within the regulatory middle-domain can potentiate Hsp104 function resulting in aggregate disaggregation and suppression of cellular toxicity (\u003Ca href=\"#ref23\">Jackrel et al., 2014\u003C/a>; \u003Ca href=\"#ref35\">March et al., 2020\u003C/a>).\u003C/p>\n\u003Cp class=\"mb0\">Several labs have used a yeast-based system in which intracellular TTR is expressed as a monomer, thus bypassing the rate limiting step of conversion from tetrameric to monomeric form, which allows for rapid TTR aggregation (\u003Ca href=\"#ref9\">Derkatch et al., 2004\u003C/a>; \u003Ca href=\"#ref19\">Gomes et al., 2012\u003C/a>; \u003Ca href=\"#ref54\">Verma et al., 2018\u003C/a>). The aggregated TTR displays hallmarks of amyloidogenic protein including detection of SDS-resistant complexes (\u003Ca href=\"#ref19\">Gomes et al., 2012\u003C/a>) and fluorescent puncta when fused to GFP (\u003Ca href=\"#ref9\">Derkatch et al., 2004\u003C/a>; \u003Ca href=\"#ref54\">Verma et al., 2018\u003C/a>). Here, we use this yeast-based system to explore how Hsp104 influences the formation of TTR aggregates \u003Ci>in vivo\u003C/i>. We find that TTR forms both SDS-resistant oligomers and aggregates of larger sizes. However, it appears that these SDS-resistant species also make up larger aggregates held together by SDS-sensitive bonds. While loss of Hsp104 reduces the abundance of detergent resistant TTR populations, it does not impact the size of SDS-resistant oligomers. While overexpression of wildtype Hsp104 is loosely associated with an increase in overall TTR aggregate size, a Hsp104 middle domain mutant containing a A503S substitution is associated with a more definitive increase in aggregate size. We suspect that this mutation plays an important role in shifting the equilibrium away from the oligomeric species towards larger aggregates. However, any Hsp104 specific influence observed on TTR aggregates during logarithmic growth no longer occurs in saturated cultures, suggesting that Hsp104 alone cannot overcome age-related proteostasis decline.\u003C/p> \u003Ca id=\"h3\" name=\"h3\">\u003C/a>\n\u003Ch2>Materials and methods\u003C/h2>\n\u003Ch3>Strains, plasmids, and cultivation procedures\u003C/h3>\n\u003Cp class=\"mb15\">All yeast strains are derivatives of the 74-D694 background and listed in \u003Ca href=\"#SM1\">Supplementary Table 1\u003C/a>. \u003Ci>hsp104&#x0394;\u003C/i> 74-D694 strains were generated by standard homologous recombination as described in \u003Ca href=\"#ref33\">Manogaran et al. (2011)\u003C/a>. Primers to generate this strain (M515) are listed in \u003Ca href=\"#SM1\">Supplementary Table 2\u003C/a>. Plasmids used in this study are listed in \u003Ca href=\"#SM1\">Supplementary Table 3\u003C/a>. Note that centromeric plasmids are usually held at 2&#x2013;10 copies per cell and 2 micron plasmids are held at 20&#x2013;50 copies per cell (\u003Ca href=\"#ref24\">Karim et al., 2013\u003C/a>). \u003Ci>hsp104&#x0394;\u003C/i> strains transformed with the TTR-GFP plasmid (p3146) were also co-transformed with plasmids containing an Hsp104 promoter (\u003Ci>HSE\u003C/i>) driving either empty vector (EV; p3168), wildtype Hsp104 (Hsp104\u003Csup>OE\u003C/sup>; p3169), Hsp104 with a A503V mutation (Hsp104\u003Csup>A503V\u003C/sup>; p3170), or Hsp104 with a A503S mutation (Hsp104\u003Csup>A503S\u003C/sup>; p3171).\u003C/p>\n\u003Cp class=\"mb0\">Yeast strains were grown using standard media and cultivation procedures (\u003Ca href=\"#ref49\">Sherman et al., 1986\u003C/a>). Nutrient rich media (YPD) or synthetic complete media containing the required amino acids and 2% dextrose (SD) was used. Growth of involved fresh transformants patched onto solid selective media and grown overnight at 30&#x000B0;C before inoculating liquid cultures. Liquid cultures were grown to log phase (OD\u003Csub>600\u003C/sub> =&#x2009;0.4&#x2013;0.8; approximately 24&#x2009;h), or until saturation (OD\u003Csub>600\u003C/sub> =&#x2009;1.6 or higher; approximately 48&#x2009;h).\u003C/p>\n\u003Ch3>Microscopy\u003C/h3>\n\u003Cp class=\"mb0\">For co-localization experiments, strains were transformed with TTR-eGFP (p3146) and mCherry (p3197) or Hsp104-mCherry (p3172). 3D images were captured with a 63X (oil immersion, N.A. 1.4) objective on a DMI600 Leica inverted microscope using Leica K5 camera and LasX software. For print, images were subjected to 3D deconvolution, using AutoQuant deconvolution software and shown as maximum projection images. For quantifying the number of cells with TTR-eGFP puncta, strains were transformed with TTR-eGFP (p3146) and either empty vector (p3168), Hsp104\u003Csup>OE\u003C/sup> (p3169), Hsp104\u003Csup>A503V\u003C/sup> (p3170), or Hsp104\u003Csup>A503S\u003C/sup> (p3171). Strains were grown to log or saturation, and 3D images of independent transformants were captured and quantified for the number of cells that contained GFP puncta compared to all cells expressing GFP.\u003C/p>\n\u003Ch3>Biochemical analysis of yeast lysates\u003C/h3>\n\u003Cp class=\"mb0\">Cell lysates were prepared from 50&#x2009;ml cultures by glass bead lysis with 1x lysis buffer (50&#x2009;mM Tris&#x2013;HCl, 100&#x2009;mM KCl, 20&#x2009;mM, MgCl\u003Csub>2\u003C/sub>&#x2022;6H\u003Csub>2\u003C/sub>0, 2&#x2009;mM EDTA, 10% glycerol; pH 7.5), protease inhibitor cocktail (Sigma) and PMSF (Sigma), while kept on ice to prevent protease degradation, as described in \u003Ca href=\"#ref48\">Sharma et al. (2017)\u003C/a>. To analyze protein steady state levels, 75&#x2013;125&#x2009;&#x03BC;g of crude cell extracts were treated with 2% SDS sample buffer (25&#x2009;mM Tris pH 6.8, 200&#x2009;mM glycine, 5% glycerol, and 0.025% bromophenol blue) and boiled for 8&#x2009;min at 98&#x000B0;C before electrophoretically resolved on 10% acrylamide gel. Gels were transferred to PVDF membrane, blocked using Tropix&#x000AE; I-Block&#x02122; solution (Applied Biosystems, Ref: T2015) before antibody exposure (\u003Ca href=\"#SM1\">Supplementary Table 4\u003C/a>). Blots were subjected to standard Western blot procedures. Given signal proximity, TTR antibody was detected with horse radish peroxidase using a luminol stubstrate, while PGK antibody was detected with alkaline phosphatase using a CDP-STAR Tropix&#x000AE; substrate. Antibody signal was captured by the Amersham Imager 600 and images quantified by ImageJ. Well-trap assays (\u003Ca href=\"#ref30\">Liebman et al., 2006\u003C/a>) were performed similarly to above, except unboiled samples were incubated at room temperature for 8&#x2009;min instead of boiling.\u003C/p>\n\u003Ch3>Sucrose gradient fractionation\u003C/h3>\n\u003Cp class=\"mb0\">Discontinuous sucrose gradients were performed as previously described \u003Ca href=\"#ref12\">Dorweiler et al. (2020)\u003C/a>. Briefly, gradients consisting of 10, 40, and 60% sucrose (w/vol) were made in 1&#x000D7; lysis buffer and stored at-80&#x000B0;C. Gradients were thawed on ice, and an aliquot containing 6&#x2013;8&#x2009;mg of protein was loaded onto the gradient. Samples were spun at 16,000&#x000D7; \u003Ci>g\u003C/i> 4&#x000B0;C for 120&#x2009;min in a swinging bucket rotor. 10 fractions of 180&#x2009;&#x03BC;l each were collected per sample. Equivalent volumes of fractions were loaded onto SDS-PAGE and subjected to standard Western blot procedures. The intensity of individual fractions was compared to total intensity of combined fractions from each trial to derive a percent value of resolvable protein per fraction. These values per fraction were then binned according to sucrose layer to derive the percent of total protein: fractions 1&#x2013;4 representing the 10% layer, fractions 5&#x2013;7 representing the 40% layer, and fractions 8&#x2013;10 and the pellet representing the 60% layer.\u003C/p>\n\u003Ch3>SDD-AGE\u003C/h3>\n\u003Cp class=\"mb0\">To analyze SDS-resistant oligomers by SDD-AGE, 230&#x2009;&#x03BC;g of crude lysate, or a 1:1 ratio of sucrose gradient fraction to 1&#x000D7; lysis buffer, was treated with 2% SDS loading buffer and incubated at room temperature for a minimum of 5&#x2009;min prior to loading into a 1.5% agarose gel containing 0.1% SDS. Protein was transferred to nitrocellulose membrane \u003Ci>via\u003C/i> capillary transfer, as described in \u003Ca href=\"#ref21\">Halfmann and Lindquist (2008)\u003C/a>. Blots were subjected to standard Western blot procedures and probed with polyclonal TTR antibody.\u003C/p> \u003Ca id=\"h4\" name=\"h4\">\u003C/a>\n\u003Ch2>Results\u003C/h2>\n\u003Ch3>Hsp104 colocalizes with visible TTR puncta\u003C/h3>\n\u003Cp class=\"mb0\">To begin to understand how Hsp104 influences TTR aggregation \u003Ci>in vivo\u003C/i>, we assessed whether Hsp104 co-localized with TTR fluorescent puncta. Using \u003Ci>hsp104\u003C/i>&#x2206; strains, where the only source of Hsp104 was from a plasmid expressing Hsp104-mCherry, TTR puncta consistently colocalized with Hsp104-mCherry in all images (\u003Ca href=\"#fig1\">Figure 1A\u003C/a>). These data suggest that Hsp104 may potentially interact with TTR-GFP aggregates and influence their formation.\u003C/p>\n\u003Cdiv class=\"DottedLine\">\u003C/div> \u003Cdiv class=\"Imageheaders\">FIGURE 1\u003C/div> \u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg\" name=\"figure1\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg\" alt=\"www.frontiersin.org\" id=\"fig1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\n\u003Cp>\u003Cb>Figure 1\u003C/b>. TTR-GFP forms fluorescent puncta that co-localizes with Hsp104. \u003Cb>(A)\u003C/b> \u003Ci>hsp104\u003C/i>&#x2206; cells were transformed with the indicated plasmid combinations and grown for approximately 48&#x2009;h. Representative fluorescent microscopy images with the indicated proteins are shown. \u003Cb>(B)\u003C/b> Cells in wildtype strains (WT; containing a genomic copy of \u003Ci>HSP104\u003C/i>), \u003Ci>hsp104\u003C/i>&#x2206; strains, and \u003Ci>hsp104\u003C/i>&#x2206; strains with a plasmid moderately overexpressing Hsp104 (Hsp104\u003Csup>OE\u003C/sup>) were grown to log (OD\u003Csub>600\u003C/sub>&#x2009;=&#x2009;0.4&#x2013;0.8, approximately 24&#x2009;h). The percentage of GFP expressing cells containing puncta was plotted from 3 independent experiments. Total number of cells counted of the three experiments is reported above. Data is shown as means and standard deviation.\u003C/p>\u003C/div> \u003Cdiv class=\"clear\">\u003C/div> \u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Cp class=\"mb15\">Previous work used visual aggregates to track TTR aggregation, well after cultures reached saturation, reporting approximately 5&#x2013;7% of cells exhibit TTR-GFP as visible puncta after 72&#x2009;h of growth (\u003Ca href=\"#ref54\">Verma et al., 2018\u003C/a>). To determine whether incubation time correlated with the number of cells with visible puncta, we assessed the percent of cells containing puncta in mid-log (OD\u003Csub>600\u003C/sub> =&#x2009;0.4&#x2013;0.8) growth after 24&#x2009;h. Wildtype strains with an endogenous copy of Hsp104 (WT) exhibited on average less than 0.5% of cells with puncta, while strains lacking \u003Ci>HSP104\u003C/i> (\u003Ci>hsp104&#x0394;\u003C/i>) had almost three times as many cells with puncta (\u003Ca href=\"#fig1\">Figure 1B\u003C/a>) suggesting that Hsp104 appears to play a role in limiting the formation of visible aggregates. In addition, considering results from \u003Ca href=\"#ref54\">Verma et al. (2018)\u003C/a>, the number of cells containing visible TTR puncta appear to increase over time.\u003C/p>\n\u003Cp class=\"mb0\">It has been shown that increased levels of Hsp104 result in the loss of an endogenous yeast amyloid called the [\u003Ci>PSI\u003C/i>\u003Csup>+\u003C/sup>] prion (\u003Ca href=\"#ref5\">Chernoff et al., 1995\u003C/a>). A plasmid containing wildtype \u003Ci>HSP104\u003C/i> driven by the \u003Ci>HSP104\u003C/i> promoter on a centromeric plasmid increases steady state Hsp104 levels approximately 8-10-fold more when compared to endogenous levels (\u003Ca href=\"#SM1\">Supplementary Figure 1\u003C/a>). When this same plasmid was introduced in a \u003Ci>hsp104\u003C/i>&#x2206; strain (Hsp104\u003Csup>OE\u003C/sup>; see materials and methods), we found that cells did not have any detectable TTR-GFP puncta after 24&#x2009;h of growth (\u003Ca href=\"#fig1\">Figure 1B\u003C/a>). It is important to note that the presence or absence of Hsp104 in log cultures does not impact TTR steady state levels (\u003Ca href=\"#SM1\">Supplementary Figure 2A\u003C/a>), and TTR expression does not impact endogenous or plasmid-derived Hsp104 steady state levels (\u003Ca href=\"#SM1\">Supplementary Figures 2B,C\u003C/a>). We also verified that these plasmids produced more than endogenous levels of Hsp104 by an independent prion-curing assay, since excess Hsp104 cures the [\u003Ci>PSI\u003C/i>\u003Csup>+\u003C/sup>] prion. Using weak [\u003Ci>PSI\u003C/i>\u003Csup>+\u003C/sup>] log cultures, we show that the plasmid derived Hsp104\u003Csup>OE\u003C/sup> resulted in 5-fold more [\u003Ci>PSI\u003C/i>\u003Csup>+\u003C/sup>] loss compared to strains with empty vector plasmids (\u003Ca href=\"#SM1\">Supplementary Figure 3\u003C/a>).\u003C/p>\n\u003Ch3>Hsp104 increases the abundance of SDS-resistant TTR populations\u003C/h3>\n\u003Cp class=\"mb0\">If the low percentage of cells with visible TTR puncta correlates with the amount of aggregated TTR, then biochemical analysis should detect high amounts of soluble monomeric TTR in all strains. Previous work has shown that TTR expressed in yeast forms SDS-resistant aggregates (\u003Ca href=\"#ref54\">Verma et al., 2018\u003C/a>). Similarly, amyloidogenic proteins are commonly detergent resistant and only enter an SDS-PAGE gel upon boiling (\u003Ca href=\"#ref25\">Kazantsev et al., 1999\u003C/a>; \u003Ca href=\"#ref27\">Kryndushkin et al., 2003\u003C/a>; \u003Ca href=\"#ref40\">Nizhnikov et al., 2014\u003C/a>; \u003Ca href=\"#ref1\">Andrich et al., 2017\u003C/a>). To determine the percentage of TTR protein that is SDS-resistant, well-trap assays were performed. In this assay, large SDS-resistant aggregates are trapped in the well in unboiled lysates and are broken and resolved as a monomer in boiled lysates. Roughly 50% of TTR from WT log cultures are SDS-resistant (\u003Ca href=\"#fig2\">Figure 2A\u003C/a>). We also found that a L55P TTR mutation, which has previously considered to be amyloidogenic in yeast (\u003Ca href=\"#ref19\">Gomes et al., 2012\u003C/a>), as well as a L110Q mutation show similar aggregation compared to wildtype TTR (\u003Ca href=\"#SM1\">Supplementary Figure 4\u003C/a>). Interestingly, there is a 5-fold reduction of SDS-resistant TTR populations in \u003Ci>hsp104&#x2206;,\u003C/i> suggesting that Hsp104 may play a role in facilitating the formation of SDS-resistant populations. Conversely, increased levels of Hsp104 through plasmid expression in Hsp104\u003Csup>OE\u003C/sup> showed a 2-fold reduction in SDS-resistant aggregates compared to WT strains expressing endogenous Hsp104. It is important to note that the amount of TTR that is not visible in unboiled WT strains is well beyond the percentage of cells that contain visible puncta (\u003Ca href=\"#fig1\">Figure 1B\u003C/a>), indicating that these SDS-resistant populations are likely not visible as fluorescent puncta.\u003C/p>\n\u003Cdiv class=\"DottedLine\">\u003C/div> \u003Cdiv class=\"Imageheaders\">FIGURE 2\u003C/div> \u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg\" name=\"figure2\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g002.jpg\" alt=\"www.frontiersin.org\" id=\"fig2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\n\u003Cp>\u003Cb>Figure 2\u003C/b>. Hsp104 enhances the formation of SDS-resistant populations, but oligomer size appears to be unaffected \u003Cb>(A)\u003C/b> (Top) Lysates from WT or \u003Ci>hsp104\u003C/i>&#x2206; strains co-transformed with TTR-GFP and HSE-EV, or \u003Ci>hsp104&#x2206;\u003C/i> strains co-transformed with TTR-GFP and HSE-Hsp104 (Hsp104\u003Csup>OE\u003C/sup>) were incubated at room temperature (&#x02212;) or boiled (+). Representative Western blots using anti-TTR or anti-PGK antibody, captured with different detection methods (see Materials and Methods), is shown. PGK was used to confirm even sample loading and quantification of the amount of SDS-resistant aggregated protein was determined by calculating the ratio of unboiled to boiled sample (Bottom). Quantification is from 3 Independent trials. Data is shown as means and ranges. &#x0002A;\u003Ci>p\u003C/i>&#x2009;&#x02264;&#x2009;0.05, &#x0002A;&#x0002A;\u003Ci>p\u003C/i>&#x2009;&#x02264;&#x2009;0.01, by unpaired two-tailed \u003Ci>t\u003C/i>-test. \u003Cb>(B)\u003C/b> SDD-AGE analysis was used to resolve SDS-resistant oligomers. Lysates from [\u003Ci>psi\u003C/i>\u003Csup>&#x02212;\u003C/sup>] or weak[\u003Ci>PSI\u003Csup>+\u003C/sup>\u003C/i>] strains (left) or TTR expressing lysates from the indicated (right) were subjected to SDD-AGE analysis and visualized with anti-Sup35 and anti-TTR, respectively. Arrows denote monomeric Sup35 (Left) or TTR-GFP (right). It is important to note that lysates from strains are loaded in a different order than \u003Cb>(A)\u003C/b>. Representative images are shown.\u003C/p>\u003C/div> \u003Cdiv class=\"clear\">\u003C/div> \u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Cp class=\"mb0\">Semi-denaturing agarose gels (SDD-AGE; \u003Ca href=\"#ref27\">Kryndushkin et al., 2003\u003C/a>; \u003Ca href=\"#ref2\">Bagriantsev et al., 2006\u003C/a>; \u003Ca href=\"#ref21\">Halfmann and Lindquist, 2008\u003C/a>) can resolve SDS-resistant oligomer populations that may be too large to enter a SDS-PAGE gel. In the case of the [\u003Ci>PSI\u003C/i>\u003Csup>+\u003C/sup>] prion, SDS-resistant oligomers consisting of approximately 9&#x2013;50 monomers of Sup35 can be detected (\u003Ca href=\"#ref27\">Kryndushkin et al., 2003\u003C/a>). We find TTR forms SDS-resistant oligomeric species in unboiled wildtype lysates (\u003Ca href=\"#fig2\">Figure 2B\u003C/a>). These TTR protein smears are resolved closer to the bottom of the gel when compared to weak [\u003Ci>PSI\u003C/i>\u003Csup>+\u003C/sup>], indicating that TTR oligomers are smaller than [\u003Ci>PSI\u003C/i>\u003Csup>+\u003C/sup>] oligomers. Given that TTR is unable to maintain its tetrameric structure in the presence of SDS (\u003Ca href=\"#ref6\">Colon and Kelly, 1992\u003C/a>), and little to no dimers or tetramers were detected by SDS-PAGE and Western blots (\u003Ca href=\"#SM1\">Supplementary Figure 5\u003C/a>), the size range of these smears, as well as their disappearance upon boiling (\u003Ca href=\"#fig2\">Figure 2B\u003C/a>), suggest TTR forms SDS-resistant oligomers and not tetramers. Interestingly, the SDS-resistant oligomer did not change size when Hsp104 was absent or overexpressed, suggesting that Hsp104 does not impact the formation of these SDS-resistant oligomers.\u003C/p>\n\u003Ch3>TTR aggregate size changes in Hsp104\u003Csup>OE\u003C/sup> strains\u003C/h3>\n\u003Cp class=\"mb0\">TTR expression in our yeast model yields both monomeric and aggregated TTR protein. While SDS-treatment shows that oligomers and aggregates are SDS-resistant, it is unclear whether the monomers generated by SDS-treatment are normally associated in higher molecular weight complexes in the absence of SDS. To answer this question, we employed a different approach to assess the general distribution of TTR aggregate sizes in all three strains. A discontinuous sucrose gradient (10, 40, and 60% sucrose, \u003Ci>w/w\u003C/i>) can trap protein complexes and aggregates of different sizes within the interface between different sucrose concentrations (\u003Ca href=\"#ref12\">Dorweiler et al., 2020\u003C/a>). Crude lysates were directly loaded onto a discontinuous gradient and collected in 10 fractions and subjected to Western blot using anti-TTR antibody (\u003Ca href=\"#fig3\">Figure 3A\u003C/a>). To quantify protein sedimentation, we combined TTR signal intensity from the top (soluble protein or small size complexes: fractions 1&#x2013;4; &#x201C;10%&#x201D;), middle (moderate size complexes: fractions 5&#x2013;7; &#x201C;40%&#x201D;), and bottom and pellet (high molecular weight complexes; fractions 8&#x2013;10 and pellet; &#x201C;60%&#x201D;; \u003Ca href=\"#fig3\">Figure 3A\u003C/a>) fractions of the gradient.\u003C/p>\n\u003Cdiv class=\"DottedLine\">\u003C/div> \u003Cdiv class=\"Imageheaders\">FIGURE 3\u003C/div> \u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg\" name=\"figure3\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g003.jpg\" alt=\"www.frontiersin.org\" id=\"fig3\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\n\u003Cp>\u003Cb>Figure 3\u003C/b>. TTR sediments with higher molecular weight complexes in Hsp104\u003Csup>OE\u003C/sup> log cultures. \u003Cb>(A)\u003C/b> Lysates from the indicated strains were loaded onto a discontinuous sucrose gradient (10, 40, 60% sucrose, \u003Ci>w/w\u003C/i>). 10 fractions were collected, with fractions 1&#x2013;4 equivalent to the supernatant and 10% sucrose, fractions 5&#x2013;7 equivalent to 40% sucrose, and fractions 8&#x2013;10 equivalent to the 60% sucrose layers. P indicates pellet and L indicates separately loaded whole cell lysates. (Top) Representative blots of TTR sedimentation in log cultures are shown. (Bottom) Quantification of sedimented TTR signal in fractions 1&#x2013;4 (10%), fractions 5&#x2013;7 (40%), or fractions 8-P (60%) compared to total protein in all fractions. All quantification represents 4&#x2013;6 independent cultures per strain. Data is shown as means and ranges. &#x0002A;\u003Ci>p\u003C/i>&#x2009;&#x02264;&#x2009;0.05 by unpaired two-tailed \u003Ci>t\u003C/i>-test. \u003Cb>(B)\u003C/b> The lysates of WT strain in log growth were either treated in the presence or absence of 2.0% SDS prior to centrifugation on discontinuous sucrose gradients. Gradients were spun at 25&#x000B0;C to prevent SDS precipitation. \u003Cb>(C)\u003C/b> Untreated lysates were subjected to sucrose gradient sedimentation, and lysates were resolved by SDD-AGE and visualized with anti-TTR. Note that L \u003Cb>(B)\u003C/b> indicates crude lysate that were boiled prior to loading. Arrows denote TTR monomers. Representative images are shown.\u003C/p>\u003C/div> \u003Cdiv class=\"clear\">\u003C/div> \u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Cp class=\"mb0\">In wildtype log cultures, the bulk of sedimented protein is in the 10% fractions (\u003Ca href=\"#fig3\">Figures 3A\u003C/a>,\u003Ca href=\"#fig3\">B\u003C/a>). Conversely, there is a large difference in sedimentation patterns between Hsp104\u003Csup>OE\u003C/sup> and the other strains. While WT and \u003Ci>hsp104&#x2206;\u003C/i> strains show the bulk of TTR fractionate to 10% (\u003Ca href=\"#fig3\">Figure 3A\u003C/a>; \u003Ca href=\"#SM1\">Supplementary Figure 6A\u003C/a>), the overexpression of Hsp104 (Hsp104\u003Csup>OE\u003C/sup>) shows TTR preferentially fractionating to either the 10% or 60% fractions (\u003Ca href=\"#fig3\">Figure 3A\u003C/a>; \u003Ca href=\"#SM1\">Supplementary Figure 6B\u003C/a>). The inconsistent TTR sedimentation pattern from Hsp104\u003Csup>OE\u003C/sup> strains is unlikely a product of variable Hsp104 expression from the centromeric plasmid since Hsp104 steady state levels appeared to be similar (\u003Ca href=\"#SM1\">Supplementary Figure 6B\u003C/a>). Closer analysis of individual trials show that an increase in TTR sedimentation in the 60% sucrose fractions is associated with a decrease in 10% sucrose fractions and vice versa (\u003Ca href=\"#SM1\">Supplementary Figure 6B\u003C/a>). Interestingly, there is no dramatic change in TTR sedimentation in the 40% fractions. Taking the SDS-treatment and sucrose gradient results together, our data show that while SDS-resistant oligomer formation is Hsp104 independent (\u003Ca href=\"#fig5\">Figure 5B\u003C/a>), the formation of SDS-resistant populations and overall TTR aggregation is influenced by Hsp104 overexpression (\u003Ca href=\"#fig3\">Figures 3A\u003C/a>, \u003Ca href=\"#fig2\">2A\u003C/a>).\u003C/p>\n\u003Cdiv class=\"DottedLine\">\u003C/div> \u003Cdiv class=\"Imageheaders\">FIGURE 5\u003C/div> \u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg\" name=\"figure5\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g004.jpg\" alt=\"www.frontiersin.org\" id=\"fig4\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\n\u003Cp>\u003Cb>Figure 5\u003C/b>. The effect of Hsp104 on aggregating TTR is muted in saturated cultures. All cultures were grown to saturation (OD\u003Csub>600\u003C/sub>&#x2009;&#x02265;&#x2009;2.0) over 48&#x2009;h. \u003Cb>(A)\u003C/b> (Top) Representative blots from lysates were incubated at room temperature (&#x02212;) or boiled (+). (Bottom) Quantification of SDS-resistant aggregated protein. Quantification is from at least 3 independent trials. Data is shown as means and ranges. \u003Cb>(B)\u003C/b> Lysates subjected to discontinuous sucrose gradient centrifugation and detected with anti-TTR antibody. (Top) Representative blots of TTR sedimentation. (Bottom) Quantification of sedimented TTR signal. All quantification represents 4&#x2013;6 independent cultures per strain. Data is shown as means and ranges. \u003Cb>(C)\u003C/b> Sucrose gradient fractions of indicated strains from saturated cultures were resolved by SDD-AGE and visualized with anti-TTR. Note that L \u003Cb>(B)\u003C/b> indicates crude lysate that were boiled prior to loading. Arrows denote TTR monomers. Representative images are shown.\u003C/p>\u003C/div> \u003Cdiv class=\"clear\">\u003C/div> \u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Cp class=\"mb0\">To better understand the relationship between SDS-resistant populations, oligomers resolved by SDD-AGE, and TTR aggregates resolved by sucrose gradient, we performed two experiments. In the first experiment, we wanted to determine whether TTR associated with the high molecular weight fractions of a sucrose gradient are involved in SDS-sensitive associations. Based on the relatively smaller size of SDS-resistant oligomers resolved by SDD-AGE, and TTR sedimentation in high molecular weight fractions, we suspected that SDS treatment of crude lysates would dissolve larger SDS-sensitive structures into smaller SDS-resistant oligomers. Therefore, crude lysates were treated with SDS prior to fractionation on the sucrose gradient. SDS-treated crude lysates result in a TTR sedimentation pattern to only the top 3 fractions of the gradient (\u003Ca href=\"#fig3\">Figure 3B\u003C/a>), suggesting that TTR protein in higher gradient fractions are held together by SDS-sensitive associations. In the second experiment, we wanted to confirm whether SDS-resistant oligomers were found in higher molecular weight TTR fractions. Untreated fractionated lysates were run on SDD-AGE gels. We found that SDS-resistant oligomers are associated with all fractions regardless of sedimentation patterns or Hsp104 levels (\u003Ca href=\"#fig3\">Figure 3C\u003C/a>). Taken together, these data support an aggregate model comprised of smaller SDS-resistant oligomers held together as higher ordered structures by SDS-sensitive associations.\u003C/p>\n\u003Ch3>Hsp104\u003Csup>A503S\u003C/sup> mutant maintains SDS-resistant TTR oligomer sizes but lead to larger TTR aggregates\u003C/h3>\n\u003Cp class=\"mb15\">The middle domain of Hsp104 has been shown to be important for regulating disaggregase activity and co-chaperone interaction during aggregate disassembly (\u003Ca href=\"#ref46\">Schirmer et al., 2004\u003C/a>; \u003Ca href=\"#ref29\">Lee et al., 2010\u003C/a>; \u003Ca href=\"#ref51\">Sielaff and Tsai, 2010\u003C/a>; \u003Ca href=\"#ref11\">Desantis and Shorter, 2012\u003C/a>; \u003Ca href=\"#ref14\">Dulle et al., 2014\u003C/a>; \u003Ca href=\"#ref23\">Jackrel et al., 2014\u003C/a>). Several mutations within the middle domain of Hsp104 have been shown to reduce aggregation and toxicity associated with aggregated amyloidogenic human protein \u003Ci>in vivo\u003C/i> (\u003Ca href=\"#ref23\">Jackrel et al., 2014\u003C/a>; \u003Ca href=\"#ref35\">March et al., 2020\u003C/a>), and potentiate the disaggregase activity with co-chaperones \u003Ci>in vitro\u003C/i> (\u003Ca href=\"#ref23\">Jackrel et al., 2014\u003C/a>). We asked whether middle domain mutations would also reduce TTR protein aggregation. Middle domain mutants A503V or A503S in a \u003Ci>hsp104&#x2206;\u003C/i> background, to create Hsp104\u003Csup>A503V\u003C/sup> and Hsp104\u003Csup>A503S\u003C/sup> strains, were tested. Steady state levels of these Hsp104 mutants were similar to Hsp104\u003Csup>OE\u003C/sup> strain at 8&#x2013;10 times higher concentration than endogenous levels (\u003Ca href=\"#SM1\">Supplementary Figure 1\u003C/a>). Similarly, TTR steady state levels and the percentage of cells exhibiting TTR puncta were similar in Hsp104\u003Csup>OE\u003C/sup>, Hsp104\u003Csup>A503V\u003C/sup>, or Hsp104\u003Csup>A503S\u003C/sup> log cultures (\u003Ca href=\"#SM1\">Supplementary Figures 2A, 7A\u003C/a>).\u003C/p>\n\u003Cp class=\"mb0\">Well-trap and SDD-AGE experiments show that the Hsp104\u003Csup>A503V\u003C/sup> and Hsp104\u003Csup>A503S\u003C/sup> mutants show similar percent SDS-resistant TTR populations and size of SDS-resistant TTR oligomers compared with Hsp104\u003Csup>OE\u003C/sup> (\u003Ca href=\"#fig4\">Figures 4A\u003C/a>,\u003Ca href=\"#fig4\">B\u003C/a>). Sucrose gradient fractionation of TTR in Hsp104\u003Csup>A503V\u003C/sup> sedimented similarly to \u003Ci>hsp104&#x2206;\u003C/i> strains with the bulk of the protein found in 10% fractions. Interestingly, Hsp104\u003Csup>A503S\u003C/sup> shows strong sedimentation of TTR to the bottom of the gradient, much more consistently than Hsp104\u003Csup>OE\u003C/sup>. The dichotomy of how each Hsp104 mutant sediments TTR populations, despite maintaining TTR oligomer sizes in all fractions (\u003Ca href=\"#fig4\">Figure 4D\u003C/a>), suggests a functional difference between the two variants.\u003C/p>\n\u003Cdiv class=\"DottedLine\">\u003C/div> \u003Cdiv class=\"Imageheaders\">FIGURE 4\u003C/div> \u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg\" name=\"figure4\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g005.jpg\" alt=\"www.frontiersin.org\" id=\"fig5\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\n\u003Cp>\u003Cb>Figure 4\u003C/b>. Strains expressing Hsp104\u003Csup>A503V\u003C/sup> show different sedimentation profiles compared to strains expressing Hsp104\u003Csup>OE\u003C/sup>. \u003Cb>(A)\u003C/b> Similar to \u003Ca href=\"#fig2\">Figure 2A\u003C/a>, TTR expressing \u003Ci>hsp104&#x2206;\u003C/i> strains co-transformed with either Hsp104\u003Csup>OE\u003C/sup>, Hsp104\u003Csup>A503V\u003C/sup>, or Hsp104\u003Csup>A503S\u003C/sup>. (Top) Representative Western blots. (Bottom) Quantification is from 3 independent trials. \u003Ci>hsp104&#x2206;\u003C/i> and Hsp104\u003Csup>OE\u003C/sup> data from \u003Ca href=\"#fig2\">Figure 2A\u003C/a>. Data is shown as means and ranges. \u003Cb>(B)\u003C/b> Log culture lysates of indicated strains were resolved by SDD-AGE. The arrow denotes TTR monomers. Representative images are shown. \u003Cb>(C)\u003C/b> Western blot of lysates from the indicated log strains subjected to a discontinuous sucrose gradient. (Top) Representative blots of TTR sedimentation from lysates, and (Bottom) quantification of TTR signal as percent of total protein, as in \u003Ca href=\"#fig3\">Figure 3A\u003C/a>. \u003Ci>hsp104&#x2206;\u003C/i> and Hsp104\u003Csup>OE\u003C/sup> data from \u003Ca href=\"#fig3\">Figure 3A\u003C/a>. All quantification represents 4&#x2013;5 independent cultures per strain. Data is shown as means and ranges. \u003Cb>(D)\u003C/b> Sucrose gradient fractions of indicated strains were resolved by SDD-AGE as in \u003Ca href=\"#fig3\">Figure 3B\u003C/a>. Arrows denote TTR monomers. Representative images are shown.\u003C/p>\u003C/div> \u003Cdiv class=\"clear\">\u003C/div> \u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Ch3>Hsp104 related changes to TTR aggregation are not observed in saturated cultures\u003C/h3>\n\u003Cp class=\"mb15\">Since visible TTR aggregates are more abundant in saturated cultures (\u003Ca href=\"#ref54\">Verma et al., 2018\u003C/a>) compared to log cultures (\u003Ca href=\"#fig1\">Figure 1B\u003C/a>), we asked how TTR aggregation changes when cultures are in saturation. Cells in saturated culture have slower cell cycles, increased chronological aging, undergo metabolic shifts in response to diminishing nutrient availability, and have reduced ATP (\u003Ca href=\"#ref3\">Bilinski et al., 2017\u003C/a>; \u003Ca href=\"#ref58\">Zimmermann et al., 2018\u003C/a>). In saturated cultures, percentage of cells with fluorescent puncta increased in both WT and \u003Ci>hsp104&#x0394;\u003C/i> strains compared to log cultures (\u003Ca href=\"#SM1\">Supplementary Figure 7\u003C/a>), confirming that the number of cells with visible aggregates increase with time. Surprisingly, increasing wildtype or mutant Hsp104 levels did not impact the number of cells with fluorescent puncta (\u003Ca href=\"#SM1\">Supplementary Figure 7B\u003C/a>), suggesting that any potential effect that Hsp104 overexpression has on puncta formation in log cultures is lost in saturation. Interestingly, Hsp104\u003Csup>OE\u003C/sup> does not seem to be completely inactive in saturated cultures since a slight but significant increase in prion loss is observed when compared to log cultures (\u003Ca href=\"#SM1\">Supplementary Figure 3\u003C/a>). However, saturated cultures showed decreased plasmid derived Hsp104 steady state levels in the presence of TTR (\u003Ca href=\"#SM1\">Supplementary Figures 2B,C\u003C/a>) and a modest increase in cell death when compared to log cultures (\u003Ca href=\"#SM1\">Supplementary Figure 8\u003C/a>).\u003C/p>\n\u003Cp class=\"mb15\">The aggregation state of TTR in saturated cultures showed no difference when comparing the percent of protein in SDS-resistant aggregates (\u003Ca href=\"#fig5\">Figure 5A\u003C/a>) or the size of oligomers (\u003Ca href=\"#SM1\">Supplementary Figure 9\u003C/a>) between strains. Similarly, sucrose gradient sedimentation showed TTR fractionating to the top two-thirds of the sucrose gradient in all strains (\u003Ca href=\"#fig5\">Figure 5B\u003C/a>). SDS-resistant oligomers persist in all sucrose gradient fractions (\u003Ca href=\"#fig5\">Figure 5C\u003C/a>), similar to log cultures. However, while log cultures showed monomeric protein found in fractions 1&#x2013;3 in all strains (\u003Ca href=\"#fig3\">Figures 3D\u003C/a>, \u003Ca href=\"#fig4\">4D\u003C/a>), the monomeric protein was absent in saturated cultures in these fractions (\u003Ca href=\"#fig5\">Figure 5C\u003C/a>).\u003C/p>\n\u003Cp class=\"mb0\">Nutrient availability declines in saturated cultures due to exhaustion of resources and buildup of waste material. To ensure that our observed TTR results from saturated cultures was not a simple product of limited nutrients, we refreshed the culture media every six hours between reaching mid-log growth to 48&#x2009;h. After 48&#x2009;h, we found that refreshing media had no effect on the percentage of TTR in SDS-resistant aggregates (\u003Ca href=\"#SM1\">Supplementary Figure 10\u003C/a>). Taken together, our saturation data indicates that aggregating TTR populations change between log and saturated cultures, but TTR aggregates do not respond to altered levels of Hsp104 in saturated cultures.\u003C/p> \u003Ca id=\"h5\" name=\"h5\">\u003C/a>\n\u003Ch2>Discussion\u003C/h2>\n\u003Cp class=\"mb0\">Here, we used a yeast-based system to understand TTR aggregate formation and how the molecular disaggregase, Hsp104, influences this process. Our study shows that fluorescently labeled Hsp104 colocalizes with visible TTR puncta (\u003Ca href=\"#fig1\">Figure 1A\u003C/a>), but fluorescent puncta are not fully representative of TTR aggregation (\u003Ca href=\"#fig1\">Figures 1B\u003C/a>, \u003Ca href=\"#fig2\">2A\u003C/a>). Instead, this co-localization between TTR and Hsp104 suggest a molecular interaction \u003Ci>in vivo\u003C/i> and is the impetus for studying whether altering levels of Hsp104 influences aggregating TTR. Increased amount of SDS-resistant TTR protein form in the presence of Hsp104 (\u003Ca href=\"#fig2\">Figure 2A\u003C/a>), yet SDS-resistant TTR oligomers and higher order structures containing SDS-sensitive associations form independently of Hsp104 (\u003Ci>hsp104&#x0394;\u003C/i>, \u003Ca href=\"#fig2\">Figures 2B\u003C/a>,\u003Ca href=\"#fig3\">3A\u003C/a>, \u003Ca href=\"#fig3\">B\u003C/a>). These results suggest that the structure of higher order TTR aggregates is comprised of smaller SDS-resistant oligomeric populations held together by SDS-sensitive bonds (\u003Ca href=\"#fig6\">Figure 6\u003C/a>). Introduction of the Hsp104\u003Csup>A503S\u003C/sup> mutant shows TTR aggregates consistently sediment in higher molecular weight fractions (\u003Ca href=\"#fig4\">Figure 4C\u003C/a>), which is consistent with previous studies that show Hsp104 middle domain mutations are more influential in the formation of human amyloidogenic protein aggregates compared to wildtype Hsp104 (\u003Ca href=\"#ref23\">Jackrel et al., 2014\u003C/a>; \u003Ca href=\"#ref35\">March et al., 2020\u003C/a>). Lastly, our work shows that Hsp104 exerts an effect on TTR aggregate populations during log phase growth, but not in saturated cultures. Given that media replacement does not change SDS-resistant TTR populations in saturated conditions (\u003Ca href=\"#fig5\">Figure 5A\u003C/a>; \u003Ca href=\"#SM1\">Supplementary Figure 10\u003C/a>), it is possible that the inability to respond to elevated Hsp104 levels is due to proteostasis collapse (\u003Ca href=\"#ref28\">Labbadia and Morimoto, 2015\u003C/a>; \u003Ca href=\"#ref26\">Klaips et al., 2018\u003C/a>).\u003C/p>\n\u003Cdiv class=\"DottedLine\">\u003C/div> \u003Cdiv class=\"Imageheaders\">FIGURE 6\u003C/div> \u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg\" name=\"figure6\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g006.jpg\" alt=\"www.frontiersin.org\" id=\"fig6\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\n\u003Cp>\u003Cb>Figure 6\u003C/b>. Model of TTR aggregate growth by excess Hsp104. Red diamonds represent SDS-resistant TTR oligomers and blue rectangles represent SDS-sensitive associations to depict large TTR aggregates. (Top) Co-chaperones, possibly along with Hsp104, play a role in maintaining smaller sized aggregates. (Bottom) Excess Hsp104, or Hsp104\u003Csup>A503S\u003C/sup>, increases aggregate size by possibly titrating chaperones away from the TTR aggregate.\u003C/p>\u003C/div> \u003Cdiv class=\"clear\">\u003C/div> \u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Ch3>TTR aggregate organization in yeast\u003C/h3>\n\u003Cp class=\"mb0\">Amyloid is commonly resistant to detergent solubilization (\u003Ca href=\"#ref25\">Kazantsev et al., 1999\u003C/a>; \u003Ca href=\"#ref27\">Kryndushkin et al., 2003\u003C/a>; \u003Ca href=\"#ref40\">Nizhnikov et al., 2014\u003C/a>; \u003Ca href=\"#ref1\">Andrich et al., 2017\u003C/a>) and therefore can be used to detect whether a protein aggregate is in an amyloidogenic state. Using well-trap assays, we show that a portion of the TTR population is in large SDS-resistant populations. Further analysis using semi-denaturing gels (SDD-AGE) shows both oligomeric and monomeric protein are detected. Tetrameric TTR-GFP is approximately 160&#x2009;kDa but is unlikely to be stable in the presence of 2% SDS (\u003Ca href=\"#ref6\">Colon and Kelly, 1992\u003C/a>). Little or no high molecular weight TTR signal is detected in our SDS-PAGE gels (\u003Ca href=\"#SM1\">Supplementary Figure 5\u003C/a>). Given the SDS-PAGE system is able to resolve proteins under 400&#x2009;kDa, the observation of larger molecule weight smears by SDD-AGE indicate a SDS-resistant TTR population larger than the tetramer.\u003C/p>\n\u003Ch3>The formation of the TTR aggregate and the role of Hsp104\u003C/h3>\n\u003Cp class=\"mb15\">Hsp104&#x2019;s fragmentation activity has been well characterized in its role in prion propagation by fragmenting aggregates and generating smaller transmissible particles that can be inherited by daughter cells (\u003Ca href=\"#ref5\">Chernoff et al., 1995\u003C/a>; \u003Ca href=\"#ref42\">Paushkin et al., 1996\u003C/a>; \u003Ca href=\"#ref50\">Shorter and Lindquist, 2004\u003C/a>; \u003Ca href=\"#ref45\">Satpute-Krishnan et al., 2007\u003C/a>). Overexpression of Hsp104 leads to prion loss, however the mechanism of how overexpressed Hsp104 acts on the prion aggregate is still under debate. There are two prominent models that can explain prion loss: trimming and malpartition. The trimming model suggests that excess Hsp104 facilitates the disassembly of the prion aggregate fibril from the ends (\u003Ca href=\"#ref57\">Zhao et al., 2017\u003C/a>; \u003Ca href=\"#ref20\">Greene et al., 2020\u003C/a>). This model is largely supported by fluorescently labeled prion protein and the observed changes in generated fluorescent puncta (\u003Ca href=\"#ref57\">Zhao et al., 2017\u003C/a>). In the malpartition model, aggregates become so large they are asymmetrically retained in the mother cell, unable to pass through the bud neck (\u003Ca href=\"#ref39\">Ness et al., 2017\u003C/a>; \u003Ca href=\"#ref20\">Greene et al., 2020\u003C/a>). It has been suggested that excess Hsp104 results in aggregate stability (\u003Ca href=\"#ref39\">Ness et al., 2017\u003C/a>). Conversely, Hsp104 overexpression could unbalance the proper co-chaperone stoichiometric ratio required to form functional Hsp104/70/40 complexes, thereby decreasing fragmentation necessary for prion propagation (\u003Ca href=\"#ref56\">Winkler et al., 2012\u003C/a>; \u003Ca href=\"#ref38\">Naeimi and Serio, 2022\u003C/a>).\u003C/p>\n\u003Cp class=\"mb15\">We show that TTR aggregates sediment in higher molecular weight fractions occasionally with Hsp104\u003Csup>OE\u003C/sup> (\u003Ca href=\"#fig3\">Figure 3A\u003C/a>) and consistently with Hsp104\u003Csup>A503S\u003C/sup> (\u003Ca href=\"#fig4\">Figure 4C\u003C/a>). It is important to recognize that SDS-resistant oligomers form in the absence of Hsp104 (\u003Ca href=\"#fig2\">Figure 2B\u003C/a>), and TTR aggregate sedimentation patterns are similar between \u003Ci>hsp104&#x2206;\u003C/i> and WT strains (\u003Ca href=\"#fig3\">Figure 3A\u003C/a>). Therefore, while Hsp104 appears to co-localize with visible aggregates (\u003Ca href=\"#fig1\">Figure 1\u003C/a>), it is unclear whether the chaperone is needed for aggregate formation, remodeling, or maintenance. In the case of TTR aggregates, it is possible that co-chaperones such as Hsp70 and Hsp40 work independently from Hsp104. This idea is supported by \u003Ci>in vitro\u003C/i> studies that show homologous human chaperone combinations disassemble and remodel human aggregating amyloidogenic proteins in the absence of Hsp104 (\u003Ca href=\"#ref13\">Duennwald et al., 2012\u003C/a>; \u003Ca href=\"#ref47\">Scior et al., 2018\u003C/a>; \u003Ca href=\"#ref16\">Franco et al., 2021\u003C/a>).\u003C/p>\n\u003Cp class=\"mb15\">Overexpression of Hsp104\u003Csup>A503S\u003C/sup> results in the sedimentation of TTR to the lowest fractions of the gradient (\u003Ca href=\"#fig4\">Figure 4C\u003C/a>), suggesting that excess Hsp104\u003Csup>A503S\u003C/sup> increases aggregate size. This increase in size is consistent with the malpartition model. It has been shown that this potentiated Hsp104 variant has increased ATP hydrolysis, has activity independent of the Hsp70 and altered substrate translocation (\u003Ca href=\"#ref23\">Jackrel et al., 2014\u003C/a>; \u003Ca href=\"#ref15\">Durie et al., 2019\u003C/a>). Given the relationship between excess Hsp104\u003Csup>A503S\u003C/sup> and increased TTR aggregate size, it is possible that the middle domain mutant may impact co-chaperones interactions that are required for maintaining smaller aggregate populations in log cultures (\u003Ca href=\"#fig6\">Figure 6\u003C/a>).\u003C/p>\n\u003Cp class=\"mb0\">In humans, the TTR monomer assembles into small oligomers and larger aggregates. These small oligomeric species are toxic (\u003Ca href=\"#ref43\">Reixach et al., 2004\u003C/a>; \u003Ca href=\"#ref8\">Dasari et al., 2019\u003C/a>) and have implications associated with poor patient outcomes. We show that in yeast, TTR forms both SDS-resistant oligomeric species and large aggregates, and overexpression of Hsp104\u003Csup>A503S\u003C/sup> appears to shift the equilibrium of TTR to larger aggregates. This shift suggests that chaperone titration may be a novel approach to ameliorating cells of toxic TTR oligomers and delay disease progression. Future studies focusing on the relationship between chaperones and their ability to shift aggregate populations away from oligomeric species may hold promise for therapeutic interventions to combat the onset and progression of ATTR, and potentially other fatal neurodegenerative diseases.\u003C/p> \u003Ca id=\"h6\" name=\"h6\">\u003C/a>\n\u003Ch2>Data availability statement\u003C/h2>\n\u003Cp class=\"mb0\">The raw data supporting the conclusions of this article are included in the article/supplementary material, further inquiries can be directed to the corresponding author.\u003C/p> \u003Ca id=\"h7\" name=\"h7\">\u003C/a>\n\u003Ch2>Author contributions\u003C/h2>\n\u003Cp class=\"mb0\">ASK and ALM contributed to the conceptual design of the study, ASK, EED, HEB, JED, LEF, and ALM contributed to the acquisition, analysis, and/or interpretation of the data, and ASK and ALM have written the manuscript.\u003C/p> \u003Ca id=\"h8\" name=\"h8\">\u003C/a>\n\u003Ch2>Funding\u003C/h2>\n\u003Cp class=\"mb0\">This work was supported by the Greater Milwaukee Foundation (20172483) and the National Institutes of Health (NIH) grant (GM131365) to AM, and the Schmitt Leadership Fellowship to AK.\u003C/p> \u003Ca id=\"h9\" name=\"h9\">\u003C/a>\n\u003Ch2>Acknowledgments\u003C/h2>\n\u003Cp class=\"mb0\">The authors would like to thank Jim Shorter, Tiago Outiero, and Susan Lindquist for plasmids used in this study. Strains were a kind gift from Susan Liebman, and the BE4 (Sup35) antibody was a gift from Viravan Prapapanich and Susan Liebman. Images were created by Biorender.\u003C/p> \u003Ca id=\"h10\" name=\"h10\">\u003C/a>\n\u003Ch2>Conflict of interest\u003C/h2>\n\u003Cp class=\"mb0\">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003C/p> \u003Ca id=\"h11\" name=\"h11\">\u003C/a>\n\u003Ch2>Publisher&#x2019;s note\u003C/h2>\n\u003Cp class=\"mb0\">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003C/p> \u003Ca id=\"h12\" name=\"h12\">\u003C/a>\n\u003Ch2>Supplementary material\u003C/h2>\n\u003Cp class=\"mb0\" id=\"SM1\">The Supplementary material for this article can be found online at: \u003Ca href=\"https://www.frontiersin.org/articles/10.3389/fnmol.2022.1050472/full#supplementary-material\">https://www.frontiersin.org/articles/10.3389/fnmol.2022.1050472/full#supplementary-material\u003C/a>\u003C/p> \u003Ca id=\"h13\" name=\"h13\">\u003C/a>\n\u003Ch2>References\u003C/h2>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref1\" id=\"ref1\">\u003C/a>Andrich, K., Hegenbart, U., Kimmich, C., Kedia, N., Bergen, H. R. 3rd, Schonland, S., et al. (2017). Aggregation of full-length immunoglobulin light chains from systemic light chain amyloidosis (AL) patients is remodeled by epigallocatechin-3-gallate. \u003Ci>J. Biol. Chem.\u003C/i> 292, 2328&#x2013;2344. doi: 10.1074/jbc.M116.750323 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28031465\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1074/jbc.M116.750323\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=K.+Andrich&#x00026;author=U.+Hegenbart&#x00026;author=C.+Kimmich&#x00026;author=N.+Kedia&#x00026;author=H.+R.+Bergen&#x00026;author=S.+Schonland&#x00026;publication_year=2017&#x00026;title=Aggregation+of+full-length+immunoglobulin+light+chains+from+systemic+light+chain+amyloidosis+(AL)+patients+is+remodeled+by+epigallocatechin-3-gallate&#x00026;journal=J.+Biol.+Chem.&#x00026;volume=292&#x00026;pages=2328-2344\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref2\" id=\"ref2\">\u003C/a>Bagriantsev, S. N., Kushnirov, V. V., and Liebman, S. W. (2006). Analysis of amyloid aggregates using agarose gel electrophoresis. \u003Ci>Methods Enzymol.\u003C/i> 412, 33&#x2013;48. doi: 10.1016/S0076-6879(06)12003-0 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/17046650\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/S0076-6879(06)12003-0\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S.+N.+Bagriantsev&#x00026;author=V.+V.+Kushnirov&#x00026;author=S.+W.+Liebman&#x00026;publication_year=2006&#x00026;title=Analysis+of+amyloid+aggregates+using+agarose+gel+electrophoresis&#x00026;journal=Methods+Enzymol.&#x00026;volume=412&#x00026;pages=33-48\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref3\" id=\"ref3\">\u003C/a>Bilinski, T., Bylak, A., and Zadrag-Tecza, R. (2017). The budding yeast \u003Ci>Saccharomyces cerevisiae\u003C/i> as a model organism: possible implications for gerontological studies. \u003Ci>Biogerontology\u003C/i> 18, 631&#x2013;640. doi: 10.1007/s10522-017-9712-x \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28573416\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s10522-017-9712-x\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=T.+Bilinski&#x00026;author=A.+Bylak&#x00026;author=R.+Zadrag-Tecza&#x00026;publication_year=2017&#x00026;title=The+budding+yeast+Saccharomyces+cerevisiae+as+a+model+organism:+possible+implications+for+gerontological+studies&#x00026;journal=Biogerontology&#x00026;volume=18&#x00026;pages=631-640\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref4\" id=\"ref4\">\u003C/a>Brett, M., Persey, M. R., Reilly, M. M., Revesz, T., Booth, D. R., Booth, S. E., et al. (1999). Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. \u003Ci>Brain\u003C/i> 122, 183&#x2013;190. doi: 10.1093/brain/122.2.183 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/10071047\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/brain/122.2.183\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Brett&#x00026;author=M.+R.+Persey&#x00026;author=M.+M.+Reilly&#x00026;author=T.+Revesz&#x00026;author=D.+R.+Booth&#x00026;author=S.+E.+Booth&#x00026;publication_year=1999&#x00026;title=Transthyretin+Leu12Pro+is+associated+with+systemic+neuropathic+and+leptomeningeal+amyloidosis&#x00026;journal=Brain&#x00026;volume=122&#x00026;pages=183-190\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref5\" id=\"ref5\">\u003C/a>Chernoff, Y. O., Lindquist, S. L., Ono, B., Inge-Vechtomov, S. G., and Liebman, S. W. (1995). Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. \u003Ci>Science\u003C/i> 268, 880&#x2013;884. doi: 10.1126/science.7754373 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/7754373\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1126/science.7754373\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y.+O.+Chernoff&#x00026;author=S.+L.+Lindquist&#x00026;author=B.+Ono&#x00026;author=S.+G.+Inge-Vechtomov&#x00026;author=S.+W.+Liebman&#x00026;publication_year=1995&#x00026;title=Role+of+the+chaperone+protein+Hsp104+in+propagation+of+the+yeast+prion-like+factor+[psi+]&#x00026;journal=Science&#x00026;volume=268&#x00026;pages=880-884\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref6\" id=\"ref6\">\u003C/a>Colon, W., and Kelly, J. W. (1992). Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. \u003Ci>Biochemistry\u003C/i> 31, 8654&#x2013;8660. doi: 10.1021/bi00151a036 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/1390650\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1021/bi00151a036\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=W.+Colon&#x00026;author=J.+W.+Kelly&#x00026;publication_year=1992&#x00026;title=Partial+denaturation+of+transthyretin+is+sufficient+for+amyloid+fibril+formation+in+vitro&#x00026;journal=Biochemistry&#x00026;volume=31&#x00026;pages=8654-8660\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref7\" id=\"ref7\">\u003C/a>da Costa, G., Ribeiro-Silva, C., Ribeiro, R., Gilberto, S., Gomes, R. A., Ferreira, A., et al. (2015). Transthyretin amyloidosis: chaperone concentration changes and increased proteolysis in the pathway to disease. \u003Ci>PLoS One\u003C/i> 10:e0125392. doi: 10.1371/journal.pone.0125392 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26147092\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pone.0125392\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=G.+da+Costa&#x00026;author=C.+Ribeiro-Silva&#x00026;author=R.+Ribeiro&#x00026;author=S.+Gilberto&#x00026;author=R.+A.+Gomes&#x00026;author=A.+Ferreira&#x00026;publication_year=2015&#x00026;title=Transthyretin+amyloidosis:+chaperone+concentration+changes+and+increased+proteolysis+in+the+pathway+to+disease&#x00026;journal=PLoS+One&#x00026;volume=10&#x00026;pages=e0125392\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref8\" id=\"ref8\">\u003C/a>Dasari, A. K. R., Hughes, R. M., Wi, S., Hung, I., Gan, Z., Kelly, J. W., et al. (2019). Transthyretin aggregation pathway toward the formation of distinct cytotoxic oligomers. \u003Ci>Sci. Rep.\u003C/i> 9:33. doi: 10.1038/s41598-018-37230-1 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30631096\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41598-018-37230-1\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+K.+R.+Dasari&#x00026;author=R.+M.+Hughes&#x00026;author=S.+Wi&#x00026;author=I.+Hung&#x00026;author=Z.+Gan&#x00026;author=J.+W.+Kelly&#x00026;publication_year=2019&#x00026;title=Transthyretin+aggregation+pathway+toward+the+formation+of+distinct+cytotoxic+oligomers&#x00026;journal=Sci.+Rep.&#x00026;volume=9&#x00026;pages=33\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref9\" id=\"ref9\">\u003C/a>Derkatch, I. L., Uptain, S. M., Outeiro, T. F., Krishnan, R., Lindquist, S. L., and Liebman, S. W. (2004). Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. \u003Ci>Proc. Natl. Acad. Sci. U. S. A.\u003C/i> 101, 12934&#x2013;12939. doi: 10.1073/pnas.0404968101 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/15326312\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1073/pnas.0404968101\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=I.+L.+Derkatch&#x00026;author=S.+M.+Uptain&#x00026;author=T.+F.+Outeiro&#x00026;author=R.+Krishnan&#x00026;author=S.+L.+Lindquist&#x00026;author=S.+W.+Liebman&#x00026;publication_year=2004&#x00026;title=Effects+of+Q/N-rich+polyQ+and+non-polyQ+amyloids+on+the+de+novo+formation+of+the+[PSI+]+prion+in+yeast+and+aggregation+of+Sup35+in+vitro&#x00026;journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&#x00026;volume=101&#x00026;pages=12934-12939\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref10\" id=\"ref10\">\u003C/a>DeSantis, M. E., Leung, E. H., Sweeny, E. A., Jackrel, M. E., Cushman-Nick, M., Neuhaus-Follini, A., et al. (2012). Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients. \u003Ci>Cells\u003C/i> 151, 778&#x2013;793. doi: 10.1016/j.cell.2012.09.038 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23141537\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.cell.2012.09.038\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+E.+DeSantis&#x00026;author=E.+H.+Leung&#x00026;author=E.+A.+Sweeny&#x00026;author=M.+E.+Jackrel&#x00026;author=M.+Cushman-Nick&#x00026;author=A.+Neuhaus-Follini&#x00026;publication_year=2012&#x00026;title=Operational+plasticity+enables+hsp104+to+disaggregate+diverse+amyloid+and+nonamyloid+clients&#x00026;journal=Cells&#x00026;volume=151&#x00026;pages=778-793\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref11\" id=\"ref11\">\u003C/a>Desantis, M. E., and Shorter, J. (2012). The elusive middle domain of Hsp104 and ClpB: location and function. \u003Ci>Biochim. Biophys. Acta\u003C/i> 1823, 29&#x2013;39. doi: 10.1016/j.bbamcr.2011.07.014 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/21843558\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.bbamcr.2011.07.014\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+E.+Desantis&#x00026;author=J.+Shorter&#x00026;publication_year=2012&#x00026;title=The+elusive+middle+domain+of+Hsp104+and+ClpB:+location+and+function&#x00026;journal=Biochim.+Biophys.+Acta&#x00026;volume=1823&#x00026;pages=29-39\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref12\" id=\"ref12\">\u003C/a>Dorweiler, J. E., Oddo, M. J., Lyke, D. R., Reilly, J. A., Wisniewski, B. T., Davis, E. E., et al. (2020). The actin cytoskeletal network plays a role in yeast prion transmission and contributes to prion stability. \u003Ci>Mol. Microbiol.\u003C/i> 114, 480&#x2013;494. doi: 10.1111/mmi.14528 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32426863\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/mmi.14528\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+E.+Dorweiler&#x00026;author=M.+J.+Oddo&#x00026;author=D.+R.+Lyke&#x00026;author=J.+A.+Reilly&#x00026;author=B.+T.+Wisniewski&#x00026;author=E.+E.+Davis&#x00026;publication_year=2020&#x00026;title=The+actin+cytoskeletal+network+plays+a+role+in+yeast+prion+transmission+and+contributes+to+prion+stability&#x00026;journal=Mol.+Microbiol.&#x00026;volume=114&#x00026;pages=480-494\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref13\" id=\"ref13\">\u003C/a>Duennwald, M. L., Echeverria, A., and Shorter, J. (2012). Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans. \u003Ci>PLoS Biol.\u003C/i> 10:e1001346. doi: 10.1371/journal.pbio.1001346 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22723742\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pbio.1001346\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+L.+Duennwald&#x00026;author=A.+Echeverria&#x00026;author=J.+Shorter&#x00026;publication_year=2012&#x00026;title=Small+heat+shock+proteins+potentiate+amyloid+dissolution+by+protein+disaggregases+from+yeast+and+humans&#x00026;journal=PLoS+Biol.&#x00026;volume=10&#x00026;pages=e1001346\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref14\" id=\"ref14\">\u003C/a>Dulle, J. E., Stein, K. C., and True, H. L. (2014). Regulation of the Hsp104 middle domain activity is critical for yeast prion propagation. \u003Ci>PLoS One\u003C/i> 9:e87521. doi: 10.1371/journal.pone.0087521 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24466354\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pone.0087521\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+E.+Dulle&#x00026;author=K.+C.+Stein&#x00026;author=H.+L.+True&#x00026;publication_year=2014&#x00026;title=Regulation+of+the+Hsp104+middle+domain+activity+is+critical+for+yeast+prion+propagation&#x00026;journal=PLoS+One&#x00026;volume=9&#x00026;pages=e87521\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref15\" id=\"ref15\">\u003C/a>Durie, C. L., Lin, J., Scull, N. W., Mack, K. L., Jackrel, M. E., Sweeny, E. A., et al. (2019). Hsp104 and potentiated variants can operate as distinct nonprocessive translocases. \u003Ci>Biophys. J.\u003C/i> 116, 1856&#x2013;1872. doi: 10.1016/j.bpj.2019.03.035 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31027887\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.bpj.2019.03.035\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+L.+Durie&#x00026;author=J.+Lin&#x00026;author=N.+W.+Scull&#x00026;author=K.+L.+Mack&#x00026;author=M.+E.+Jackrel&#x00026;author=E.+A.+Sweeny&#x00026;publication_year=2019&#x00026;title=Hsp104+and+potentiated+variants+can+operate+as+distinct+nonprocessive+translocases&#x00026;journal=Biophys.+J.&#x00026;volume=116&#x00026;pages=1856-1872\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref16\" id=\"ref16\">\u003C/a>Franco, A., Gracia, P., Colom, A., Camino, J. D., Fernandez-Higuero, J. A., Orozco, N., et al. (2021). All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of alpha-synuclein toxic species. \u003Ci>Proc. Natl. Acad. Sci. U. S. A.\u003C/i> 118:e2105548118. doi: 10.1073/pnas.2105548118\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1073/pnas.2105548118\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Franco&#x00026;author=P.+Gracia&#x00026;author=A.+Colom&#x00026;author=J.+D.+Camino&#x00026;author=J.+A.+Fernandez-Higuero&#x00026;author=N.+Orozco&#x00026;publication_year=2021&#x00026;title=All-or-none+amyloid+disassembly+via+chaperone-triggered+fibril+unzipping+favors+clearance+of+alpha-synuclein+toxic+species&#x00026;journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&#x00026;volume=118&#x00026;pages=e2105548118\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref17\" id=\"ref17\">\u003C/a>Gertz, M. A., Benson, M. D., Dyck, P. J., Grogan, M., Coelho, T., Cruz, M., et al. (2015). Diagnosis, prognosis, and therapy of transthyretin amyloidosis. \u003Ci>J. Am. Coll. Cardiol.\u003C/i> 66, 2451&#x2013;2466. doi: 10.1016/j.jacc.2015.09.075\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/j.jacc.2015.09.075\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+A.+Gertz&#x00026;author=M.+D.+Benson&#x00026;author=P.+J.+Dyck&#x00026;author=M.+Grogan&#x00026;author=T.+Coelho&#x00026;author=M.+Cruz&#x00026;publication_year=2015&#x00026;title=Diagnosis+prognosis+and+therapy+of+transthyretin+amyloidosis&#x00026;journal=J.+Am.+Coll.+Cardiol.&#x00026;volume=66&#x00026;pages=2451-2466\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref18\" id=\"ref18\">\u003C/a>Glover, J. R., and Lindquist, S. (1998). Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. \u003Ci>Cells\u003C/i> 94, 73&#x2013;82. doi: 10.1016/S0092-8674(00)81223-4\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/S0092-8674(00)81223-4\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+R.+Glover&#x00026;author=S.+Lindquist&#x00026;publication_year=1998&#x00026;title=Hsp104+Hsp70+and+Hsp40:+a+novel+chaperone+system+that+rescues+previously+aggregated+proteins&#x00026;journal=Cells&#x00026;volume=94&#x00026;pages=73-82\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref19\" id=\"ref19\">\u003C/a>Gomes, R. A., Franco, C., Da Costa, G., Planchon, S., Renaut, J., Ribeiro, R. M., et al. (2012). The proteome response to amyloid protein expression in vivo. \u003Ci>PLoS One\u003C/i> 7:e50123. doi: 10.1371/journal.pone.0050123 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23185553\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pone.0050123\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+A.+Gomes&#x00026;author=C.+Franco&#x00026;author=G.+Da+Costa&#x00026;author=S.+Planchon&#x00026;author=J.+Renaut&#x00026;author=R.+M.+Ribeiro&#x00026;publication_year=2012&#x00026;title=The+proteome+response+to+amyloid+protein+expression+in+vivo&#x00026;journal=PLoS+One&#x00026;volume=7&#x00026;pages=e50123\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref20\" id=\"ref20\">\u003C/a>Greene, L. E., Saba, F., Silberman, R. E., and Zhao, X. (2020). Mechanisms for curing yeast prions. \u003Ci>Int. J. Mol. Sci.\u003C/i> 21:6536. doi: 10.3390/ijms21186536 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32906758\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/ijms21186536\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=L.+E.+Greene&#x00026;author=F.+Saba&#x00026;author=R.+E.+Silberman&#x00026;author=X.+Zhao&#x00026;publication_year=2020&#x00026;title=Mechanisms+for+curing+yeast+prions&#x00026;journal=Int.+J.+Mol.+Sci.&#x00026;volume=21&#x00026;pages=6536\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref21\" id=\"ref21\">\u003C/a>Halfmann, R., and Lindquist, S. (2008). Screening for amyloid aggregation by semi-denaturing detergent-agarose gel electrophoresis. \u003Ci>J. Vis. Exp.\u003C/i> 17:838. doi: 10.3791/838 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/19066511\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3791/838\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Halfmann&#x00026;author=S.+Lindquist&#x00026;publication_year=2008&#x00026;title=Screening+for+amyloid+aggregation+by+semi-denaturing+detergent-agarose+gel+electrophoresis&#x00026;journal=J.+Vis.+Exp.&#x00026;volume=17&#x00026;pages=838\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref22\" id=\"ref22\">\u003C/a>Hammarstrom, P., Wiseman, R. L., Powers, E. T., and Kelly, J. W. (2003). Prevention of transthyretin amyloid disease by changing protein misfolding energetics. \u003Ci>Science\u003C/i> 299, 713&#x2013;716. doi: 10.1126/science.1079589 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/12560553\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1126/science.1079589\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=P.+Hammarstrom&#x00026;author=R.+L.+Wiseman&#x00026;author=E.+T.+Powers&#x00026;author=J.+W.+Kelly&#x00026;publication_year=2003&#x00026;title=Prevention+of+transthyretin+amyloid+disease+by+changing+protein+misfolding+energetics&#x00026;journal=Science&#x00026;volume=299&#x00026;pages=713-716\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref23\" id=\"ref23\">\u003C/a>Jackrel, M. E., DeSantis, M. E., Martinez, B. A., Castellano, L. M., Stewart, R. M., Caldwell, K. A., et al. (2014). Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. \u003Ci>Cells\u003C/i> 156, 170&#x2013;182. doi: 10.1016/j.cell.2013.11.047 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24439375\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.cell.2013.11.047\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+E.+Jackrel&#x00026;author=M.+E.+DeSantis&#x00026;author=B.+A.+Martinez&#x00026;author=L.+M.+Castellano&#x00026;author=R.+M.+Stewart&#x00026;author=K.+A.+Caldwell&#x00026;publication_year=2014&#x00026;title=Potentiated+Hsp104+variants+antagonize+diverse+proteotoxic+misfolding+events&#x00026;journal=Cells&#x00026;volume=156&#x00026;pages=170-182\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref24\" id=\"ref24\">\u003C/a>Karim, A. S., Curran, K. A., and Alper, H. S. (2013). Characterization of plasmid burden and copy number in Saccharomyces cerevisiae for optimization of metabolic engineering applications. \u003Ci>FEMS Yeast Res.\u003C/i> 13, 107&#x2013;116. doi: 10.1111/1567-1364.12016 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23107142\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/1567-1364.12016\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+S.+Karim&#x00026;author=K.+A.+Curran&#x00026;author=H.+S.+Alper&#x00026;publication_year=2013&#x00026;title=Characterization+of+plasmid+burden+and+copy+number+in+Saccharomyces+cerevisiae+for+optimization+of+metabolic+engineering+applications&#x00026;journal=FEMS+Yeast+Res.&#x00026;volume=13&#x00026;pages=107-116\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref25\" id=\"ref25\">\u003C/a>Kazantsev, A., Preisinger, E., Dranovsky, A., Goldgaber, D., and Housman, D. (1999). Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. \u003Ci>Proc. Natl. Acad. Sci. U. S. A.\u003C/i> 96, 11404&#x2013;11409. doi: 10.1073/pnas.96.20.11404 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/10500189\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1073/pnas.96.20.11404\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Kazantsev&#x00026;author=E.+Preisinger&#x00026;author=A.+Dranovsky&#x00026;author=D.+Goldgaber&#x00026;author=D.+Housman&#x00026;publication_year=1999&#x00026;title=Insoluble+detergent-resistant+aggregates+form+between+pathological+and+nonpathological+lengths+of+polyglutamine+in+mammalian+cells&#x00026;journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&#x00026;volume=96&#x00026;pages=11404-11409\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref26\" id=\"ref26\">\u003C/a>Klaips, C. L., Jayaraj, G. G., and Hartl, F. U. (2018). Pathways of cellular proteostasis in aging and disease. \u003Ci>J. Cell Biol.\u003C/i> 217, 51&#x2013;63. doi: 10.1083/jcb.201709072 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29127110\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1083/jcb.201709072\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+L.+Klaips&#x00026;author=G.+G.+Jayaraj&#x00026;author=F.+U.+Hartl&#x00026;publication_year=2018&#x00026;title=Pathways+of+cellular+proteostasis+in+aging+and+disease&#x00026;journal=J.+Cell+Biol.&#x00026;volume=217&#x00026;pages=51-63\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref27\" id=\"ref27\">\u003C/a>Kryndushkin, D. S., Alexandrov, I. M., Ter-Avanesyan, M. D., and Kushnirov, V. V. (2003). Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. \u003Ci>J. Biol. Chem.\u003C/i> 278, 49636&#x2013;49643. doi: 10.1074/jbc.M307996200 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/14507919\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1074/jbc.M307996200\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+S.+Kryndushkin&#x00026;author=I.+M.+Alexandrov&#x00026;author=M.+D.+Ter-Avanesyan&#x00026;author=V.+V.+Kushnirov&#x00026;publication_year=2003&#x00026;title=Yeast+[PSI+]+prion+aggregates+are+formed+by+small+Sup35+polymers+fragmented+by+Hsp104&#x00026;journal=J.+Biol.+Chem.&#x00026;volume=278&#x00026;pages=49636-49643\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref28\" id=\"ref28\">\u003C/a>Labbadia, J., and Morimoto, R. I. (2015). The biology of proteostasis in aging and disease. \u003Ci>Annu. Rev. Biochem.\u003C/i> 84, 435&#x2013;464. doi: 10.1146/annurev-biochem-060614-033955 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25784053\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1146/annurev-biochem-060614-033955\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+Labbadia&#x00026;author=R.+I.+Morimoto&#x00026;publication_year=2015&#x00026;title=The+biology+of+proteostasis+in+aging+and+disease&#x00026;journal=Annu.+Rev.+Biochem.&#x00026;volume=84&#x00026;pages=435-464\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref29\" id=\"ref29\">\u003C/a>Lee, S., Sielaff, B., Lee, J., and Tsai, F. T. (2010). CryoEM structure of Hsp104 and its mechanistic implication for protein disaggregation. \u003Ci>Proc. Natl. Acad. Sci. U. S. A.\u003C/i> 107, 8135&#x2013;8140. doi: 10.1073/pnas.1003572107 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20404203\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1073/pnas.1003572107\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S.+Lee&#x00026;author=B.+Sielaff&#x00026;author=J.+Lee&#x00026;author=F.+T.+Tsai&#x00026;publication_year=2010&#x00026;title=CryoEM+structure+of+Hsp104+and+its+mechanistic+implication+for+protein+disaggregation&#x00026;journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&#x00026;volume=107&#x00026;pages=8135-8140\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref30\" id=\"ref30\">\u003C/a>Liebman, S. W., Bagriantsev, S. N., and Derkatch, I. L. (2006). Biochemical and genetic methods for characterization of [PIN+] prions in yeast. \u003Ci>Methods\u003C/i> 39, 23&#x2013;34. doi: 10.1016/j.ymeth.2006.04.010 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/16793281\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.ymeth.2006.04.010\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S.+W.+Liebman&#x00026;author=S.+N.+Bagriantsev&#x00026;author=I.+L.+Derkatch&#x00026;publication_year=2006&#x00026;title=Biochemical+and+genetic+methods+for+characterization+of+[PIN+]+prions+in+yeast&#x00026;journal=Methods&#x00026;volume=39&#x00026;pages=23-34\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref31\" id=\"ref31\">\u003C/a>Liu, Y. H., Han, Y. L., Song, J., Wang, Y., Jing, Y. Y., Shi, Q., et al. (2011). Heat shock protein 104 inhibited the fibrillization of prion peptide 106-126 and disassembled prion peptide 106-126 fibrils in vitro. \u003Ci>Int. J. Biochem. Cell Biol.\u003C/i> 43, 768&#x2013;774. doi: 10.1016/j.biocel.2011.01.022 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/21296677\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.biocel.2011.01.022\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y.+H.+Liu&#x00026;author=Y.+L.+Han&#x00026;author=J.+Song&#x00026;author=Y.+Wang&#x00026;author=Y.+Y.+Jing&#x00026;author=Q.+Shi&#x00026;publication_year=2011&#x00026;title=Heat+shock+protein+104+inhibited+the+fibrillization+of+prion+peptide+106-126+and+disassembled+prion+peptide+106-126+fibrils+in+vitro&#x00026;journal=Int.+J.+Biochem.+Cell+Biol.&#x00026;volume=43&#x00026;pages=768-774\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref32\" id=\"ref32\">\u003C/a>Lo Bianco, C., Shorter, J., Regulier, E., Lashuel, H., Iwatsubo, T., Lindquist, S., et al. (2008). Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease. \u003Ci>J. Clin. Invest.\u003C/i> 118, 3087&#x2013;3097. doi: 10.1172/JCI35781 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/18704197\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1172/JCI35781\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+Lo+Bianco&#x00026;author=J.+Shorter&#x00026;author=E.+Regulier&#x00026;author=H.+Lashuel&#x00026;author=T.+Iwatsubo&#x00026;author=S.+Lindquist&#x00026;publication_year=2008&#x00026;title=Hsp104+antagonizes+alpha-synuclein+aggregation+and+reduces+dopaminergic+degeneration+in+a+rat+model+of+Parkinson+disease&#x00026;journal=J.+Clin.+Invest.&#x00026;volume=118&#x00026;pages=3087-3097\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref33\" id=\"ref33\">\u003C/a>Manogaran, A. L., Hong, J. Y., Hufana, J., Tyedmers, J., Lindquist, S., and Liebman, S. W. (2011). Prion formation and polyglutamine aggregation are controlled by two classes of genes. \u003Ci>PLoS Genet.\u003C/i> 7:e1001386. doi: 10.1371/journal.pgen.1001386 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/21625618\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pgen.1001386\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+L.+Manogaran&#x00026;author=J.+Y.+Hong&#x00026;author=J.+Hufana&#x00026;author=J.+Tyedmers&#x00026;author=S.+Lindquist&#x00026;author=S.+W.+Liebman&#x00026;publication_year=2011&#x00026;title=Prion+formation+and+polyglutamine+aggregation+are+controlled+by+two+classes+of+genes&#x00026;journal=PLoS+Genet.&#x00026;volume=7&#x00026;pages=e1001386\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref34\" id=\"ref34\">\u003C/a>March, Z. M., Mack, K. L., and Shorter, J. (2019). AAA+ protein-based technologies to counter neurodegenerative disease. \u003Ci>Biophys. J.\u003C/i> 116, 1380&#x2013;1385. doi: 10.1016/j.bpj.2019.03.007 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30952364\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.bpj.2019.03.007\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Z.+M.+March&#x00026;author=K.+L.+Mack&#x00026;author=J.+Shorter&#x00026;publication_year=2019&#x00026;title=AAA++protein-based+technologies+to+counter+neurodegenerative+disease&#x00026;journal=Biophys.+J.&#x00026;volume=116&#x00026;pages=1380-1385\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref35\" id=\"ref35\">\u003C/a>March, Z. M., Sweeney, K., Kim, H., Yan, X., Castellano, L. M., Jackrel, M. E., et al. (2020). Therapeutic genetic variation revealed in diverse Hsp104 homologs. \u003Ci>eLife\u003C/i> 9:e57457.\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Z.+M.+March&#x00026;author=K.+Sweeney&#x00026;author=H.+Kim&#x00026;author=X.+Yan&#x00026;author=L.+M.+Castellano&#x00026;author=M.+E.+Jackrel&#x00026;publication_year=2020&#x00026;title=Therapeutic+genetic+variation+revealed+in+diverse+Hsp104+homologs&#x00026;journal=eLife&#x00026;volume=9&#x00026;pages=e57457\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref36\" id=\"ref36\">\u003C/a>Misumi, Y., Ando, Y., Goncalves, N. P., and Saraiva, M. J. (2013). Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis. \u003Ci>Lab. Investig.\u003C/i> 93, 911&#x2013;920. doi: 10.1038/labinvest.2013.83 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23817086\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/labinvest.2013.83\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y.+Misumi&#x00026;author=Y.+Ando&#x00026;author=N.+P.+Goncalves&#x00026;author=M.+J.+Saraiva&#x00026;publication_year=2013&#x00026;title=Fibroblasts+endocytose+and+degrade+transthyretin+aggregates+in+transthyretin-related+amyloidosis&#x00026;journal=Lab.+Investig.&#x00026;volume=93&#x00026;pages=911-920\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref37\" id=\"ref37\">\u003C/a>Mogk, A., Bukau, B., and Kampinga, H. H. (2018). Cellular handling of protein aggregates by disaggregation machines. \u003Ci>Mol. Cell\u003C/i> 69, 214&#x2013;226. doi: 10.1016/j.molcel.2018.01.004 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29351843\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.molcel.2018.01.004\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Mogk&#x00026;author=B.+Bukau&#x00026;author=H.+H.+Kampinga&#x00026;publication_year=2018&#x00026;title=Cellular+handling+of+protein+aggregates+by+disaggregation+machines&#x00026;journal=Mol.+Cell&#x00026;volume=69&#x00026;pages=214-226\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref38\" id=\"ref38\">\u003C/a>Naeimi, W. R., and Serio, T. R. (2022). Beyond amyloid fibers: accumulation, biological relevance, and regulation of higher-order prion architectures. \u003Ci>Viruses\u003C/i> 14:1635. doi: 10.3390/v14081635 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35893700\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/v14081635\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=W.+R.+Naeimi&#x00026;author=T.+R.+Serio&#x00026;publication_year=2022&#x00026;title=Beyond+amyloid+fibers:+accumulation+biological+relevance+and+regulation+of+higher-order+prion+architectures&#x00026;journal=Viruses&#x00026;volume=14&#x00026;pages=1635\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref39\" id=\"ref39\">\u003C/a>Ness, F., Cox, B. S., Wongwigkarn, J., Naeimi, W. R., and Tuite, M. F. (2017). Over-expression of the molecular chaperone Hsp104 in Saccharomyces cerevisiae results in the malpartition of [PSI(+)] propagons. \u003Ci>Mol. Microbiol.\u003C/i> 104, 125&#x2013;143. doi: 10.1111/mmi.13617 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28073182\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/mmi.13617\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=F.+Ness&#x00026;author=B.+S.+Cox&#x00026;author=J.+Wongwigkarn&#x00026;author=W.+R.+Naeimi&#x00026;author=M.+F.+Tuite&#x00026;publication_year=2017&#x00026;title=Over-expression+of+the+molecular+chaperone+Hsp104+in+Saccharomyces+cerevisiae+results+in+the+malpartition+of+[PSI(+)]+propagons&#x00026;journal=Mol.+Microbiol.&#x00026;volume=104&#x00026;pages=125-143\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref40\" id=\"ref40\">\u003C/a>Nizhnikov, A. A., Alexandrov, A. I., Ryzhova, T. A., Mitkevich, O. V., Dergalev, A. A., Ter-Avanesyan, M. D., et al. (2014). Proteomic screening for amyloid proteins. \u003Ci>PLoS One\u003C/i> 9:e116003. doi: 10.1371/journal.pone.0116003 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25549323\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pone.0116003\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+A.+Nizhnikov&#x00026;author=A.+I.+Alexandrov&#x00026;author=T.+A.+Ryzhova&#x00026;author=O.+V.+Mitkevich&#x00026;author=A.+A.+Dergalev&#x00026;author=M.+D.+Ter-Avanesyan&#x00026;publication_year=2014&#x00026;title=Proteomic+screening+for+amyloid+proteins&#x00026;journal=PLoS+One&#x00026;volume=9&#x00026;pages=e116003\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref41\" id=\"ref41\">\u003C/a>Parsell, D. A., Kowal, A. S., Singer, M. A., and Lindquist, S. (1994). Protein disaggregation mediated by heat-shock protein Hsp104. \u003Ci>Nature\u003C/i> 372, 475&#x2013;478. doi: 10.1038/372475a0 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/7984243\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/372475a0\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+A.+Parsell&#x00026;author=A.+S.+Kowal&#x00026;author=M.+A.+Singer&#x00026;author=S.+Lindquist&#x00026;publication_year=1994&#x00026;title=Protein+disaggregation+mediated+by+heat-shock+protein+Hsp104&#x00026;journal=Nature&#x00026;volume=372&#x00026;pages=475-478\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref42\" id=\"ref42\">\u003C/a>Paushkin, S. V., Kushnirov, V. V., Smirnov, V. N., and Ter-Avanesyan, M. D. (1996). Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. \u003Ci>EMBO J.\u003C/i> 15, 3127&#x2013;3134. doi: 10.1002/j.1460-2075.1996.tb00675.x \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/8670813\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/j.1460-2075.1996.tb00675.x\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S.+V.+Paushkin&#x00026;author=V.+V.+Kushnirov&#x00026;author=V.+N.+Smirnov&#x00026;author=M.+D.+Ter-Avanesyan&#x00026;publication_year=1996&#x00026;title=Propagation+of+the+yeast+prion-like+[psi+]+determinant+is+mediated+by+oligomerization+of+the+SUP35-encoded+polypeptide+chain+release+factor&#x00026;journal=EMBO+J.&#x00026;volume=15&#x00026;pages=3127-3134\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref43\" id=\"ref43\">\u003C/a>Reixach, N., Deechongkit, S., Jiang, X., Kelly, J. W., and Buxbaum, J. N. (2004). Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. \u003Ci>Proc. Natl. Acad. Sci. U. S. A.\u003C/i> 101, 2817&#x2013;2822. doi: 10.1073/pnas.0400062101 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/14981241\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1073/pnas.0400062101\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=N.+Reixach&#x00026;author=S.+Deechongkit&#x00026;author=X.+Jiang&#x00026;author=J.+W.+Kelly&#x00026;author=J.+N.+Buxbaum&#x00026;publication_year=2004&#x00026;title=Tissue+damage+in+the+amyloidoses:+transthyretin+monomers+and+nonnative+oligomers+are+the+major+cytotoxic+species+in+tissue+culture&#x00026;journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&#x00026;volume=101&#x00026;pages=2817-2822\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref44\" id=\"ref44\">\u003C/a>Santos, S. D., Fernandes, R., and Saraiva, M. J. (2010). The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems. \u003Ci>Neurobiol. Aging\u003C/i> 31, 280&#x2013;289. doi: 10.1016/j.neurobiolaging.2008.04.001 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/18485534\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.neurobiolaging.2008.04.001\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S.+D.+Santos&#x00026;author=R.+Fernandes&#x00026;author=M.+J.+Saraiva&#x00026;publication_year=2010&#x00026;title=The+heat+shock+response+modulates+transthyretin+deposition+in+the+peripheral+and+autonomic+nervous+systems&#x00026;journal=Neurobiol.+Aging&#x00026;volume=31&#x00026;pages=280-289\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref45\" id=\"ref45\">\u003C/a>Satpute-Krishnan, P., Langseth, S. X., and Serio, T. R. (2007). Hsp104-dependent remodeling of prion complexes mediates protein-only inheritance. \u003Ci>PLoS Biol.\u003C/i> 5:e24. doi: 10.1371/journal.pbio.0050024 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/17253904\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pbio.0050024\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=P.+Satpute-Krishnan&#x00026;author=S.+X.+Langseth&#x00026;author=T.+R.+Serio&#x00026;publication_year=2007&#x00026;title=Hsp104-dependent+remodeling+of+prion+complexes+mediates+protein-only+inheritance&#x00026;journal=PLoS+Biol.&#x00026;volume=5&#x00026;pages=e24\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref46\" id=\"ref46\">\u003C/a>Schirmer, E. C., Homann, O. R., Kowal, A. S., and Lindquist, S. (2004). Dominant gain-of-function mutations in Hsp104p reveal crucial roles for the middle region. \u003Ci>Mol. Biol. Cell\u003C/i> 15, 2061&#x2013;2072. doi: 10.1091/mbc.e02-08-0502 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/14978213\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1091/mbc.e02-08-0502\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=E.+C.+Schirmer&#x00026;author=O.+R.+Homann&#x00026;author=A.+S.+Kowal&#x00026;author=S.+Lindquist&#x00026;publication_year=2004&#x00026;title=Dominant+gain-of-function+mutations+in+Hsp104p+reveal+crucial+roles+for+the+middle+region&#x00026;journal=Mol.+Biol.+Cell&#x00026;volume=15&#x00026;pages=2061-2072\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref47\" id=\"ref47\">\u003C/a>Scior, A., Buntru, A., Arnsburg, K., Ast, A., Iburg, M., Juenemann, K., et al. (2018). Complete suppression of Htt fibrilization and disaggregation of Htt fibrils by a trimeric chaperone complex. \u003Ci>EMBO J.\u003C/i> 37, 282&#x2013;299. doi: 10.15252/embj.201797212 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29212816\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.15252/embj.201797212\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Scior&#x00026;author=A.+Buntru&#x00026;author=K.+Arnsburg&#x00026;author=A.+Ast&#x00026;author=M.+Iburg&#x00026;author=K.+Juenemann&#x00026;publication_year=2018&#x00026;title=Complete+suppression+of+Htt+fibrilization+and+disaggregation+of+Htt+fibrils+by+a+trimeric+chaperone+complex&#x00026;journal=EMBO+J.&#x00026;volume=37&#x00026;pages=282-299\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref48\" id=\"ref48\">\u003C/a>Sharma, J., Wisniewski, B. T., Paulson, E., Obaoye, J. O., Merrill, S. J., and Manogaran, A. L. (2017). De novo [PSI +] prion formation involves multiple pathways to form infectious oligomers. \u003Ci>Sci. Rep.\u003C/i> 7:76. doi: 10.1038/s41598-017-00135-6 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28250435\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41598-017-00135-6\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+Sharma&#x00026;author=B.+T.+Wisniewski&#x00026;author=E.+Paulson&#x00026;author=J.+O.+Obaoye&#x00026;author=S.+J.+Merrill&#x00026;author=A.+L.+Manogaran&#x00026;publication_year=2017&#x00026;title=De+novo+[PSI++]+prion+formation+involves+multiple+pathways+to+form+infectious+oligomers&#x00026;journal=Sci.+Rep.&#x00026;volume=7&#x00026;pages=76\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref49\" id=\"ref49\">\u003C/a>Sherman, F., Fink, G.R., and Hicks, J.B. (1986). \u003Ci>Methods in Yeast Genetics.\u003C/i> Plainview, New York: Cold Spring Harbor Lab.\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?author=F.+Sherman&#x00026;author=G.R.+Fink&#x00026;author=J.B.+Hicks&#x00026;publication_year=1986&#x00026;journal=Methods+in+Yeast+Genetics.&#x00026;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref50\" id=\"ref50\">\u003C/a>Shorter, J., and Lindquist, S. (2004). Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. \u003Ci>Science\u003C/i> 304, 1793&#x2013;1797. doi: 10.1126/science.1098007 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/15155912\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1126/science.1098007\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+Shorter&#x00026;author=S.+Lindquist&#x00026;publication_year=2004&#x00026;title=Hsp104+catalyzes+formation+and+elimination+of+self-replicating+Sup35+prion+conformers&#x00026;journal=Science&#x00026;volume=304&#x00026;pages=1793-1797\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref51\" id=\"ref51\">\u003C/a>Sielaff, B., and Tsai, F. T. (2010). The M-domain controls Hsp104 protein remodeling activity in an Hsp70/Hsp40-dependent manner. \u003Ci>J. Mol. Biol.\u003C/i> 402, 30&#x2013;37. doi: 10.1016/j.jmb.2010.07.030 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20654624\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.jmb.2010.07.030\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=B.+Sielaff&#x00026;author=F.+T.+Tsai&#x00026;publication_year=2010&#x00026;title=The+M-domain+controls+Hsp104+protein+remodeling+activity+in+an+Hsp70/Hsp40-dependent+manner&#x00026;journal=J.+Mol.+Biol.&#x00026;volume=402&#x00026;pages=30-37\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref52\" id=\"ref52\">\u003C/a>Surguchov, A. (2021). Invertebrate models untangle the mechanism of neurodegeneration in Parkinson's disease. \u003Ci>Cells\u003C/i> 10:407. doi: 10.3390/cells10020407 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33669308\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/cells10020407\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Surguchov&#x00026;publication_year=2021&#x00026;title=Invertebrate+models+untangle+the+mechanism+of+neurodegeneration+in+Parkinson's+disease&#x00026;journal=Cells&#x00026;volume=10&#x00026;pages=407\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref53\" id=\"ref53\">\u003C/a>Tittelmeier, J., Nachman, E., and Nussbaum-Krammer, C. (2020). Molecular chaperones: a double-edged sword in neurodegenerative diseases. \u003Ci>Front. Aging Neurosci.\u003C/i> 12:581374. doi: 10.3389/fnagi.2020.581374 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33132902\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fnagi.2020.581374\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+Tittelmeier&#x00026;author=E.+Nachman&#x00026;author=C.+Nussbaum-Krammer&#x00026;publication_year=2020&#x00026;title=Molecular+chaperones:+a+double-edged+sword+in+neurodegenerative+diseases&#x00026;journal=Front.+Aging+Neurosci.&#x00026;volume=12&#x00026;pages=581374\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref54\" id=\"ref54\">\u003C/a>Verma, M., Girdhar, A., Patel, B., Ganguly, N. K., Kukreti, R., and Taneja, V. (2018). Q-rich yeast prion [PSI(+)] accelerates aggregation of transthyretin, a non-Q-rich human protein. \u003Ci>Front. Mol. Neurosci.\u003C/i> 11:75. doi: 10.3389/fnmol.2018.00075 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29593496\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fnmol.2018.00075\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Verma&#x00026;author=A.+Girdhar&#x00026;author=B.+Patel&#x00026;author=N.+K.+Ganguly&#x00026;author=R.+Kukreti&#x00026;author=V.+Taneja&#x00026;publication_year=2018&#x00026;title=Q-rich+yeast+prion+[PSI(+)]+accelerates+aggregation+of+transthyretin+a+non-Q-rich+human+protein&#x00026;journal=Front.+Mol.+Neurosci.&#x00026;volume=11&#x00026;pages=75\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref55\" id=\"ref55\">\u003C/a>Wentink, A., Nussbaum-Krammer, C., and Bukau, B. (2019). Modulation of amyloid states by molecular chaperones. \u003Ci>Cold Spring Harb. Perspect Biol.\u003C/i> 11:a033969. doi: 10.1101/cshperspect.a033969\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1101/cshperspect.a033969\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Wentink&#x00026;author=C.+Nussbaum-Krammer&#x00026;author=B.+Bukau&#x00026;publication_year=2019&#x00026;title=Modulation+of+amyloid+states+by+molecular+chaperones&#x00026;journal=Cold+Spring+Harb.+Perspect+Biol.&#x00026;volume=11&#x00026;pages=a033969\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref56\" id=\"ref56\">\u003C/a>Winkler, J., Tyedmers, J., Bukau, B., and Mogk, A. (2012). Hsp70 targets Hsp100 chaperones to substrates for protein disaggregation and prion fragmentation. \u003Ci>J. Cell Biol.\u003C/i> 198, 387&#x2013;404. doi: 10.1083/jcb.201201074 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22869599\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1083/jcb.201201074\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+Winkler&#x00026;author=J.+Tyedmers&#x00026;author=B.+Bukau&#x00026;author=A.+Mogk&#x00026;publication_year=2012&#x00026;title=Hsp70+targets+Hsp100+chaperones+to+substrates+for+protein+disaggregation+and+prion+fragmentation&#x00026;journal=J.+Cell+Biol.&#x00026;volume=198&#x00026;pages=387-404\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref57\" id=\"ref57\">\u003C/a>Zhao, X., Rodriguez, R., Silberman, R. E., Ahearn, J. M., Saidha, S., Cummins, K. C., et al. (2017). Heat shock protein 104 (Hsp104)-mediated curing of [PSI(+)] yeast prions depends on both [PSI(+)] conformation and the properties of the Hsp104 homologs. \u003Ci>J. Biol. Chem.\u003C/i> 292, 8630&#x2013;8641. doi: 10.1074/jbc.M116.770719 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28373280\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1074/jbc.M116.770719\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=X.+Zhao&#x00026;author=R.+Rodriguez&#x00026;author=R.+E.+Silberman&#x00026;author=J.+M.+Ahearn&#x00026;author=S.+Saidha&#x00026;author=K.+C.+Cummins&#x00026;publication_year=2017&#x00026;title=Heat+shock+protein+104+(Hsp104)-mediated+curing+of+[PSI(+)]+yeast+prions+depends+on+both+[PSI(+)]+conformation+and+the+properties+of+the+Hsp104+homologs&#x00026;journal=J.+Biol.+Chem.&#x00026;volume=292&#x00026;pages=8630-8641\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref58\" id=\"ref58\">\u003C/a>Zimmermann, A., Hofer, S., Pendl, T., Kainz, K., Madeo, F., and Carmona-Gutierrez, D. (2018). Yeast as a tool to identify anti-aging compounds. \u003Ci>FEMS Yeast Res.\u003C/i> 18:foy020. doi: 10.1093/femsyr/foy020 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29905792\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/femsyr/foy020\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Zimmermann&#x00026;author=S.+Hofer&#x00026;author=T.+Pendl&#x00026;author=K.+Kainz&#x00026;author=F.+Madeo&#x00026;author=D.+Carmona-Gutierrez&#x00026;publication_year=2018&#x00026;title=Yeast+as+a+tool+to+identify+anti-aging+compounds&#x00026;journal=FEMS+Yeast+Res.&#x00026;volume=18&#x00026;pages=foy020\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003C/div> \u003Cdiv class=\"thinLineM20\">\u003C/div> \u003Cdiv class=\"AbstractSummary\">\n\u003Cp>\u003Cspan>Keywords:\u003C/span> Hsp104, transthyretin, molecular chaperone, protein aggregation, transthyretin amyloidosis, amyloid, polyneuropathy, aging\u003C/p>\n\u003Cp>\u003Cspan>Citation:\u003C/span> Knier AS, Davis EE, Buchholz HE, Dorweiler JE, Flannagan LE and Manogaran AL (2022) The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation. \u003Ci>Front. Mol. Neurosci\u003C/i>. 15:1050472. doi: 10.3389/fnmol.2022.1050472\u003C/p>\n\u003Cp class=\"timestamps\">\u003Cspan>Received:\u003C/span> 21 September 2022; \u003Cspan>Accepted:\u003C/span> 19 October 2022;\u003Cbr> \u003Cspan>Published:\u003C/span> 16 December 2022.\u003C/p> \u003Cdiv>\n\u003Cp>Edited by:\u003C/p> \u003Ca href=\"https://loop.frontiersin.org/people/122913/overview\">Andrei Surguchov\u003C/a>, University of Kansas Medical Center, United States\u003C/div> \u003Cdiv>\n\u003Cp>Reviewed by:\u003C/p> \u003Ca href=\"https://loop.frontiersin.org/people/363601/overview\">Irina G. Sourgoutcheva\u003C/a>, University of Kansas Medical Center, United States\u003Cbr> \u003Ca href=\"https://loop.frontiersin.org/people/608012/overview\">Maria Ros&#x00E1;rio Almeida\u003C/a>, Universidade do Porto, Portugal\u003C/div>\n\u003Cp>\u003Cspan>Copyright\u003C/span> &#x000A9; 2022 Knier, Davis, Buchholz, Dorweiler, Flannagan and Manogaran. This is an open-access article distributed under the terms of the \u003Ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">Creative Commons Attribution License (CC BY)\u003C/a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\u003C/p>\n\u003Cp>\u003Cspan>&#x0002A;Correspondence:\u003C/span> Anita L. Manogaran, \u003Ca id=\"encmail\">YW5pdGEubWFub2dhcmFuQG1hcnF1ZXR0ZS5lZHU=\u003C/a>\u003C/p> \u003Cdiv class=\"clear\">\u003C/div> \u003C/div>","\u003Cul class=\"flyoutJournal\"> \u003Cli>\u003Ca href=\"#h1\">Abstract\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h2\">Introduction\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h3\">Materials and methods\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h4\">Results\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h5\">Discussion\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h6\">Data availability statement\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h7\">Author contributions\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h8\">Funding\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h9\">Acknowledgments\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h10\">Conflict of interest\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h11\">Publisher&#x2019;s note\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h12\">Supplementary material\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h13\">References\u003C/a>\u003C/li> \u003C/ul>",[623,628,634,637,643],{"name":624,"fileServerPackageEntryId":19,"fileServerId":625,"fileServerVersionNumber":361,"type":626},"EPUB.epub","1050472/epub",{"code":627,"name":627},"EPUB",{"name":629,"fileServerPackageEntryId":630,"fileServerId":631,"fileServerVersionNumber":361,"type":632},"fnmol-15-1050472.pdf","fnmol-15-1050472/fnmol-15-1050472.pdf","1050472/pubmed-zip",{"code":633,"name":633},"PDF",{"name":629,"fileServerPackageEntryId":19,"fileServerId":635,"fileServerVersionNumber":361,"type":636},"1050472/publishers-proof/pdf",{"code":633,"name":633},{"name":638,"fileServerPackageEntryId":639,"fileServerId":631,"fileServerVersionNumber":361,"type":640},"fnmol-15-1050472.xml","fnmol-15-1050472/fnmol-15-1050472.xml",{"code":641,"name":642},"NLM_XML","XML",{"name":644,"fileServerPackageEntryId":19,"fileServerId":645,"fileServerVersionNumber":361,"type":646},"Provisional PDF.pdf","1050472/provisional-pdf",{"code":633,"name":633},"v3",{"title":649,"link":650,"meta":654,"script":762},"Frontiers | The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation",[651],{"rel":652,"href":653},"canonical","https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/full",[655,658,661,663,666,670,673,677,680,683,686,688,690,692,694,696,699,702,704,707,709,711,714,717,720,723,726,730,734,737,739,742,744,747,749,752,754,757,759],{"hid":656,"property":656,"name":656,"content":657},"description","Patients with the fatal disorder Transthyretin Amyloidosis (ATTR) experience polyneuropathy through the progressive destruction of peripheral nervous tissue....",{"hid":659,"property":659,"name":660,"content":649},"og:title","title",{"hid":662,"property":662,"name":656,"content":657},"og:description",{"hid":664,"name":664,"content":665},"keywords","Hsp104,transthyretin,molecular chaperone,protein aggregation,transthyretin amyloidosis,Amyloid,polyneuropathy,Aging",{"hid":667,"property":667,"name":668,"content":669},"og:site_name","site_name","Frontiers",{"hid":671,"property":671,"name":354,"content":672},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/1050472/fnmol-15-1050472-HTML/image_m/fnmol-15-1050472-g001.jpg",{"hid":674,"property":674,"name":675,"content":676},"og:type","type","article",{"hid":678,"property":678,"name":679,"content":653},"og:url","url",{"hid":681,"name":681,"content":682},"twitter:card","summary_large_image",{"hid":684,"name":684,"content":685},"citation_volume","15",{"hid":687,"name":687,"content":116},"citation_journal_title",{"hid":689,"name":689,"content":669},"citation_publisher",{"hid":691,"name":691,"content":604},"citation_journal_abbrev",{"hid":693,"name":693,"content":605},"citation_issn",{"hid":695,"name":695,"content":506},"citation_doi",{"hid":697,"name":697,"content":698},"citation_firstpage","1050472",{"hid":700,"name":700,"content":701},"citation_language","English",{"hid":703,"name":703,"content":507},"citation_title",{"hid":705,"name":705,"content":706},"citation_keywords","Hsp104; transthyretin; molecular chaperone; protein aggregation; transthyretin amyloidosis; Amyloid; polyneuropathy; Aging",{"hid":708,"name":708,"content":512},"citation_abstract",{"hid":710,"name":710,"content":521},"citation_article_type",{"hid":712,"name":712,"content":713},"citation_pdf_url","https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/pdf",{"hid":715,"name":715,"content":716},"citation_xml_url","https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1050472/xml",{"hid":718,"name":718,"content":719},"citation_fulltext_world_readable","yes",{"hid":721,"name":721,"content":722},"citation_online_date","2022/10/19",{"hid":724,"name":724,"content":725},"citation_publication_date","2022/12/16",{"hid":727,"name":728,"content":729},"citation_author_0","citation_author","Knier, Adam S. ",{"hid":731,"name":732,"content":733},"citation_author_institution_0","citation_author_institution","Department of Biological Sciences, Marquette University, United States",{"hid":735,"name":728,"content":736},"citation_author_1","Davis, Emily E. ",{"hid":738,"name":732,"content":733},"citation_author_institution_1",{"hid":740,"name":728,"content":741},"citation_author_2","Buchholz, Hannah E. ",{"hid":743,"name":732,"content":733},"citation_author_institution_2",{"hid":745,"name":728,"content":746},"citation_author_3","Dorweiler, Jane E. ",{"hid":748,"name":732,"content":733},"citation_author_institution_3",{"hid":750,"name":728,"content":751},"citation_author_4","Flannagan, Lauryn E. ",{"hid":753,"name":732,"content":733},"citation_author_institution_4",{"hid":755,"name":728,"content":756},"citation_author_5","Manogaran, Anita L. ",{"hid":758,"name":732,"content":733},"citation_author_institution_5",{"hid":760,"name":760,"content":761},"dc.identifier","doi:10.3389/fnmol.2022.1050472",[763,766,768,770,772],{"src":764,"body":13,"type":765,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":767,"body":13,"type":765,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML",{"src":769,"body":13,"type":765,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":771,"body":13,"type":765,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fnmol.2022.1050472?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":773,"body":13,"type":765,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articleHubSlug":19,"articleHubPage":775,"articleHubArticlesList":776,"canJournalHasArticleHub":295,"articleDoiList":777},{},[],[],{"title":19,"image":-1,"breadcrumbs":779,"linksCollection":780,"metricsCollection":782},[],{"total":358,"items":781},[],{"total":358,"items":783},[]]</script>
<script>window.__NUXT__={};window.__NUXT__.config={public:{isDevMode:false,appName:"article-pages-2024",baseUrl:"https://www.frontiersin.org",domain:"frontiersin.org",loopUrl:"https://loop.frontiersin.org",ssMainDomain:"frontiersin.org",contentfulUrl:"https://graphql.contentful.com/content/v1/spaces",spaceId:1,spaceName:"Frontiers",liveSpaceId:1,tenantLogoUrl:"",frontiersGraphUrl:"https://apollo-federation-gateway.frontiersin.org",registrationApiUrl:"https://onboarding-ui.frontiersin.org",emailDigestApiUrl:"https://api-email-digest.frontiersin.org",journalFilesApiUrl:"https://files-journal-api.frontiersin.org",publicPagesFilesUrl:"https://public-pages-files-2025.frontiersin.org",searchApiUrl:"https://search-api.frontiersin.org",productionForumApiUrl:"https://production-forum-api-v2.frontiersin.org",gtmServerUrl:"https://tag-manager.frontiersin.org",gtmId:"GTM-M322FV2",gtmAuth:"owVbWxfaJr21yQv1fe1cAQ",gtmPreview:"env-1",figsharePluginUrl:"https://widgets.figshare.com/static/figshare.js",figshareApiUrl:"https://api.figshare.com/v2/collections/search",figshareTimeout:3000,crossmarkPublishedDate:"2015/08/24",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",googleRecaptchaKeyName:"FrontiersRecaptchaV2",faviconSize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png",faviconSize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png",faviconSize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantFavicon-Frontiers.png",faviconSize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantFavicon-Frontiers.png",faviconSize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantFavicon-Frontiers.png",socialMediaImg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/Guidelines-Frontiers_Logo_1200x628_1-91to1.png",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"},{\"articleTypeId\":30,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",acceptedArticleExcludedJournalIds:"'[2766,979]'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase>> article",settingsFeaturesSwitchers:"'{\"displayTitlePillLabels\":true,\"displayRelatedArticlesBox\":true,\"showEditors\":true,\"showReviewers\":true,\"showLoopImpactLink\":true,\"enableFigshare\":false}'\n",journalsWithArticleHub:"'{\"strings\":[\"science\"]}'\n",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"Frontiers\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my frontiers\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"research topic management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"research topic\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"research topics\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Topic Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Community Reviewer\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"topic\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"topic summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country/region\",\"frontiersDefaultTerm\":\"country/region\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries/regions\",\"frontiersDefaultTerm\":\"countries/regions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Topic Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Community Reviewers\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"endorse\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"endorsed\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"endorse publication\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"endorsed publication\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"editor role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"editor roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"editorial role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"editorial roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"call_for_paper\",\"tenantTerm\":\"Call for paper\",\"frontiersDefaultTerm\":\"Call for paper\",\"category\":\"Label\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Journal Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"submissions_team\",\"tenantTerm\":\"Journal Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinator\",\"tenantTerm\":\"topic coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"topic_coordinators\",\"tenantTerm\":\"topic coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"},{\"sequenceNumber\":274,\"key\":\"frontiers_journal_team\",\"tenantTerm\":\"frontiers journal team\",\"frontiersDefaultTerm\":\"frontiers journal team\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantTerm\":\"RT:IC Submission\",\"frontiersDefaultTerm\":\"RT:IC Submission\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantTerm\":\"RT:IC Submission participant\",\"frontiersDefaultTerm\":\"RT:IC Submission participant\",\"category\":\"Label (Role)\"}]}'\n",impactGtmId:"GTM-NJF2ML9B",impactGtmAuth:"fYo-7NoDm9w37QgFMs03SA",impactGtmPreview:"env-1",impactGoogleMapsApiKey:"AIzaSyCTEhX2EU8PWfi86GW9FI00FTcyKk6Ifr8",qualtricsV4ToV3:"'{\"enabled\":true,\"interceptId\":\"SI_er0E2ze69Oz8Yn4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsUmux:"'{\"enabled\":false,\"interceptId\":\"SI_89fPHY3eTxQBwtU\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsContinuousBrand:"'{\"enabled\":true,\"interceptId\":\"SI_9ZuT94UT81FcRh4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",defaultArticleTemplate:"v3"},app:{baseURL:"/",buildId:"ed555f16-85f7-4f41-8f2f-451827c59120",buildAssetsDir:"ap-2024/_nuxt",cdnURL:""}}</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" type="text/javascript" async></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" type="text/javascript" async></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" type="text/javascript" async></script>
<script src="https://api.altmetric.com/v1/doi/10.3389/fnmol.2022.1050472?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15" type="text/javascript" async></script>
<script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript" async></script></body></html>